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Contusion injuries cause significant muscle damage, that effects skeletal muscle in its entirety, 
including the innervating motorneuron and the myofibre’s neuromuscular junction (NMJ). Upon 
injury, the acetylcholine receptors (AChR) scatter and disintegrate yet reaggregate over time to re-
create an optimally functioning motor end-plate. This process involves the upregulation of the 
receptor subunits’ – α, β, γ, δ, ε – expression to varying degrees. 
Satellite cells are key role players in muscle regeneration, but studies linking the regenerative roles 
of satellite cells to the rehabilitating NMJ are limited. Moreover, the majority of studies on 
acetylcholine receptors investigate the effects of a denervation event rather than an injury that 
affects the muscle tissues in their entirety. Bromodeoxyuridine (BrdU) is a useful tool in labelling and 
tracking proliferated satellite cells. 
Two experimental groups (referred to as PCR and BrdU group) of male BALB/C mice were subjected 
to a hind limb contusion injury induced with the mass-drop technique. Alzet® mini-osmotic pumps 
delivering BrdU (50 mM, 1.0 μl.h−1 release rate) were inserted into the BrdU group prior to injury. 
Animals were sacrificed at days 1, 3, 5, 7, 10 and 14 post injury. Both injured and contralateral, non-
injured gastrocnemius muscles were collected. qPCR was performed for AChR-γ and AChR-ε mRNA 
expression on the muscles of the PCR mice. 
Muscles from the BrdU group were cryo-sectioned in longitudinal orientation and stained with 1) 
H&E and 2) immunohistochemically with α-bungarotoxin to visualise AChRs; and also with 
antibodies against laminin and BrdU. Images were obtained by light microscopy (1) to detect and 
describe contusion injury in longitudinal section and confocal microscopy (2) to observe the form, 
prevalence and arrangement of NMJs along both the injured and non-injured muscle. AChRs position 
themselves into junctional folds that adopted a coral-like appearance – identifiable as a NMJ. A 3D z-
stack image at 40x magnification revealed myonuclei residing beneath the NMJ in intimate 
connection. 
These NMJ were arranged along the muscle in central band; however contusion injury resulted in a 
disintegration of part of or the entire junctional complex. 
Super-resolution microscopy revealed in depth structural arrangement in the intact NMJ. This 
became jagged and dispersed following contusion injury, by 7 days. Robust, regenerating NMJs were 
detected in muscle sections at 14 days post injury. Surface area and volume were measured and 




revealed a trend towards a decrease in NMJ size at 7 days post injury, followed by an exaggerated 
increase in NMJ size by day 14 post injury. 
A two-step staining procedure exposed BrdU+ cells residing beneath the neuromuscular junction at 
14 days post injury.  
The results of this study show that NMJ morphology is indeed affected by muscle contusion injury, 
and repairs itself by increasing its AChR subunit production. We explored novel techniques for 
analysis of neuromuscular morphology and its changes after injury and during regeneration. We 
have also ascertained the migration of satellite cells to beneath the NMJ following contusion injury. 
These findings lay the foundation for future research to better understand the role players involved 
in neuromuscular regeneration. 





Kontusie-beserings veroorsaak beduidende spierskade wat skeletspiere as geheel beïnvloed, 
insluitend die innerverende motorneuron en die spierweefsel se neuromuskulêre-aansluiting (NMA). 
Tydens besering disintegreer en spat die asetielcholienreseptore (AChR) uitmekaar, en hergroepeer 
tog oor tyd om 'n optimaal-funksionerende motor-eindplaat te herskep. Hierdie proses behels die 
opregulering van die reseptor-subeenhede – α, β, γ, δ, ε – uitdrukking tot verskillende grade. 
Satellietselle is die sleutelrolspelers in hergenerering van spierweefsel, maar min studies wat die 
verband tussen hergenererende funksies van satellietselle en die rehabilitasie van NMA ondersoek is 
beskikbaar. Verder behandel die meerderheid van die studies wat asetielcholienreseptore 
ondersoek die gevolge van 'n senuwee-onderbreking, in plaas van beserings wat die spierweefsel as 
geheel beïnvloed. Bromodeoksi-uridine (BrdU) is 'n nuttige hulpmiddel in die merking en die 
monitering van prolifereerde satellietselle. 
Twee eksperimentele groepe (naamlik PCR en BrdU groepe) van manlike BALB/C muise was 
onderworpe aan kontusie-besering van agterste ledemate, wat met die gewigimpaktegniek 
veroorsaak is. Alzet® mini-osmotiese-pompe wat BrdU lewer (50 mM, 1.0 μl.h-1 vrylatingstempo) is 
voor die besering in die BrdU groep ingeplant. Diere is geslag en die beseerde en kontralaterale, nie-
beseerde gastrocnemius-spiere is ingesamel. qPCR is gedoen vir AChR-γ en AChR-ε mRNA 
uitdrukking op die spiere van die PCR-muise. 
‘n Lengte-kriodeursnee van spiere van die BrdU groep was geneem en is met 1) H&E gekleur en 2) 
immunohistochemies gekleur met α-bungarotoksien om AChRs te visualiseer; en ook met 
teenliggaampies gekleur vir laminin en BrdU. Beelde is verkry deur ligmikroskopie (1) om kontusie 
besering in lengtesnee te observeer en te beskryf, en konfokale mikroskopie (2) om die vorm, 
voorkoms en rangskikking van NMAs langs beide die beseerde en nie-beseerde spiere te observeer. 
AChRs het hulself in aansluitingsvoue posisioneer en 'n koraal-agtige voorkoms aangeneem - wat as 
'n NMA identifiseer kan word. 'n 3D z-stapel beeld op 40x vergroting het gewys dat myonukleusse in 
‘n noue verband onder die neuromuskulêre aansluiting teenwoordig is. 
Hierdie neuromuskulêre-aansluitings is gereël langs die spiere in sentrale band; hoewel kontusie-
besering gelei tot 'n verbrokkeling van 'n gedeelte of van die hele aansluitingskompleks. 
Super-resolusie mikroskopie het ‘n in-diepte strukturele rangskikking getoon in ongeskonde NMA. 
Dit het binne 7 dae gekronkel en versprei na kontusie-besering. Robuuste, hergenererende NMAs is 
14 dae na die besering in spierlengtesnee waargeneem. Oppervlakte en volume is gemeet en het 




getoon dat NMA grootte 7 dae na besering neig om af te neem, gevolg deur 'n oordrewe toename in 
NMA grootte op die 14de dag na besering. 
'n Twee-stap verkleuring-prosedure het 14 dae na die besering BrdU+ selle onder die 
neuromuskulêre aansluiting blootgestel. 
Die resultate van hierdie studie toon dat NMA morfologie inderdaad deur kontusie-besering van 
spiere beïnvloed, en herstel self deur die van die AChR subeenheid produksie te verhoog. Ons verken 
nuwe tegnieke vir analisering van neuromuskulêre morfologie en veranderinge na 'n besering en 
tydens hergenerering. Ons het ook vasgestel dat migrasie van satelliet selle onder die NMA na 
kontusie-besering plaasvind. Hierdie bevindinge lê die grondslag vir toekomstige navorsing om die 
rolspelers betrokke by neuromuskulêre hergenerering beter te verstaan.  
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ANOVA  Analysis of Variance 
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MuSK  Muscle Specific Tyrosine Kinase 
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PBS   Phosphate Buffered Saline 
 
qPCR  Quantitative Real Time Polymerase Chain Reaction 
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SFI   Sciatic Functional Index 
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Chapter1 Literature Review 
1.1 Introduction 
“For humans, as for most members of the animal kingdom, to move is to survive.”1 
Muscle Contusion Injury 
 Skeletal muscle tissue spans the interior of the body - providing for movement and an additional 
protective function for the internal organs. Therefore, skeletal muscle is regularly subjected to many 
types of injury, or myotrauma, (e.g. mechanical, chemical or thermal) at various levels of severity. In 
a study involving 6300 healthy adults, ± 25 % experienced a musculoskeletal injury of some sort 
within 12 months—of which 83 % were activity-related2. Contusion injuries commonly occur in 
sports, particularly contact sports, as well as in motor vehicle accidents and in industrial settings. A 
contusion injury is defined as an event where a blunt non-penetrating object impacts on the skeletal 
muscle, crushing the local tissue3. This results in acute loss of structure and function, followed by 
muscle mass breakdown. In some instances, entire limbs are debilitated. In severe cases, death can 
result3! 
Muscle fibres subjected to contusion injuries are compressed and torn. Contusions can be 
complicated by additional bone fracturing that threatens to puncture the already traumatised 
muscle and increases the extent and complexity of the injury. The severity of these injuries depends 
on which particular muscle has been affected and the degree of impact4. 
In this study, events following muscle contusion injury will be investigated. Two particular 
components that are close to, and interact with, muscle fibres will receive most attention, namely 
satellite cells and the neuromuscular junction. 
Satellite cells 
Satellite cells (SC) are the muscle’s resident stem cells that are activated in events such as 
myotrauma and proliferate to produce additional muscle cells (myoblasts). These myoblasts assist 
with both muscle repair and the regeneration of new myofibres in a manner that is sustainable for 
the satellite cell pool. The various roles of satellite cells in the process of muscle repair have been 
extensively researched3,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23 and will be discussed in Section 1.3. 
 




The Neuromuscular Junction 
The neuromuscular junction (NMJ) encompasses the area connecting the myofibre and its 
innervating motor neuron – providing the crucial link for communication between the two25–27. 
Damage to the neuromuscular junction results in its degradation and results in the inability of the 
myofibre to receive and respond to signals sent from the motor neuron. This leads to loss of 
contractile function and muscle wastage27–31. 
Acetylcholine receptors (AChRs) are the key components of the neuromuscular junction, arranged 
along the junctional folds in the muscle membrane to accommodate the incoming nerve axon. 
AChRs receive the neurotransmitter, acetylcholine, which initiates the action potential in the muscle 
fibre and leads to muscle contraction. Different AChR subunits exist which create different types of 
AChRs. Skeletal muscle initially expresses a fetal type – AChR-γ – and, post-natally, a mature type – 
AChR-ε. 
Following strain injury, AChRs scatter from their junctional complexes, or even disintegrate26. In 
events where the nerve is damaged, the lack of neural stimulation also promotes scattering and 
disintegration of the AChRs. 
During regeneration, the synaptic AChR regions are replenished by either recycled AChRs, or newly 
synthesized AChRs. A transcriptional switch occurs between the fetal - and adult AChR type as 
myofibres revert back to predominantly fetal AChR expression in the beginning phases of NMJ 
regeneration and gradually shift back to producing the adult type AChR as NMJ integrity is restored. 
This study aimed to measure the changing expression of AChR-γ and -ε following muscle contusion 
injury and to describe and quantify the morphological changes of the NMJ following injury as well as 
be the first to describe and quantify the morphological changes in the regenerating NMJ. 
Additionally, this study strove to identify activated satellite cells beneath the regenerating NMJ to 
announce a supportive role played by the SCs in NMJ repair. 
1.2 Skeletal muscle 
1.2.1 Introduction 
Skeletal muscle consists of a multifaceted arrangement of muscle cells (muscle fibres) and 
represents the largest tissue mass in the body3. Skeletal muscle mass accounts for 34.1 ± 5.7% of 
body weight in women (healthy young females, age: 18-29 yr; weight: 65.0 ± 16.8 kg) and 42.3 ± 4.4 




% in men (healthy young males, age: 18-23 yr; weight: 79.9 ± 15.4 kg)32. Skeletal muscle allows for 
respiration; postural stability; joint movement and locomotion and force production3,33 - crucial 
functions for the independent, mobile human being. Its complex nature involves other structures in 
close proximity, such as a highly organised nerve- and blood vessel networks; and an extracellular 
connective-tissue matrix. 
1.2.2 Anatomy 
1.2.1.1 Myofibres  
Muscle fibres, also referred to as myofibres, are elongated muscle cells and appear distinctly spindle-
shaped, averaging between 10-100 µm in diameter33 and reaching lengths of up to 12 cm1. 
Myofibres are abundant in skeletal muscle, with the large muscles of the lower limbs boasting the 
most fibre bundles. In humans, around 271 350 myofibres reside in the tibialis anterior and as many 
as 1 033 0001 in the medial gastrocnemius – the muscle of focus in this study.  
A plasma membrane – the sarcolemma – encloses each myofibre1. The sarcolemma, in turn, is 
coated by an extracellular matrix of glycoproteins called the basement membrane1,34. This 
membrane is composed of two layers: an internal basal lamina and an external reticular lamina34. 
Multiple nuclei (specifically termed myonuclei) are situated on the borders of the muscle fibre, 
nestled under the sarcolemma3. Each myofibre also possesses a number of muscle stem cells known 
as satellite cells - residing outside the sarcolemma, but beneath basal laminae of the basement 
membrane. These cells play an important role in muscle maintenance and regeneration and are 
discussed in detail later (see Section 1.3). 
1.2.1.2 Connective tissue 
A series of connective tissue layers give the muscle the structure and organisation it needs to fulfil its 
functional requirements. A thin layer of areolar connective tissue -the endomysium - encloses each 
myofibre, but allows the entry of blood capillaries and nerve fibres. A thicker sheath of connective 
tissue - the perimysium - groups between 100-200 individual myofibres together into bundles called 
fascicles11. Yet another layer of thick connective tissue - the epimysium - encases the entire muscle 
and projects inwards, creating compartments of fascicles3. The epimysium is continuous with the 
extra-cellular connective-tissue matrix, known as the myofascia33, which separates the muscle from 
adjacent muscles. This ‘bundle-within-a-bundle' arrangement is depicted in Figure 1.1. 
Skeletal muscle attaches itself to the corresponding bone structure with bundles of collagen fibres 
known as tendons11,33. 









Skeletal muscle represents the largest component of the metabolically active cell mass of the body35 
and these high metabolic demands of the muscle tissue require extensive networks of blood 
capillaries to help maintain homeostasis within the muscle, especially during strenuous exercise1. 
Blood vessels transport oxygen and nutrients - essential for muscle metabolism and contraction - to 
the myofibres and waste material – such as heat and chemical products (e.g. lactate and carbon 
dioxide) - away from the myofibres1. Beyond their nutrient role, blood vessels transport the essential 
white blood cells (leukocytes, neutrophils, macrophages) to the muscle fibres. These cells fight 
infections and disease and assist in the major repair work that will be investigated in this study. 
1.2.1.4 Innervation 
As skeletal muscle is required for voluntary movements, rapid communication is essential and a 
highly organised level of innervation exists within the muscle tissue27. Motor neurons are muscle-
specific nerves that innervate the myofibres. The term motor unit refers to a motor neuron and all 
the myofibres that it innervates. Hence each motor unit is able to contract singularly despite being 
made up of multiple fibres. The number of myofibres innervated by a single motor neuron varies 
between muscles (and even within the same muscle) based on the force requirements. For gross 
motor movements one motor neuron can innervate more myofibres, generally found in larger 
muscles, e.g. 20 myofibres innervated by one motor neuron in the gluteus maximus27. Smaller 
Figure 1.1 Structural organization of the skeletal muscle. 
This structure demonstrates a bundle-within-a-bundle 
type of organisation - from the muscle fibres to the 
fascicles grouped to form the entire muscle. [Copyright 
© 2011 Pearson Education, Inc.] 




muscles, requiring fine motor coordination, contain more motor units, innervating fewer myofibres 
per motor unit33. Some motor units consist of only one myofibre and its innervating motor neuron33. 
More motor units are activated in response to greater force production demands33. This enables the 
muscle to work as a unit while allowing for variation of force.  Each myofibre receives an action 
potential from the neuron that sparks a complete contraction known as an all-or-nothing response. 
However, the number of fibres recruited for contraction increases according to the increased 
demand for force. This allows the perceived graded response as, for example, voluntarily recruiting 
60% of one’s muscle fibres is sufficient to generate about 60% of one’s maximal force for that 
specific muscle. 
The motor neuron branches into axon terminals to connect to each myofibre within the fascicle33,27. 
The myofibre requires a way to receive and respond to the impulses sent from the motor neuron. 
This gap is filled by a complex known as the neuromuscular junction (NMJ) (see Section 1.4). 
1.3 Satellite cells 
1.3.1 Introduction 
Satellite cells (SCs) are widely known as the muscle’s very own stem cells, whose function is to 
develop, maintain, repair and regenerate the myofibres on their journey from embryonic to mature 
muscle and thereafter3,36,37. Since myofibres are terminally differentiated38, this SC reserve supplies 
the major source of additional deoxyribonucleic acids (DNA) needed for adaptations to the muscle 
during growth as well as in more drastic events. 
1.3.2 Appearance, position and number 
As mentioned earlier, SCs lie outside the myofibre, between the sarcolemma and the basal 
lamina6,37,39,40 (see Figure 1.2) - in fact their name originates from this peripheral ‘niche’ position and 
its relation to the myofibre36,38. These cells are normally mitotically quiescent36,37,41,42, but become 
activated, proliferate and differentiate in response to a variety of stimuli3,41. 
In early post-natal stages, the SC content of mouse muscle comprises ~30-35% of its total number of 
sub-laminal plus sub-sarcolemmal nuclei37. Undifferentiated, mono-nucleated quiescent SCs 
comprise a high nuclear-to-cytoplasmic volume ratio41. Activated SCs increase in cytoplasmic 
volume; display fine granulation and microfilaments within their cytoplasm; and develop abundant 
rough endoplasmic reticulum as well as some rounded mitochondria41. Once differentiated, these 




SCs lend themselves to the formation of muscle tissue - termed myogenesis - of the developing 
myofibres as they lengthen and increase in diameter. 
SCs contribute additional cytoplasmic mass and valuable nuclei to the growing myofibres. The added 
nuclei empower the myofibre to increase protein synthesis necessary for structural components and 
regulatory molecules for rapid and effective communication and myogenesis. As the muscle 
matures, the number of myonuclei increases and SC numbers diminish to a proportion of between 1 
- 6 % of total sub-laminal nuclei 3,37,40,42,43. (Percentages may differ according to different types of 
muscles, muscle fibre types (slow- or fast-twitch) and even between species. Nevertheless, SCs are 
present in all muscle fibre types with slow-twitch muscle fibres having generally more SCs than fast-
twitch muscle fibres3. 
Concerning differences in muscle fibre types, Mackay et al. 2009 counted more SCs in Slow Type I 
myofibres (mean 0.070 ± 0.24 per 100 myofibres) compared to Type II (mean 0.066 ± 0.30 per 100 
myofibres) although no comparison was made between the two to determine whether differences 
were significant40. 
SC number in myofibres can vary with circumstances and two most commonly occurring factors 
affecting SC number are aging (decreases SC number) and exercise (increases SC number). Shefer et 
al. (2010) describe means for SC number in isolated fibres of the gastrocnemius muscle - the muscle 
focused on in our study – in sedentary male rats42. They found 24 ± 2 SC nuclei in young male rats 
(age: 3.5 months) and a diminished 8 ± 1 SC nuclei in old male rates (age: 15 - 17 months)42. In the 
same study, rats put on an exercise regime for 20 minutes of running, 6 days a week, for 13 weeks 
boasted increased means of 30 ± 2 and 15 ± 2 SCs/fibre in young and old male rats respectively42.  
Different muscle types distribute their SCs in various patterns, i.e. in the slow twitch Type I muscle - 
the soleus - SCs amass around the middle, localizing around the motor end-plate of the innervating 
motor neuron, while SC’s on the fast twitch Type II muscles - the tibialis anterior and the extensor 
digitorium longus - seem scattered randomly along the length of the myofibre36. 
1.3.3 Physiology 
In adult muscle, under normal circumstances, SCs mostly remain mitotically quiescent36,37,44, but are 
activated in events that compromise the muscle’s homeostasis such as the stimuli for hypertrophy, 
repair and regeneration14,38,43,44 (see Figure 1.2). Events resulting in myotrauma include: exercise 
(micro-damage), weight-bearing and mechanical stretch, wounds such as burns or lacerations, 
myodegenerative diseases and - in light of this study - contusion injuries37,38,44. Upon activation, SCs 
will proliferate and generate myoblasts – defined as such when the SC expresses myogenic 




proteins41. Once SCs have differentiated into myonuclei, they fuse to form myotubes for new 
myofibres or repair existing myofibres44,45 (see Figure 1.2). This contributes to the growth and repair 
of the muscle fibres. 
The magnitude and rate of SC response differs according to the incidence and severity of the 
damage, i.e. low in maintaining homeostasis and stretching and high in large-scale damage that 
requires muscle regeneration. SCs are activated within a few hours of activity/damage - with rat 
myoblasts expressing myogenin with 8 hours37,46 - and proliferation is highest within the first 12 – 48 
hours36,40,46. 
The proportion of activated SC numbers is low in resting muscle – mean 0.5 % in human 
gastrocnemius medialis muscle biopsies taken in resting conditions40. Increases in response to e.g. 
electrical stimulation are high and rapid (mean 10 %; 48 hours after stimulation) whereas responses 
to exercise are less: resistance training, where 12 weeks of low resistance training showed a higher 
proportion of activated SCs (mean 2.5 %) in comparison to the same period of high resistance 
training (mean 1.4%)40. 
SC proliferation sustains the quiescent SC pool. Most SCs undergo at least one division in vivo before 
committing to terminal differentiation37.  This allows myofibres to continue regenerating effectively 
in response to repeated damage – Sadeh et al. (1985) tracked effective regeneration up to 50 
repeated cycles following extensive injury using myotoxins47. Even without such damage, there is a 
baseline myonuclei turnover within the myofibre (1 – 2 % per week in rodent studies)37.  
SCs can proliferate rapidly and extensively in response to injury. In early studies, Studitsky (1964) 
removed rodent muscle fibres, minced these fibres and replaced muscles them into the animal, after 
which they witnessed complete in vivo transformation into new functional muscle48. Zammit et al. 
revealed instances where 3 - 5.5 % SCs on an isolated and ablated myofibre needed only 4-5 days in 
vitro to expand in number and wholly replace that myofibre’s myonuclei49. 
1.3.4 Satellite cell transcription factors 
SCs activation, proliferation and differentiation are regulated by a number of transcription factors41. 
The main factors are briefly introduced below: 
A. Pax7 – is a satellite cell-specific transcription factor and is expressed in activated and 
proliferating SCs41. Pax7 is also a key regulator for satellite cell pool maintenance in the 
postnatal period36. Pax7 activates another group of transcription factors – the MRFs (see 
below). 




The myogenic regulatory factors (MRFs) – are a family of muscle-specific helix–loop–helix 
transcription factors that are responsible for activating genes involved in muscle differentiation and 
comprise Myf5, MyoD, Mrf4, and myogenin3,5031,36,38,41.  
B. Myf5 - expression is upregulated first, for SC quiescence to activation , and in turn activates 
C. MyoD - expressed upon SC activation and proliferation  
D. MRF4 – SC differentiation  
E. Myogenin - expression is upregulated in differentiated SCs that are fusing into myotubes and 
undergoing myotube maturation 
Analysis of the expression of these transcription factors allows one to determine the state in which 





Figure 1.2 Satellite cell quiescent position and activity following myofibre damage. SCs lie between 
the sarcolemma and the basal lamina on the myofibre. Upon damage (A) myofibre sends signals 
that trigger SC activation. SCs replicate (B) to form one new dormant cell and one proliferating cell. 
Proliferated daughter SCs either form new myofibres (C) or repair the damage on the original fibre 
(D). Cells from elsewhere (e.g. bone marrow stem cells) may also assist in myofibre repair (E). 
(Adapted from http://www.life-enhancement.com/images/LEM1407satellite-cells548.gif) 




1.4 The Neuromuscular Junction 
1.4.1 Introduction 
The neuromuscular junction (NMJ) encompasses the synapse between the motor neuron and the 
outer sarcolemma of its innervated skeletal muscle fibre25,26 and enables communication between 
the two structures – thus providing the final crucial link between the peripheral nervous system and 
muscle action. The complex structural and signalling network of the NMJ ensures highly reliable 
neuromuscular signal transmission25. 
1.4.2 Basic location and structure 
The neuromuscular junction can be separated into 3 parts: 
Presynaptic – the motor nerve terminal branches that end in enlarged synaptic knobs or terminal 
bouton. This motor nerve terminal packages the neurotransmitter, acetylcholine (ACh), into synaptic 
vesicles25 that are released into the synaptic cleft upon motor axon depolarization. In vitro studies 
have shown that other nerve derived factors exert regulatory roles on post-synaptic structures51, 
such as neural agrin and neuregulin which play roles in the production and organization of the 
postsynaptic receptors25,51. 
Intrasynaptic – the synaptic basal lamina comprises an extra-cellular matrix, providing structural 
support to the sarcolemma as well as facilitating the organization of the post-synaptic membrane25. 
Postsynaptic – refers to the sub-synaptic area of the sarcolemma where nerve signals/impulses are 
received, known as the motor end-plate25. This specialized part of the sarcolemma incorporates a 
dense area of nicotinic acetylcholine receptors (AChR) and other signaling proteins such as low-
density lipoprotein receptor-related protein 4 (Lrp4), muscle specific tyrosine kinase (MuSK), 
downstream of kinase 7 (Dok7), ErbB and Rapsyn25. These molecules are necessary for the 
establishment and proper functioning and maintenance of the motor end-plate and are discussed 
further in Sections 1.4.4 and 1.4.5. 
To cater for the several twisting branches of the axon terminals, each end-plate creates a network of 
stabilizing invaginations, known as junctional folds26. This explains the exquisite coral-like structure 
of the typical motor end-plate henceforth referred to as the NMJ (see Figure 1.3). 




1.4.3 Basic functioning of the neuromuscular junction: from impulse to 
contraction 
The innervating motor neuron initiates the entire NMJ interaction through its chemo-electrical 
transmission of the action potential (AP). 
In the motor neuron, choline acetyltransferase (ChAT) synthesizes acetylcholine (ACh)25, which is 
packaged into presynaptic vesicles and stored in the synaptic knob. The arrival of an AP causes the 
voltage-gated calcium channels (VGCC) to open and extracellular calcium (Ca2+) streams into the 
motor nerve terminal25. This Ca2+ influx triggers the release of ACh by the presynaptic vesicles 
moving towards and merging with the presynaptic membrane. This releases the ACh, through 
exocytosis, out of the vesicle and nerve terminal and into the synaptic cleft. 
Acetylcholine receptors (AChR) are expressed on the surface of the motor end-plate. Morphology of 
the AChR is discussed in detail in Section 1.4.5. ACh diffuses over the synaptic basal lamina and binds 
to AChRs25. This binding generates an end-plate potential26. The AChR opens via a conformational 
change of its subunits52, increasing the cell’s permeability by inducing the opening of voltage-gated 
sodium channels (VGSC). The resultant influx of sodium and other cations depolarizes the 
sarcolemma to the extent where its threshold of -55mV is exceeded, thus continuing the neural 
action potential into the post-synaptic myofibre as it spreads along the sarcolemma25,52. 
After exerting its effect, ACh is hydrolyzed by acetylcholinesterase (AChE)25, ensuring that its 
influence upon the AChR is limited, preventing prolonged contractions and liberating the receptor 
for ACh binding when the next AP is transferred. 
 
 
Figure 1.3 Axon (green) covered in a 
myelin sheath (blue) innervating the 
NMJ (red). From Court et al. (2008).  




1.4.4 Associated structural and signalling molecules 
1.4.4.1 Introduction 
The NMJ consists of many structural and signaling components that interact and ensure the proper 
development and functioning of this vital communicative complex. The components that will be 
discussed here are all part of postsynaptic structural apparatuses and transverse the basal lamina of 
the myofibre25. These postsynaptic components are introduced in order of their coordinating 
signaling molecules, receptors and downstream targets (see Figure 1.4). 
1.4.4.2 Acetylcholine and its receptor 
Acetylcholine (ACh) 
Aside from its pivotal role in signal transmission, ACh release from the nerve terminal during early 
development aids in ‘selecting’ the AChR cluster that will form a particular NMJ25. With the onset of 
neuronal activity AChR clusters that have formed spontaneously but lack agrin stabilization are 
dispersed25.  
Acetylcholine Receptors (AChR) 
The AChR receives the ACh molecule and continues the transmission of the AP from the motor 
neuron to the myofibre. AChRs are the focus of this study and are discussed in detail in Section 1.4.5. 
1.4.4.3 The neural agrin/Lrp4/MuSK/Dok7 signalling pathway  
Neural Agrin  
Neural agrin is an extracellular matrix molecule that plays a major role in the assembly of the 
postsynaptic apparatus through initiation of the neural agrin/Lrp4/MuSK/Dok7 signaling pathway25. 
Neural agrin pre-aggregates the AChRs opposite the nerve terminals ensuring correct organization of 
the motor-end plate during development as well as for maintenance in adulthood25. In vitro studies 
have demonstrated agrin’s role in the organization of AChRs and other postsynaptic proteins into 
aggregates, without immediately enhancing AChR production51. 
Lipoprotein receptor-related protein 4 (Lrp4) 
Neural agrin binds to Lrp4 which initiates activation of the downstream signaling pathways via MuSK 
and also plays a role in ensuring stabilization of the AChRs25. 
 
 




Muscle-specific receptor tyrosine kinase (MuSK) 
Muscle-specific receptor tyrosine kinase (MuSK) is a key protein that orchestrates AChR pre-
aggregation in the center of the developing muscle prior to innervation. This ‘pre-patterning’ of the 
uninnervated postsynaptic apparatus relies on ligand-independent activation of MuSK25. Ligand-
dependent roles of MuSK include AChR clustering at the motor end plate and differentiation of the 
NMJ25. Upon activation, MuSK and its downstream signaling processes reorganize the actin 
cytoskeleton, phosphorylate the AChR β-subunit and recruit AChRs into stable clusters12. Along with 
AChR clustering, MuSK plays roles in the differentiation of the NMJ as seen in MuSK mutant mice 
which fail to form NMJs31. However, AChR clustering and NMJ formation can be restored post natally 
following the introduction of MuSK31. 
Downstream of kinase 7 (Dok7) 
The binding of Dok7 plays a role in the aggregation of AChRs and bridges the activation of MuSK to 
downstream signalling pathways25. 
The Pathway 
Upon secretion, neural agrin binds to laminin (specifically laminin-221) in order to incorporate itself 
stably into the synaptic basal lamina25. Its C-terminal binds to low-density lipoprotein receptor-
related protein 4 (Lrp4) which activates the phosphorylation of muscle specific tyrosine kinase 
(MuSK), allowing for the binding of downstream of kinase 7 (Dok7)25 and of the adaptor protein, 
rapsyn (see Postsynaptic components and Figure 1.4). The agrin/Lrp4/MuSK/Dok7 signalling complex 
has a major role in stabilization of the postsynaptic AChRs, - giving them a superior stability despite 
metabolic activity when compared to non-synaptic counterparts25. 
Neurotrypsin 
Neurotrypsin is a protease that targets neural agrin, cleaving it at two sites and thus rendering the 
agrin inactive25. This leads to the disassembly of the entire junctional complex.  
1.4.4.4 Other anchoring components 
Rapsyn 
Rapsyn stabilizes AChR clusters by binding to dystroglycan, mediating its binding to the f-actin 
cytoskeleton25. Rapsyn mutations can result in congenital myasthenia in humans indicating the 
continual role of rapsyn beyond developmental stages and well into adult life and during aging25. 





Dystroglycan plays an anchoring role, binding the AChRs, Lrp4 and ErbB receptors to the f-actin 













Figure 1.4 Structural and signalling components of the NMJ. Choline acetyltransferase 
(ChAT) synthesizes neurotransmitter, acetylcholine (ACh) which is packaged into 
presynaptic vesicles. Arriving action potentials (AP) open voltage gated calcium channels 
(VGCC) and the resultant influx of Ca2+ triggers the release of ACh into the synapse. ACh 
binds to the AChRs which open the voltage gated sodium channels (VGSC) generating an 
AP in the postsynaptic myofibre thus continuing the signal. Acetylcholine esterase (AChE) 
subsequently hydrolyses ACh. During development, neural agrin is secreted from the 
nerve terminal and anchors the postsynaptic apparatuses by binding to 1) laminin-221 
(LM-221) for stable incorporation into the basal lamina and 2) to lipoprotein receptor-
related protein4 (Lrp4) which phosphorylates muscle specific tyrosine kinase (MuSK), 
allowing MuSKs binding to downstream of kinase 7 (Dok7). This agrin/Lrp4/MuSK/Dok7 
downstream signalling pathway is responsible for AChR aggregation at the NMJ. 
Neurotrypsin cleaves agrin which renders it inactive and results in the disassembly of the 
entire NMJ complex. Rapsyn plays a necessary anchoring role for the AChRs by binding to 
dystroglycan – mediating binding to the f-actin cytoskeleton. Dystroglycan in turn binds 
to laminins, further securing the postsynaptic AChRs. Nerve secreted neuregulin binds to 
Erb Receptor tyrosine kinases (ErbB) initiating the phosphorylation of α-dystrobrevin to 
recycle AChRs at the adult NMJ. Adapted from Punga et al. 2012. 




1.5 Acetylcholine receptors 
1.5.1  Introduction 
Acetylcholine receptors (AChR) are ligand-activated cholinergic receptors – activated by the 
neurotransmitter AChR – and are present throughout the body, expressed by both neuronal and 
non-neuronal cells 53. They are classified into two major subtypes. 
The muscarinic acetylcholine receptor (mAChR) are metabotropic receptors present as second 
messenger, G protein-coupled seven-transmembrane proteins53. They are named according to their 
sensitivity to muscarine (a toxin from the mushroom Amanita muscaria) and experience relatively 
slow activation (milliseconds to seconds) in comparison with their nicotinic counterparts53. 
The nicotinic acetylcholine receptor (referred to as nAChR or AChR, the latter abbreviation is used 
throughout this study to describe nicotinic AChRs) are ionotropic cationic receptors linking directly 
to ion channels and without the involvement of a second messenger53,54. They are named according 
to their sensitivity to nicotine and are fast reacting (activated within micro- to sub-micro seconds). 
The AChRs are the focus of this study. 
AChRs are broadly classified into two subtypes: neuronal- and muscle type. Their classification is 
determined by the combination of AChR subunits making up the specific receptor.   
1.5.2 AChR subunits 
Seventeen different AChR subunits exist, all homologous, but genetically distinct52,53 (see Table 1.1). 
Each subunit comprises four transmembrane domains with both the N- and C-terminus located 
extracellularly8 (see Figure 1.5). 
Table 1.1 AChR subtypes 
Neuronal type Muscle type 
I II III IV 
1 2 3 
α9, α10 α7, α8 α2, α3, α4, α6 Β2, β4 α5, β3 α1, β1, δ, γ, ɛ 
 
Five subunits are arranged symmetrically around a central pore to form the AChR pentamere 
(280kDa)54,55. AChRs in the brain and autonomic ganglia consist of only α-type subunits or α- and β-
type subunits. In mammalian muscle-type AChRs express α-1, β-1, δ, γ (fetal) and ε (adult) 




subunits52,53,56. Of these five different subunits, two combinations are possible for the creation of a 
functional AChR heteropentamere, in a ratio of 2:1:1:152,53. 
The first type of subunit is the fetal AChR (AChR-γ), which consists of two α-1 subunits and one β-, δ- 
and γ- subunit (α2βγδ). The second type of subunit is the adult AChRs (AChR-ɛ), consisting of two α-
1 subunits and one β-, δ- and ε- subunit (α2βεδ). 




1.5.3 AChR numbers and distribution 
The fusion of myoblasts into myotubes activates synaptic genes that produce AChRs along with the 
many other sub-synaptic proteins. AChR subunits are assembled into pentameres and inserted into 
the myotube membrane51. This initial production creates densities of ~1000 AChR/µm2 (measured in 
rodent studies)51, although some AChRs aggregate into higher density clusters termed ‘hot spots’. 
Muscle type AChRs are also categorized by their location along the myofibre. Synaptic AChRs are 
located directly beneath the synaptic knob, i.e. form part of the NMJ. These AChRs occupy about 0.1 
- 1% of the total sacrolemmal surface25,57. AChRs in this region are densely packed into clusters of 10 
000 – 20 000/μm2 ) and assume a coral-like formation for optimal receiving ability12,51.  Furthermore, 
post-synaptic AChRs are metabolically much more stable than their non-synaptic counter parts25. 
Figure 1.5 AChR atomic structure showing cryo-electron microscopy of an 
AChR. From the Torpedo electric organ at A) 9Å resolution and B) 4Å 
resolution. From Sine, 2012. 




Subsynaptic myonuclei in both developing and mature muscle are known to transcribe AChR genes 
at higher rates in comparison with non-synaptic myonuclei58. 
Non-synaptic AChRs are located all along the other 99% of the sarcolemma (i.e. do not form part of 
the NMJ) at a greatly decreased negligible density of <10/μm251.  
As mentioned earlier, the motor neuron plays a major role in controlling the abundance, subunit 
composition and localization of AChRs in the myofibre56 by the release of neurogenic factors as well 
as through its signal transduction that induces electrical activity in the myofibre56. 
1.5.4 Development of the neuromuscular junction through AChR 
production and aggregation 
The development of the neuromuscular junction is a multi-faceted process, directed by both the 
myofibre and the motor neuron. Two paradigms exist concerning this development.  
The traditional view edicts that the axon growing towards the myofibre releases neural stimuli51. 
This stimulus, namely neural agrin, is released into the extracellular matrix and prompts the 
aggregation of AChRs towards the sarcolemmal area immediately below the nerve terminal25. The 
motor neuron ignores pre-existing ‘hot spots’ and creates its own new clusters of AChRs along a 
central ’end-plate’ band51. These spontaneous ‘hot spots’ subsequently disappear and the neural 
AChRs proceed to mold themselves in an intricate coral-like branches to surround the infiltrating 
branches of the nerve terminal51. 
The paradigm challenging the traditional view proposes that the axon is attracted to the muscle-
produced cluster sites of AChRs and by this attraction, associated NMJs are formed51. The neuron 
then incorporates some of these aneural ‘hot spots’ into its NMJ design, remodeling innervated 
clusters to align accordingly51. This idea suggests that the muscle pre-patterns the area of NMJ 
formation to some extent and is supported by observing aneural AChRs arranging themselves into 
similar coral-like formations without any innervation51. 
NMJs of different muscles vary in their shape, size and distribution, as well as in their metabolism, 
physiology and gene expression. Two distinct patterns of NMJ formation have been defined, with 
regards to how AChR clusters are formed25: 
Fast Synapsing – a mature NMJ formation is complete within one day (e.g. tibialis anterior or 
extensor digitorium longus) 
Delayed Synapsing – NMJ formation takes up to five days (e.g. diaphragm or soleus) 




In the developmental stages, i.e. embryonic and early postnatal, AChR insertion is the dominant 
activity on the postsynaptic membrane, promoting the proper formation and growth of the NMJ25.  
New AChRs are synthesized and inserted into the post-synaptic region largely through local gene 
transcription from myonuclei situated directly underneath the NMJ (subsynaptic myonuclei)25. 
Neural agrin/Lrp4/MuSK/Dok7 signaling facilitates this localized transcription in addition to its 
stabilizing role resulting in the superior metabolic stability of synaptic AChRs to that of their non-
synaptic counterparts25.  
At birth the immature NMJ appears as an amalgamated, formless entity, but is swiftly organized into 
junctional folds around the innervating motor neuron. By day 14 post natally, NMJs start to 
resemble the classic coral-like structure of a mature NMJ59 (see Figure 1.6). 
As the NMJ matures, the need arises for renewal of old and damaged AChRs, shifting focus away 
from the predominant insertion of new AChRs. These old AChRs are removed and either a) repaired 
and reinserted (a process termed ‘recycling’) or b) wholly replaced by newly synthesized AChRs25.  
Neuregulin, by its alternate signaling pathway - the neuregulin/ErbB/dystrobrevin signaling pathway 
- is closely linked to the recycling of old and damaged AChRs25. The concentrated collection of 
postsynaptic AChRs, maintained by their constant individual insertions and removal, caters for a 





1.5.5 Transcriptional switch from fetal AChR-γ to adult AChR-ɛ 
At birth, muscle expresses only the fetal AChR type (α2βγδ)25,56, regulated by members of the MRF 
family of transcription factors31. During development, the AChR-γ subtype covers the sarcolemma 
and starts accumulating at the end-plate, as the nerve comes into contact with the myofibre56. 
AChR-α subunits follow the same pattern as AChR-γ subunits – with post-natal expression along the 
entire fibre and localization at the end-plate following innervation56. 
Increased post-natal innervation, as well as neural agrin and neuregulin secretion, gradually shifts 
AChR expression to the adult type (α2βεδ)25,58, i.e. the γ-subunit is replaced by the ε-subunit, while 
Figure 1.6 Development of the NMJ from 5 days postnatal (P5), through to adolescence (Ad). 
From Shi et al. 2012. 




the α-, β- and δ-subunits are always present in both AChR types.  MRF members are involved in this 
transcriptional change31, indicating that it coincides with transcription of multiple muscle-specific 
proteins during myotube differentiation. These adult AChRs localize around the motor end-plate to 
create the mature NMJ25,56. Interestingly, in Witzemann et al., the appearance of adult AChRs 
immediately after birth was not restricted by experimental denervation – suggesting the existence of 
other control mechanisms for gene activation in the myofibre itself56. 
The adult AChR is functionally superior to the fetal type with a longer end-plate channel opening 
mean time and better conductivity (i.e. a larger voltage)25. As AChR-ɛ subtype levels increase and 
AChR-γ subtype levels subsequently disappear - this is referred to as the AChR subunit switch in 
maturing (and regenerating) muscle56. 
1.6  NMJ Injury Models 
1.6.1 Introduction 
Neuromuscular injury (an injury to the nerve or muscle which affects neuromuscular transmission) is 
noticeable by a decrease in voluntary function. Functional assessments (e.g. by determining sciatic 
functional index (SFI); muscle force and power production etc.) show a decrease in muscle reactivity 
and function following injury with a return to normal function over time27. This recovery in function 
results from regeneration of both the muscle and the nerve, directed at themselves; one another; 
and the interface, the NMJ. 
Although well established and constant in their operations/activity, NMJ’s show remarkable 
plasticity after damage to the muscle or nerve and are able to reform and restore themselves to 
continue in their vital communicative role26,31. Models of denervation have frequently been used to 
simulate neural injury and lack of synaptic communication at the NMJ, while botulinum toxin (BoTX) 
injection prevents Ach binding to its receptor, thus also preventing proper synaptic communication.  
Literature focusing on NMJ injury and regeneration use a variety of different in vivo models to 
induce injury (See Table 2.1 on Nerve Injuries): 
A. Nerve transection - an incision is made in the skin covering the target area and the specific 
nerve (most commonly, the sciatic nerve) is located and carefully lifted from the tissue. The 
nerve is cut with a fine pair of scissors or a sharp scalpel.  This destroys the presynaptic 
nerve terminal and affects both the neuron and the subsynaptic structures that rely on 
neural stimulation and/or secreted regulatory factors for maintenance12,56,60,61. 




B. Surgical excision - an incision is made in the skin covering the target area, any muscle 
covering nerve may be bluntly split (the gluteal muscle to expose sciatic nerve in proximal 
part of the thigh (P9)) and the specific neuron is located and carefully lifted from the tissue. 
Magnification is required for studies involving small rodents. A section of the nerve (ranging 
from 2 – 30 mm) is excised with fine scissors or a sharp scalpel. Nerve resection completely 
prevents reinnervation12,31,60,62,63. 
C. Nerve crush – a direct crush is performed on the innervating nerve. An incision is made in 
the skin covering the target area, any muscle covering nerve may be bluntly split (e.g. biceps 
femoris to expose the sciatic nerve27 and the specific nerve is located and carefully lifted 
from the tissue. Magnification is required for studies involving small rodents. The nerve is 
crushed using fine-tipped forceps. This technique allows one to injure only the nerve and 
focuses on the degradation and regeneration of this nerve as well as the effects of the lack 
of neural simulation on its targeted muscle and the deinnervated neuromuscular junction 
structures27,28,64. 
D. Chronic nerve compression– induces damage to motor neurons (chronic nerve compression  
injury induces a robust Schwann cell response with axonal sprouting, but without 
morphologic evidence of axonal injury)65. 
E. Eccentric exercise – target muscle is subjected to multiple lengthening contractions26. 
F. Injection of a neuro-toxic substance – targeted area is injected with a neurotoxin (e.g. 
botullinum toxin). This technique maintains the structural integrity of the nerve terminal, 
but interrupts neuromuscular transmission. While the method is simple, any additional 
effects resulting from the introduction of a foreign substance can confound findings29–31,56,66. 
G. Chronic administration of a pharmacological substance – substances delivered via mini-
osmotic pumps either 1) throughout the body or 2) a targeted area (e.g. the sciatic nerve) 
via sterile silicone rubber tubing threaded under the skin ending in a silastic cuff that can be 
placed around the sciatic nerve56. 
1.6.2 Effect of denervation on AChR subunit transcription 
In the event of denervation, AChR-γ is again expressed along the entire fibre, until reinnervation 
once more replaces the fetal type with AChR-ɛ56. However, ɛ-subunits remain fairly constant in 
numbers and accumulation at the end-plate, even in the absence of the nerve and electrical 
stimulation56. Interpretation of results should take into account the mechanism for lack of NMJ 




function, the time course of sampling following the injury, and whether or not a modality was used 
to promote re-innervation.   
In a study involving various methods of chronic denervation, a 30-50 fold increase in α- and δ-
subunit mRNA as well as a strong relative increase in γ-subunit mRNA were seen56. Lesser increases 
were seen in β- and ɛ-subunits56. Therefore, loss of function is shown to increase sub-unit mRNA 
expression. When muscle was subjected to electrical stimulation following denervation, northern 
blot analysis showed a strong reduction in the α-, γ- and δ-subunits, whereas the ß-subunit mRNAs 
displayed a much smaller decrease and ɛ-subunit mRNA remained unchanged corresponding with 
their lesser changes in the denervation phase56.  
Ma et al. compared models: a single intramuscular injection of botulinum toxin (BoTX) in the 
gastrocnemius muscle vs. transecting the muscle’s innervating tibial nerve29,30.  Injured muscle was 
compared to either the saline-injected30 or uninjured29 contralateral leg which served as a control. 
Most AChR subunits (α, γ, δ and ɛ) increased mRNA expression within the first week of denervation 
after which expression levels returned to normal by about 2 weeks. BoTX treatment influenced the 
number and distribution of AChRs in a similar manner to chronic denervation. However, BoTX was 
followed by axon sprouting facilitating the recovery of paralyzed end-plates through reinnervation30. 
 In terms of a more detailed time course, AChR-α mRNA expression in BoTX injected muscles 
increased significantly at 3 days; peaked with a 15-fold increase at 7 days after injection and 
returned to normal by 15 days.30,31 AChR-α mRNA expression in muscles from legs subjected to nerve 
transection showed the same pattern of increases at day 3 and peaking at day 7 although expression 
was still slightly elevated (but not significantly) by day 14 , returning to normal levels by day 30 
indicating a longer recovery period29.  
AChR-γ mRNA followed the same pattern, but with a 50-fold increase at 7 days post injection30. In 
the nerve transection study, however, γ-subunit mRNA did not increase significantly by day 3 and 
showed only a 4-fold increase by day 7 – far more modest changes compared to the findings in the 
BoTX model29. This may explain the requirement for longer recovery if the initial response was 
diminished.  
The AChR-ε subunit mRNA increased, but not significantly, at 3 days then peaked significantly at 7 
days post injection (with a 3-fold increase) and also returned to normal levels by 15 days30. ε-Subunit 
mRNA after nerve transection followed the same pattern of increases and returned to normal by 14 




days post injury29. Again the ε-subunit appears to be less affected, regardless of the model. The 
AChR-δ mRNA expression response was only slightly higher, peaking at 3 days following injection 
with only a 9-fold increase; it remained significantly higher at day 7 and gradually declined to control 
levels30. Nerve transected muscle showed a similar pattern29. The least affected in both models was 
the AChR-β subunit. No significant increases were detected in AChR-β subunit expression in the 
injected or nerve transected muscle throughout the duration of the study29,30. 
 




Study  Species Injury Type Time points of 
Sacrifice 








Surgical excision (sciatic nerve, 
5mm) 
0, 5, 10, 20, 48- and 
72 hours  
Electrical stimulation  
(for 6 days) 
mRNA: AChR subunits (α, β, δ, 
γ) 












- Nerve transection (sciatic 
nerve) or 
- Pharmacological  
(*chronic/**single) 
 TTX* (sciatic nerve) 
 α-Btx* (soleus) 
 BoTX**(triceps surae)  
- Nerve crush (phrenic nerve) 
7, 14, 30 days Electrical stimulation 
(for 7 days) 
Or no intervention 
mRNA: All AChR subunits 
(qPCR) 
In situ hybridization 
RNA protection assay 
Electrophysiological 
Northern Blots of total RNA 
Densitomertic (Audiogram) 





Dawley rats, Adult 
Soleus  
Surgical excision (sciatic nerve, 
5mm) 
Chronic conduction block by 
TTX (sciatic nerve) 
0, 1 ½ , 1, 3, 5, 7, 
12, 14 days 
Electrical stimulation 
(for 7 days or 5 days 
off/5 days on ) 
Or no intervention 
mRNA: All AChR subunits 
(qPCR) 





Female FVB mice 
1 month post-natal   
Tibialis anterior 
Surgical excision (sciatic nerve, 
2-3mm) 
2-3mm, sciatic nerve 









Sciatic nerve crush injury 3, 5, 7, 9, 11, 14 
days 
Electrical stimulation NCAM and Neurofilament  
(Light microscopy) 
Electrical & Motor function 
evaluation  
Pinter et al.67 
2003 
 
Wistar rats  
Adult, Male 
Soleus 




• Autologous  nerve graft 
• Suture 
1, 3, 5, 7, 10, 21, 
28, 35 days 
Intramuscular notexin 
injection (total  muscle 




Standard electron microscopy 
(EM) 
Table 1.2 Nerve Injury Models 
Stellenbosch University  https://scholar.sun.ac.za









Nerve crush (sciatic nerve)  1, 2, 3, 4, 6 weeks None Axon, Schwaan cell, AChR 
(Whole mount confocal 
microscopy) 
Walking track analysis 






1 month old, Male 
Gastrocnemius 
Local Botox injection 
(gastrocnemius) 
3, 7, 15, 30 , 90,  
180 and 360 days  
†2 weeks, 2 & 6 
months and 1 year 
None 
 
†removal of muscle 
segment 
mRNA: All AChR subunits 
(qPCR) 
 
†AChR (Confocal microscopy) 






1 month old, Male 
Gastrocnemius 
Local Botox injection 
(gastrocnemius) 
3, 7, 14, 30 , 90,  
180 and 360 days 
None mRNA: α-AChR subunit; MuSK; 
myogenin; MRF4; IGF-1 and 
P21  (qPCR) 






1 month old, Male 
Gastrocnemius 
Nerve transection (tibial nerve) 3, 7, 14, 30 , 90,  
180 and 360 days 
None All AChR subunits (qPCR) 
* and ** indicate experiments were done in the same lab (* The Physiological Institute of Basel University and ** Department of Orthopaedic Surgery, 
Wake Forest University Medical Center) 
Stellenbosch University  https://scholar.sun.ac.za




In summary, these findings outline the heavy dependence on the synthesis of fetal form of AChRs 
(with γ-subunit) within the initial phases of NMJ regeneration, with significant (nearly 10-fold) 
increases in mRNA expression by day 3 and very high increases by day 7 (50-fold), while the adult ε-
subunit only started showing significant increases by day 7 with much lower fold-differences30. This 
seems to be the case for various muscles: A study involving the denervation of rat soleus muscle by 
excision of a portion of the sciatic nerve (Kues et al. 1995) revealed maximal levels of transcription 
for AChR ɛ-subunits’ mRNA on day 5, specifically centrally in the muscle, where former synapses 
were located60. 
In a later multi-gene study by the same group, MRF mRNA expression analysis showed increases in 
certain MRFs following denervation by BoTX injection. At day 7 post-injury, AChR subunits α, δ and γ 
showed mRNA increases as expected31 and MRF pro-differentiation genes, MRF4 and myogenin, had 
mRNA increases of more than 5- and 8-fold respectively.  
Observing changes in MRFs over time, MRF4 increased drastically at 3 days post injection with 
further increase by 7 days and remained significantly higher than in the contralateral leg (which 
served as the uninjured control) by 14 days post injection31. Myogenin mRNA increased significantly 
from contralateral control leg at all time points up to 2 months (days 3, 7, 14, 30 and 60) with two 
peaks at day 7 and day 60 following injection 31. No significant increases were seen in Myf5 and 
MyoD mRNA.  
Furthermore, vital supporting NMJ component MuSK’s mRNA increased, but not significantly, by day 
3, then peaked with an over 8-fold increase at day 7 following injection. MuSK mRNA expression 
remained at significantly higher expression compared to the contralateral control leg when assessed 
at 2 weeks and even 1 month following injection31. This may support the theory of its less important 
structural role, but it also indicates that regeneration of a functional post-synaptic NMJ unit may 
take longer than would be expected if only AChR mRNA was investigated. 
1.6.3 Relocation of AChR subunits 
Apart from denervation, studies observing the effect of inactivity, ageing or absence of associated 
proteins and genetic disorders have all contributed to the understanding of AChR regeneration. 
Diseases that can affect the NMJ structure and functioning include diseases of the motor neuron 
(e.g. amyotrophic lateral sclerosis68); the junction itself (e.g. congenital myasthenia or receptor 
mutations)25,69; and the muscle (e.g. muscle dystrophy26). 




Congenital myasthenia directly targets the AChRs resulting in muscle weakness and fatigue25. There 
is a growing interest in understanding this neuromuscular condition and an increasing amount of 
novel information about AChRs can be gleaned from these studies. Using techniques other than 
those focussing on gene transcription has yielded more information about changes in morphology. 
Several studies indicate that NMJ morphology is altered in dystrophic skeletal muscle26, although, 
again, most studies have used denervation models. 
1.6.4 Effect of denervation and disease on NMJ morphology 
In normal uninjured muscle, each end-plate is innervated by a single axon.  Magill et al. (2008) 
showed the degeneration/regeneration relationship between the innervating axons and their motor 
end-plates in the tibialis anterior muscle of mice subjected to sciatic nerve denervation27. Confocal 
microscopy showed denervation of all end-plates at one week following injury. At 14 days following 
injury, partial reinnervation had occurred and observations at 21 and 28 days saw the hyper-
innervation of end-plates – with instances of more than one axon per end-plate. By 42 days, the 
relationship between axon and end-plate was restored to the 1:1 ratio seen in normal muscle. 
However, this study did not note the number of end-plates present or assess the level of structural 
disorganization of the end-plates that lost their neural stimuli. 
Ma et al. (2005) saw no influence on NMJ morphology of the gastrocnemius muscle (assessed by 
surface area and gutter depth of junctional folds) from denervation by BoTX A injection at 14 days 
after the intervention30. While NMJs became larger as the mice matured over 30 days, at 60 days 
after BoTX injection the gutter depth was significantly reduced in comparison to the saline injected 
contralateral leg which served as the control30. This denervation effect diminished over time and by 
6 months, gutter depth of the injured gastrocnemius returned to near-control levels. At 360 days 
post injection NMJ gutter depth in control and experimental muscles was uniform again. 
Hirata et al. (2005) reports the complete loss of accumulated AChRs in muscle 1 day after 
denervation by an injection of bupivacaine14.  
Pratt et al. (2014) depicted the morphological changes in the NMJ in intact, dystrophic and 
lengthening injured WT mice26 where NMJs of dystrophic mice lack organization and were far more 
vulnerable to injury, losing what little organization they had and clumping into islands (see Figure 
1.7). 




Schmidt et al. (2011) observed a loss of synaptic branches in ErbB mutant mice with AChRs 
developing perforations – seen by presence of AChE activity in areas with no positively stained 




1.7 The muscle contusion injury model 
1.7.1 Definitions of different muscle injury models 
In light of this study, additional injury models involving the muscle were investigated. As with nerve 
injury models, different categories of in vivo, mechanical muscular injuries also exist:  
A. Laceration - a cut of any nature that severs muscle fibres 
B. Elongation - caused when a muscle is stretched beyond its capacity – common in activities 
demanding eccentric contractions26.  Certain muscle fibres can also become torn in this 
manner 
C. Strain - caused when intense and rapid contraction is demanded of a muscle. Such 
contractions can be too strong for muscle fibres to resist 
Figure  1.7 NMJ morphology  of  normal (wild type ) mice (A, B)  and  dystrophic  
(mdx )mice (C, D)  in  uninjured quadriceps muscle (A, C) and quadriceps after 
injury induced by lengthening contractions .  Image from Pratt et al., 2013. 




D. Muscle denervation – (same as in Nerve Injury models) is also used as an intervention for 
muscle damage and regeneration studies43 
E. Muscle contusion injuries – can be classified as either invasive or non-invasive and include: 
F. Muscle crush - a precise surgical procedure where the skin is incised and exposed muscle is 
clamped, for example between a pair of tweezers, and a pre-determined force is exerted 
onto the structure60,70,71 
G. Mass drop injury - caused by impact from a blunt object onto the muscle. The limb 
containing the target muscle (either surgically exposed prior to injury or unexposed) is 
carefully positioned on a specially designed apparatus that causes a crushing blow to that 
area3,46(see Figure 1.8) 
Invasive contusion injury models (muscle crush or mass drop injury with exposed muscle) include the 
likelihood of local and systemic inflammatory responses to the surgery which may complicate 
findings. This model, however, would be appropriate for crush injuries occurring in workplace or car 
accidents when lacerations may indeed be present. In the arena of contact sports, the majority of 
impact injuries are non-invasive. Therefore this study uses the non-invasive mass drop injury model 
to assess muscle damage and regeneration which will henceforth be referred to as the muscle 
contusion injury. 
1.7.2 Introduction 
According to the American Journal of Sports Medicine, contusion and strain injuries make up 
approximately 90% of all muscle-related sports injuries72. Muscle contusion injuries result from 
events where a blunt non-penetrating object impacts on the skeletal muscle, crushing the local 
tissue3. Muscle groups in the arms, hands, legs, feet, and buttocks are most commonly affected3, and 
contusion injuries are especially prevalent in the quadriceps and gastrocnemius muscle groups in the 
legs73. 
Contusion injury leads to a weakening of the muscle tissue’s structural components therefore 
decreasing functional efficiency - to a greater or lesser degree depending on the extent of the injury. 
An injury sustained by skeletal muscle can also impair or alter bone healing and dictate the long 
term success of prosthesis, if the magnitude of the injury is such to include skeletal system 
damage74. 
Not only does a contusion injury cause mechanical damage to the muscle fibres, it can also rupture 
the surrounding capillaries and harm or restrict the motor neurons that innervate the impacted 




muscles. These events lead to further complications such as blood pools in the area through the 
ruptured capillaries forming painful haematomas3 and impaired neurons and associated structures 
result in ineffectual communication between the nerve and the muscle25.  
1.7.3 Muscle regeneration following contusion injury 
Muscle tissue has developed remarkable ways of repairing itself, a process known as skeletal muscle 
regeneration. When a muscle is subjected to an injury it suffers disruption of fibre structures, decay 
of cellular structures and cell rupture. In response to these injuries debris is cleared (by immune cell 
activity) and the existing fibre/s are either rebuilt or new replacement fibres are generated. Satellite 
cells are key role players in these events providing additional nuclei and muscle protein synthetic 
potential to the cause. Extensive research tracks the activation and migration of these cells to 
injured sites3,36–38,43,46,49,71,75,76. 
1.7.4 Characteristics of the contusion injury jig 
The muscle contusion injury model with a specified apparatus – the contusion injury jig – has 
previously been used by our research group. The jig was designed and produced by our engineering 
faculty3,77 and met the criteria for use in rat models: The exact height was determined in order to 
generate a moderately severe contusion injury, without creating further complications such as 
limping or compartment syndrome3. Later, an adapted apparatus allowed for contusion studies in 
mouse models77. The adapted apparatus for mice was used in this study.  
The specialized contusion injury jig consists of a narrow, cylindrical tube set on a heavy platform (see 
Figure 1.8 and 2.3). The design involves releasing a pin, holding up a small weight (35 g) from the 
desired height (ranging from 10 – 30 cm). This weight falls onto another weighted cylinder (4.5 
mm2), carefully positioned on the desired muscle, with a small circular platform (of same diameter) 
positioned under the muscle to ensure the desired impact without a momentum-derived movement 
of the lower limb3,77. 
1.7.5 Selection of muscle group 
The majority of research for both neuromuscular components and satellite cells has utilized the 
soleus19,60,62,67 the tibialis anterior 9,11–13,20,27,64,78,79 or the gastrocnemius muscle10,29–31,40. Given the 
nature of the contusion injury jig, the size and accessibility of the gastrocnemius muscle made it the 
prime choice for this investigation, without incurring complications such as bone damage. 
 






1.7.6 Selection of Time points 
For selecting relevant time points for AChR analyses, the literature employing nerve injury models 
was carefully considered (see Table 1.2).  
Early studies selected sampling time points within hours of nerve injury (by a 5mm surgical excision 
of the sciatic nerve), e.g. Goldman et al. (1988) analysed mRNA expression of AChR subunits α, β, δ 
and γ (by RNA blotting) from male Sprague Dawley rats selected time points at 0, 5, 10, 48  and 72 
hours post injury62. Later, the same research group (indicated with *) performed qPCR analysis of 
AChR subunit expression - with the addition of adult type ε-subunit – in time points that extended 
into several weeks post injury (7, 14 and 30 days)56.  In this study, groups of male Sprague Dawley 
rats were subjected to various nerve injury models, namely: i) nerve transection; ii) chronic blockade 
of impulse conduction by tetrodotoxin (TTX); iii) chronic blockade of neuromuscular transmission by 
α-bungarotoxin (α-btx); iv) single injection of botulinum toxin (BoTX) or v) nerve crush. 
Following on from these studies, Kues et al. (1995) from the same research group used a 
combination of time points from the previous studies, performing similar qPCR analysis on various 
days focussing on more early time points: 0, 1 ½, 3, 5, 7, 12 and 14 days post injury. Both male 
Sprague Dawley and Wistar rats were used and were subjected to nerve injury either by surgical 
excision (5 mm) of the sciatic nerve or chronic conduction block to the sciatic nerve by TTX60. 
For microscopy studies, Gervasio et al. (2007) selected a similar combination of time points from 0 to 
10 days post injury (2-3 mm surgical excision of sciatic nerve) for confocal microscopy and confocal 
Figure 1.8 The mass-drop contusion 
injury jig 




Fluorescence Resonance Energy Transfer (FRET) visualisation of AChRs and rapsyn in female FVB 
mice12. 
Gigo-Benato et al. (2010) performed light microscopy analysis for neural cell adhesion molecule 
(NCAM) and neurofilament protein on samples from male Wistar rats subjected to a sciatic nerve 
crush injury with time points commencing 3-4 days later than those of Gervasio et al., i.e. at 3, 5, 7, 
9, 11 and 14 days post injury 64. 
Pinter et al. (2003) selected days ranging from 1, 3, 5, 7, 10, 21, 28 and 35 days post injury for H&E 
as well as AChE analysis of samples from male Wistar rats subjected to an extreme surgical excision 
(length of 30 mm) from the sciatic nerve67. Magill et al. (2007) again followed a period of weeks post 
sciatic nerve crush injury (1, 2, 3, 4 and 6 weeks) and visualisation was done on whole mount 
samples of the tibialis anterior of homozygous thy1-YFP mice, using confocal microscopy to identify 
axons, AChRs and Schwann cells27. 
Studies by Ma and Shen et al. (2005, 2006, 2007) use time points that extend up to 1 year (3, 7, 14 or 
15, 30, 90, 180 and 360 days) post injury, either by local BoTX injection (gastrocnemius)30,31 or nerve 
transection (tibial nerve)29.  Their analysis included qPCR of all AChR subunits29,30 as well as MuSK, 
myogenin, MRF4, IGF-1 and P2131. Ma et al. (2005) performed additional confocal microscopy 
analysis of NMJ morphometry (assessed by AChR staining) on muscle segments taken from the 
gastrocnemius (taken adjacent to the motor end-plate area) at 2 weeks, 2 months, 6 months and 1 
year after local BoTX injection30. 
Taken together the above studies have selected time points that included early response, early 
regenerative response and long-term recovery. In our laboratory, we have previously focussed on 
early time points:  Macaluso (2009) made use of the following time points: 0 (control), 4 hours and 1, 
2, 3, 5 and 10 days to assess the mouse specific contusion injury jig77. Rotter et al. (2008) used a 
muscle crush injury model and chose time points: 1, 7, 14 with an extra, far later point of 42 days70. 
Considering these time points, this study elected a combination of 1, 3, 5, 7, 10, 14, 21, and 28 days 
for post-injury analyses. 
1.8 Linking Satellite cells to the Neuromuscular Junction 
There are some studies have investigated the possible involvement of satellite cells in the 
regeneration of injured NMJ14,43,71,80.  
Vigue et al. (1997) counted of satellite cells in denervated rat muscle by means of electron 
microscopy and demonstrated a 2- to 3-fold increase in their number during the first few weeks 




following denervation80. Later, Borisov et al. (2005) observed long term SC regeneration efforts in 
denervated muscle at 1, 2, 4 and 7 months post denervation by identifying and quantifying the 
presence and number of small myotubes (products of SC differentiation)43. They found a significant 
increase (12- to 14-fold that of the control muscle) by the end of the first month following 
denervation. By 2 months after denervation, an extraordinary 44-fold increase over the control was 
noted. The presence of these small myotubes decreased by 30% and 60% from the level observed in 
2 month denervated muscle after 4 and 7 months of denervation, respectively43. 
Increased densities of satellite cells have been detected at the NMJ3,5 with about 20-fold greater 
frequency than at non-junctional regions in adult rat and human muscles5. A review by Zammit et al. 
(2006) included a sterling image of an immunohistochemically stained isolated soleus myofibre, 
displaying Pax7 stained SCs distributed in the proximity of the NMJ37 (see Figure 1.9). This 
accumulation of SCs can be explained by factors secreted by the nerve which attract the SCs58. In 
return, when the nerve suffers damage and disconnection from the NMJ, it is credible to hypothesise 
that the SCs are activated (through muscle signals and perhaps the sudden lack of neural signals) and 
accelerate the NMJ regeneration process especially of the endplate. 
Hirata et al. (2005) presented one of the few studies to use immunohistochemical techniques to 
assess both the NMJ with α-btx and SCs with BrdU in regenerating muscle (tibialis anterior) after 
denervation. However, staining for these two role players was performed separately on consecutive 
sections and no BrdU+ myonuclei were shown in the vicinity of the NMJs14. 
Court et al. (2008) conducted a different study that also used immunohistochemical staining with 
both α-btx for AChRs and BrdU for SCs. Again, they used separate, consecutive sections. 
Interestingly, they investigated a cell that covers, or ‘caps’, the NMJ by using novel cytoskeletal 
antibody 216657. Failure of M-cadherin, N-CAM and desmin staining to label these cells ascertained 
that the NMJ capping cells were not in fact satellite cells. 
Numerous studies exist that investigate the effects of denervation on gene expression of AChR sub-
units of the AChR12,27,29–31,56,60,62,64,67 (See Table 1.2 Nerve injuries and time points). However, there is 
a lack in literature reporting the effects of injuries of a different nature on the AChR subunit mRNA 
expression. Furthermore, while some studies have considered a role for SCs in NMJ regeneration5, 
visual proof of this has yet to be presented. On the one hand, this allowed for a novel model to be 
used. On the other hand, this also posed methodological issues that needed to be resolved. 








1.9 Study Design Considerations 
1.9.1 Introduction 
This study required the selection and use of antibodies and techniques that were not familiar to our 
research group. These novel components warranted additional investigation and the factors to 
consider are discussed below. 
1.9.2 Super-resolution imaging of NMJ structure 
1.9.2.1 Previous super-resolution studies 
NMJs are a popular structure for the community of neurophysiology researchers using 
immunofluorescent techniques; however most super resolution experiments are focused on the 
developing and diseased NMJ26,34,69. 
Shi et al. (2012) beautifully illustrated the development of the NMJ from 5 days postnatal to the 
matured adult NMJ81 (see Figure 1.6). 
Pratt et al. (2014) depicted the morphological changes in the NMJ in intact, dystrophic and muscle-
lengthening injured WT mice26 where NMJs of dystrophic mice lacked organization and were far 
more vulnerable to injury. Upon injury, these poorly organized NMJs were disrupted and dispersed 
into scattered islands of signaling proteins (see Figure 1.7). 
Figure 1.9 Satellite cells’ distribution in proximity to NMJ in soleus muscle. A) Soleus myofibers 
usually have an accumulation of satellite cells (Pax7, green) around the motor end plate (α-btx, red) 
where the motoneuron contacts the myofibre (B) All nuclei present were identified using 4,6-
diamidino-2-phenylindole (DAPI) counterstaining (blue). From Zammit et al. (2006). 




Schmidt et al. 2011 observed a loss of synaptic branches in ErbB mutant mice with AChRs developing 
perforations – seen by presence of AChE activity in areas with no positively stained AChR69. This 
study created 3D images by means of combining confocal image stacks. 
Although such advances are appearing in the literature, the study in this thesis was the first to focus 
in depth on the NMJ degeneration and regeneration using immunohistochemistry, as well as 
observing the effects of injury on the surrounding muscle tissue. 
1.9.3.2 Selection of antibody for NMJ visualization 
Nicotinic acetylcholine receptors are the best-studied of the ionotropic receptors53,54. Two 
discoveries have allowed for the extensive study of these receptors, namely: 
A. The finding of the AChR-rich electric organ of the fish, Torpedo californica. This provided an 
abundance of AChRs for receptor purification53,54. 
B. The discovery of α-bungarotoxin (α-btx) - a neurotoxic component of krait snake (Bungarus 
multicinctus) venom. α-Btx binds to the α-subunit of the AChR and inhibits its function, 
resulting in debilitation of the NMJ and paralysis of the affected myofibres53,82. The 
advantage is that the binding is quite specific.  
The efficacy of α-btx in labelling AChRs has made it the trade mark probe in immunohistochemical 
analyses12,26,36,76,80,57,83–85. The tetramethyl-rhodamine α-bungarotoxin probe (from Molecular 
ProbesTM) alone boasts over 100 publications in its product bibliography that have utilized this 
probe.  The popularity of this probe may be a substantial reason for the synonymy of AChRs and the 
NMJ in immunofluorescent research. 
Other antibodies used in NMJ research include various antibodies against presynaptic (e.g. 
neuregulin78, syntaxin12, synaptophysin69 and neurofilament69) and postsynaptic (e.g. Lrp485) 
components. Another popular method involves staining for AChE activity which involves a very 
simple, but effective staining protocol56, although immunohistochemical staining for AChE is also 
used69. 
For this thesis, an AlexaFluor® 488 conjugate of α-btx (Life Technologies, B13422) was used due to 
the preferred fluorescent brightness; pH insensitivity and greater photo stability than other variants 
of α-btx82. 




1.9.3 Satellite Cell detection 
1.9.3.1 Introduction 
SCs were originally detected in frog skeletal muscle by means of electron microscopy in 196136,86. 
Fortunately, scientists have described a number of molecular markers expressed by quiescent, 
activated and proliferating SCs, allowing researchers to illuminate the role of these dynamic cells 
under light microscopy. Below are some of the popular SC markers used in many laboratories: 
 CD56/NCAM – a membrane marker that recognises the neural cell adhesion molecule 
(NCAM) and stains both quiescent and activated SCs. CD56 also stains lymphocytes (natural 
killer cells); nerves, neuromuscular junctions and the cytoplasm of the occasional 
myofibre3,40,41. This multi-staining does not allow for specificity unless co-stained.  
 M-cadherin – a transmembrane protein that’s expression is upregulated in activated SCs41 
 Pax7 – is a popular marker for SCs and specifically labels quiescent and activated SCs37 
 The myogenic regulatory factors (MRFs) – staining with antibodies for these SC markers 
(Myf5, MyoD, Mrf4 and Myogenin) allows one to ascertain which phase the identified SC is 
presently undergoing. 
Many immature cells, such as SCs, go through proliferation prior to differentiation. During DNA 
replication nucleotide insertion can be tracked, for example using administration in vivo of 
bromodeoxyuridine (BrdU) with subsequent analysis of samples using an anti-BrdU AlexaFluor® 555 
conjugated antibody. 
1.9.3.2 Definition of Bromodeoxyuridine  
Bromodeoxyuridine (BrdU) is a synthetic thymidine analogue which incorporates itself into a cell's 
DNA when the cell is dividing (during the S-phase of the cell)87–89. BrdU is commonly used in the 
detection of proliferating cells in living tissues or as a cell cycle marker. It is administered to animals 
either shortly before euthanasia or as a chronic treatment88–90. A common reason for chronic 
administration is to monitor the proliferation of experimentally administered stem cells90.  
1.9.3.3 Selection of method of Bromodeoxyuridine dose administration 
BrdU (molecular weight 307.1) has a half-life of roughly 5-6 hours, according to Harvard Department 
of Stem Cell and Regenerative Biology88, although this will vary depending on the dose given. BrdU 
doses range mostly from 50 mg/kg up to 200 mg/kg for rodents (see BrdU in vivo dose table in 
Appendix I). 






Methods of BrdU administration considered for this study included: 
 Intra-peritoneal method – Animals receive a single or multiple BrdU injections over the 
course of the experiment. Boston Guidelines recommend daily IP injections (~ 2 mg in 100 μl 
of sterile saline) for mice90. This method is relatively simple and effective, although repeated 
injections can cause stress to the animals. (See Appendix I for a table of BrdU in vivo doses 
used in different studies.) 
Since satellite cells start proliferating a few hours after injury37, an initial IP injection at the 
time of injury is a good start – especially considering that the animal is under anaesthetic at 
that time so discomfort is minimized. 
Drinking Water method - A daily dose of between 0.25-1mg/ml is recommended for up to 6 
weeks before sacrifice/analysis88, This method is preferred for longer term studies where 
BrdU incorporation can be detected in proliferated cells for up to 70 days (after a design of 
receiving 9 consecutive days of drinking water containing BrdU; followed by a no further 
administration)87. However, this mixture must be prepared daily, and discarded BrdU 
solution from the previous day renders this method both wasteful and expensive87. In 
addition, oral administration may lead to lower plasma levels than IP administration and 
thus eliminates the chance to precisely control the exact time and level of BrdU ingested – 
introducing variability into the experiment88. 
Osmotic pumps - insertion of mini-osmotic pumps (either IP or subcutaneously) filled with a 
BrdU solution of desired concentration allows for consistent administration of BrdU 
(releasing a certain tiny dose every hour). This overcomes the 5 - 6 hour time limit of BrdU in 
the blood system and thus proves to be more consistent, effective and superior to both of 
Figure 1.10 BrdU incorporation into dividing 
cells. From Conboy et al  2007 




the above-mentioned methods. Although expensive, this method is far less invasive than 
daily IP injections. 
BrdU incorporation is detected in areas such as the small intestine, thymus and bone marrow just 30 
minutes post-injection, while in other tissues it can usually be detected within 24 hours87. It is 
important to determine the amount of time it takes for BrdU to incorporate into the tissue in 
question (in our case, skeletal muscle) as this, along with the short in vivo half-life of BrdU and the 
invasiveness of IP injections forces one to make critical decisions in order to settle for the best 
number and timing of injections delivered. 
  




1.10 Aims and Hypothesis 
Methodological Aims 
The study in this thesis includes a number of methodological aims for the establishment of the 
desired animal model and sample analysis.  
A. To induce a standardised skeletal muscle contusion injury in mice using a non-invasive 
technique 
B. Depicting muscle fibres in longitudinal section in a) intact and b) injured skeletal muscle 
C. Identifying the most effective method of BrdU administration for the tracking of proliferated 
satellite cells by quantifying number of BrdU+ stained myonuclei per myofibre 
D. Successfully imaging BrdU+ cells and NMJs (represented by α-bungarotoxin stained AChRs) in 
the same myofibre  with immunofluorescent microscopy and counting number of BrdU+ cells 
residing beneath each NMJ as well as in the surrounding area 
Thereafter the following hypotheses could be tested:  
Injury to both muscle fibres and associated peripheral NMJs will result in: 
A. Elevated mRNA levels of fetal (γ) but not adult (ɛ) AChRs, measured by qPCR, in injured but 
not in non-injured mouse gastrocnemius muscle in days following muscle contusion injury 
that will be similar to that found with other models of denervation.  
B. Altered a) morphology and b) arrangement of the NMJ end-plate will be visible on relatively 
intact muscle in the border zone of the injury 
C. Different morphologies for the intact, injured and regenerating NMJs in gastrocnemius 
muscle are visible under immunofluorescent microscopy 
D. Decreases in surface area and volume of the NMJ with injury and, upon regeneration, 
increases towards normal levels as seen in the intact NMJ. 
E. Proliferation of SCs (quantified by counting of BrdU+ myonuclei) in gastrocnemius muscle in 
days following muscle contusion injury 
F. BrdU+, proliferated satellite cells located beneath the NMJ in gastrocnemius muscle in the 
later days following muscle contusion injury 
  




Chapter 2 Materials and Methods 
2.1 Study Design 
2.1.1 Animals 
Male BALB/C mice were bred at the University of Cape Town Research Animal Facility. Once weaned, 
animals were housed in the Small Animal Unit in the Department Physiological Sciences at 
Stellenbosch University. Animals were divided and housed in groups of six for the duration of the 
study, with the exception of the mice implanted with mini-osmotic pumps containing BrdU, for the 
labelling of satellite cells. These mice were housed individually after their pump implantation 
surgery. All animals had access to food and tap water ad libitum and were exposed to a 12 hr 
light/dark cycle (lights cycle starting at 6:30am). Ambient temperature was controlled at 21 - 24°C, 
and rooms ventilated at 10 changes/hour. Mice were handled regularly and cages were cleaned 
once a week (minimum). All experimental protocols were approved by the Animal Ethics Committee 
of Sub-Committee B of Stellenbosch University, (SU-ACUM12-00025).  
All mice were allowed to reach maturity (>8 weeks; mean weight: 24.16 ± 2.66g) before subject to 
any intervention. 
2.1.2 Experimental groups 
Preceding the onset of the implantation surgery and contusion injury, experimental mice were 
randomly divided into the following groups: 
A. Mice for PCR analysis (PCR; n = 48; 6 mice per time point) – subjected to injury only. 
B. Mice for immunohistochemistry (IHC) analysis (BrdU; n = 42; 6 mice per time point) – 
subjected to pump implantation surgery and injury. 
The mice in each group were further divided according to the specific time-points that they would be 
sacrificed after the contusion injury. These time points were set at 1, 3, 5, 7, 10, 14, 21 and 28 days 
post-injury. The 21 day time point was excluded from the BrdU group due to limited availability of 
mini-osmotic pumps. 
The contralateral non-injured leg served as the control for all animals. As the insertion of mini-
osmotic pumps is a standard BrdU administration technique (see Appendix I), no sham group was 
included. 




2.1.3 Intervention protocols 
The study included 2 intervention protocols:  
A. Implantation surgery of mini-osmotic pumps for BrdU administration (BrdU group only) 
B. Muscle contusion injury 
Briefly, the pump implantation was followed immediately by the mass-drop contusion injury, after 
which the animals were allowed to recover and muscle samples were collected at the specified time 
points after injury for subsequent analysis. 
In the BrdU groups, BrdU delivery via the pumps continued throughout, up to the point of sacrifice, 
with the exception of the 28 day group: these pumps were removed after 14 days to avoid 
complications of a depleted pump. 
Mice were weighed before anaesthesia in both groups and were weighed again just before sacrifice. 
The study design is outlined in Figure 2.1. 
  






Figure 2.1 Study Design. Mice were divided into two groups –PCR and IHC (with BrdU). The BrdU 
group received pump implantation surgery and both groups were subjected to a contusion injury by 
a mass-drop technique in one leg only (injured leg).The contralateral leg served as control (non-
injured leg).  Animals were sacrificed on days 1, 3, 5, 7, 10, 14, 21 and 28 post injury. Gastrocnemius 
muscles from both legs were collected and either snap frozen (PCR group) or cryo-preserved (BrdU 
group). Histology for the BrdU group included H&E as well as IHC staining. IHC stained tissue was 
analysed by confocal microscopy, super resolution imaging and 3D renders of images. 




2.1.3.1 Pump implantation 
Pump Priming 
Alzet® mini-osmotic pumps (model 2001, 1.0 μl.h−1 release rate and 200 µl volume) were prepared in 
a sterile environment the evening before implantation. Priming was performed according to 
instructions on www.alzet.com/. Pumps were filled with 50 mM BrdU (Sigma-Aldrich, Inc.; B5002, 
CAS 59-14-3, dissolved in 1x PBS) and left to prime overnight at 37°C (See Figure 2.2). 
Anaesthesia 
Mice were anaesthetised (Ohmeda Isotec 4) in a pyrex container, inhaling 3% Isoflurane (Isofor, 
Piramal Health Care; 28/2.1/0165) in 100 % oxygen for induction. Following onset of anaesthesia, 
the mouse was placed in prone position on the work board, with its head placed in a mobile tube 
connected to the Isofluorane supply. Flow rate was reduced to 2 % isoflurane for maintenance of 
anaesthesia. 
Implantation surgery 
Surgery instruments were sterilised with 70% alcohol commencing each surgery step and in between 
each surgery. Pump insertion was performed in groups of 6 mice each at 9am on the specified day 
assigned to each time group (7 groups in total) – spanning a period of two weeks. Pumps were 
implanted according to Reyskens (Ethics Application 11NF_REY01), under the guidance of animal 
technician, Mr Noel Markgraaff. 
An area ± 2.0 cm long and 1.5 cm wide was shaved slightly posterior to the scapulae and sterilised 
with 10% iodine solution (Dismed Pharma; Q/13.1/65) followed by an alcohol swab. 
Skin was lifted up with a pair of wide-tipped forceps and a section of ± 1.0 cm was cut horizontally 
above the pelvis. A haemostat was inserted under the incision to spread superior subcutaneous 
tissue and create a pocket 0.5 cm longer than the pump (each pump is 3 cm in length and 0.7 cm in 
diameter). The pump was inserted snugly with the open end of the pump furthest from the incision 
to prevent the escape of BrdU solution through the healing incision wound (See Figure 2.2). 
It was ensured that the bottom end of the pump fits in at a lower level than the incision area. It was 
closed with two sutures in order to create an elevation of the stitched area. This was done to 
prevent the mouse from gnawing the stitches loose. Mice received a 1 ml injection of buprenorphine 
(Schering-Plough, Temgesic®, Nr. L/2.9/157.56) to relieve any pain resulting from surgery. 




Additionally, mice were housed individually to prevent any potential violent behaviour or gnawing 









Contusion of the hind limb was created by a non-invasive apparatus (see Figure 1.7 and 2.3). 
Briefly, the lower section of the apparatus comprised a large metal platform, with a small cylindrical 
platform in the centre, on which the hind limb of the animal rested just prior to and during injury. A 
plastic tube fastened perpendicularly to and directly above the smaller platform directed the 
passage of the flat, circular weight (mass = 35 g; impact surface area = 4.5 mm2) from the desired 
height (11 cm) to the area of the muscle identified for injury. A steel peg placed in one of the holes 
in the plastic tube kept the mass in place at the desired height above the muscle, so that its removal 
resulted in a standardised mass dropping speed (see Figure 2.3).  
A string is attached to the weight which is held loosely during injury and pulled tight immediately on 
impact to prevent a rebounding, second contusion injury. 
Procedure 
Mice were placed under anaesthesia as described in section 2.1.3.1. The left leg was shaved to 
prevent the weight from slipping off the sleek fur. This was done just before the injury was 
performed for PCR animal group, and prior to the pump insertion for the BrdU animal group. The 
injury immediately followed the pump implantation surgery for the BrdU animal group, while they 
were anaesthetised. 
Mice were turned to supine position with left hind limb held at a right angle to create a bulge in the 
calf and expose the medial portion of the gastrocnemius muscle. The calf was positioned on the 
Figure 2.2 Alzet® mini osmotic pump priming (left) and 
insertion into mouse (right). 




platform, with the leg moderately extended away from the animal to prevent injuring the underlying 
bone. The positioning weight was placed slightly distal from the belly of the gastrocnemius muscle to 
target the maximum number of neuromuscular junctions, located in this central area of the muscle 
(see Figure 2.4). 
Samples are referred to as GI (injured gastrocnemius) and GN (non-injured gastrocnemius). 
Directly post-injury, mice were allowed to recover in their respective cages and monitored until 
regaining consciousness. 
2.2 Sacrifice and sample collection 
2.2.1 Sacrifice 
Entry of mice into the intervention protocols was staggered so that no more than 2 groups were 
sacrificed on a single day. All sacrifice procedures took place between 09:00 and 11:00 in the 
morning to ensure accuracy of time point. All experimental animals were weighed prior to sacrifice 
and killed by cervical dislocation. The chest was observed to ascertain no signs of heart beat and 
toes were pinched to ensure no toe-spreading reflex occurred. After sacrifice, both left injured and 
right control gastrocnemius muscle were excised (see Section 2.2.2). 
2.2.2 Muscle collection 
Within 5 minutes of cervical dislocation, each mouse was laid in supine position. The gastrocnemius 
muscle of the each hind leg was exposed by an incision made across the shin and the skin and 
connective tissue surrounding the muscle was removed. 
One arm of a fine tipped forceps was inserted at the attachment of the Achilles tendon and slid up to 
separate the calf muscle complex (gastrocnemius, soleus and plantaris). The connecting fascia (top) 
and Achilles tendon (bottom) were cut to free the calf complex from the leg. Remaining fascia was 
cut and soleus and plantaris muscles were pulled away from the gastrocnemius. The gastrocnemius 
was trimmed before cryostorage so only the injured central area and a sufficient amount of 
surrounding muscle tissue remained.  
For preliminary histology and IHC work, the gastrocnemius, soleus and plantaris muscles were stored 
for analysis. 













Figure 2.3 A) Position of mouse with contusion injury jig. B) Location of Contusion Effect 
of different impact areas on the Calf Muscle Complex. i) Standard belly of muscle impact 
(red star) affects the lateral and medial portion of the gastrocnemius (red areas in image 
iii) better for cross-sectional muscle injury studies. ii) Posterior positioning of impact area 
adapted to target the middle portion of the muscle (orange areas in image iii). This 
positioning was used for this longitudinal section study targeted at the neuromuscular 
junctions. (Positioning the weight too close to the bone results in the contusion impact 
affecting the soleus (SOL) and plantaris (PLA) muscles rather than the gastrocnemius 
(GAS). This also runs the risk of fracturing the bone. The red line indicates the midline of 
the calf complex with the medial head of the gastrocnemius on the left and the lateral 
head on the right. The yellow line indicates the impact point of the contusion injury 
weight. Visual interpretation from verbal descriptions by Dr Filippo Macaluso). 
A) 
B) i) ii) iii) 




Muscles from the BrdU group were laid in longitudinal orientation on a square of cork, immediately 
coated in Tissue Freezing Medium® (Jung; 03702259) and immersed in pre-cooled isopentane 
(Merck KGaA, Darmstadt, Germany; 1.07177.1000). Muscles destined for PCR analysis were placed in 
1.5ml eppendorf tubes and snap-frozen in liquid nitrogen. All samples were carried in a tank of liquid 








2.3 Sample analysis 
Three different analytical procedures were used: 
A. mRNA isolation and RT-PCR analysis were performed on snap-frozen muscle tissue 
B. Histological staining and visualization of muscle sections 
C. Immunohistochemical analysis of muscle sections and individual neuromuscular junction 
(NMJ) complexes 
2.3.1 Cryo-sectioning 
Muscle samples were placed in the cryostat (Leica CM1860 UV Cryostat) at 25°C to adjust to the 
cryostat temperature for 1 hour. Each sample was fixed to a specimen platform with Tissue Freezing 
Medium® (Jung, 03702259) – applying either the cork square base of the BrdU samples or directly 
placing the muscle onto the specimen platform for snap frozen samples undergoing PCR analysis. 
Samples were securely frozen to the platform within a minute and were secured in the specimen 
cylinder for cryo-sectioning. 
Figure 2.4 Exposed gastrocnemius muscle 5 days post-injury showing A) non-injured and B) 
injured leg (white arrow shows impact area). 




BrdU samples were sectioned longitudinally at a thickness of 10 µm. Sections were then pressed 
onto a slide coated with poly-L-lysine (Sigma Aldrich; P4707) and stored in a sealed container at -20 
°C until staining.  
PCR samples were sectioned longitudinally at a thickness of 20 µm, placed in a 1.5 ml eppendorf 
tube and weighed until 30 - 40 mg of tissue was obtained. Tissue was suspended in 750 ml of TriPure 
Isolation Reagent (Roche Diagnostics GmbH; 11667165001). Eppendorf tubes were placed on ice 
until stored at - 80°C for further use. The remainder of the tissue was placed back into its original 
eppendorf tube and kept at – 80 °C for possible further analysis. 
2.3.2 PCR 
2.3.2.1 RNA preparation 
Cryosectioned muscle tissue was homogenised (Kinematica; Polytron PT2100). Chloroform (Sigma 
Aldrich, C2432) was added and the sample was left to stand for 10 minutes before being centrifuged 
at 12 000 g for 15 minutes to separate tissue mRNA from DNA and protein. mRNA was carefully 
removed and added to a new eppendorf tube containing 2-propanol (Sigma Aldrich, I9516). The 
mRNA sample was shaken, left to stand for 10 minutes at room temperature and then centrifuged at 
12 000 g for 10 minutes to separate mRNA from the liquid. The supernatant was removed and the 
mRNA pellet was left to dry before being resuspended in 70% ethanol (Sigma Aldrich, E7023). It was 
then centrifuged at 8500 g for 6 minutes to remove any excess 2-propanol from the pellet. Ethanol 
was removed and pellet left to dry. Once dry, the pellet was resuspended in Tris/Borate/EDTA (TBE) 
buffer (Ambion®; AM9849) for subsequent mRNA quantification. See Appendix A for detailed 
protocols. 
2.3.2.2 RNA quantification 
1 µl mRNA was added to RNAse free water (Sigma® Life Sciences; W4502) at a concentration of 1:20 
and was quantified using the Nanodrop Lite Spectrophotometer (Thermo Scientific), according to 
Appendix B. 
2.3.2.3 Reverse transcription (RT) 
Residual genomic DNA was eradicated by incubating samples at 30°C for 20 minutes with the use of 
the DNAse 1 enzyme from the DNAse 1 recombinant RNAse free treatment kit (Roche Diagnostics; 
04716728001). 0.2M EDTA (Ambion®; AM9260G) was added and the sample was heated to 75°C for 
10 minutes to inactivate the DNAse 1 recombinant. mRNA was reverse transcribed into cDNA using a 
Transcriptor first strand cDNA synthesis kit (Roche Diagnostics; 04896866001). Random Hexamer 




primers were added and sample heated on a Thermal Cycler 2720 (Applied Biosystems) for 10 
minutes at 60°C to denature any secondary structures present in the mRNA. Buffer (5x); Reverse 
Transcriptase Enzyme; protector RNAse and deoxynucleotide triphosphate (DNTP) were added and 
samples underwent the following heat treatments: 10 minutes at 25°C (for random hexamer binding 
to mRNA); 60 minutes at 50°C (for RT enzyme conversion of mRNA into cDNA) and 5 minutes at 85°C 
(for inactivation of the RT enzyme). See Appendix C for RT protocol. 
2.3.2.4 Quantitative Real Time Polymerase Chain Reaction (qPCR) 
Targeted genes were the adult and fetal AChR isoforms - AChR-ε and AChR-γ respectively - as well as 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a house-keeping gene. Samples were 
analysed in 96 well plates, running 2 plates per gene to accommodate the amount of samples (i.e. 6 
plates in total). Each plate included 2 control samples (from non-injured leg of a mouse from the 
practise group) as reference samples for mRNA calculation (see Section 2.3.2.5). 
Two-Step qPCR was performed on the StepOne Plus™ Real time PCR System (Applied Biosystems).  
Samples were run in duplicate at a concentration of 50 ng cDNA for GAPDH and 100 ng cDNA for 
AChR-ε and AChR-γ. 
Genes were primed using TaqMan® Probes (Applied Biosystems; Mm00437411_m1 (for AChR-ε); 
Mm00437419_m1 (for AChR-γ); Mm03302249_g (for GAPDH)). Each PCR reaction contained cDNA of 
sample, primer, H2O and TaqMan® Gene Expression Master Mix (Applied Biosystems; 4369016) 
according to Table 2.1. 
Table 2.1 Reagents for PCR reaction for GAPDH, AChR-ε and AChR-γ genes and RT-PCR cycle 
conditions. 
Gene  cDNA Primer H20 Master Mix 
GAPDH 1 µl 1 µl 8 µl 10 µl 
AChR-ε 2 µl 1 µl 7 µl 10 µl 
AChR-γ 2 µl 1 µl 7 µl 10µl 
     
 
Cycle conditions for qPCR were: 
A. 95°C for 5 min for DNA denaturation and synthesis of 1st cDNA strand 




B. 40 cycles at 60°C (1min) (primer binding and reading) and 95°C for 15 seconds for 
completion of 2nd cDNA strand, PCR amplification of cDNA 
In the reverse transcription (RT) step, cDNA is reverse transcribed from RNA. In the PCR step, PCR 
products are quantitatively synthesized from cDNA samples using the TaqMan Gene Expression 
Master Mix. 
Fluorescence was measured after each cycle according to the equation: 
ΔRn = Rn (post-PCR read) – Rn (pre-PCR read) 
where Rn refers to the normalized reporter dye. The ΔRn is henceforth referred to as the cycle 
threshold (CT). 
Days 21 and 28 were omitted from qPCR analysis due to financial constraints of running extra plates. 
2.3.2.5 Calculation of 2ddct values 
Quantification was plotted by the 2(-Delta Delta (CT)) calculation according to Livak & Schmittgen 
(2001)91. 
CT values were plotted on Microsoft Excel and 2ddtt values were determined by the following 
calculations: 
              (       )            (       ) 
        (      )     (               ) 
2-ddct = Final value 
E.g. of calculation (Sample:  Mouse 1, Day 1): 
                   (           )            (           ) 
                    
          
        (      )     (               ) 
                
           
2-ddct = 0.095061 





Longitudinal sections (L/S) (10 μm) were stained with haematoxylin and eosin (H&E) (see Appendix 
D) to subjectively visualise the injured area by observing the extent of immune cell infiltration, fibre 
oedema and damaged myofibres (see Figure 2.6). 
2.3.3.1 H&E staining 
Briefly, frozen sections were left in their respective coplin jars to thaw at room temperature (RT) for 
3 minutes. Sections were then rinsed in distilled deionised water (ddH2O) before being stained with 
Haematoxylin Solution (Merck Chemicals (Pty) Ltd; SAAR282200ILC) to stain the basophilic structures 
(i.e. structures containing nucleic acids such as cell nuclei). Differentiation from background staining 
was achieved by bleaching with acid alcohol (280ml 100% ethanol, 120ml ddH2O; 1,2ml HCl). Scott’s 
Tap Water (2g NaHCO3 + 20g MgSO4.7H2O + 1l dH2O) was used to give haematin structures a blue 
appearance92. Cells were stained with eosin (5 wt % solution in H2O) (Sigma Aldrich; 318905) to 
visualise intra- or extracellular proteins (mostly cytoplasm and red blood cells)3. 
2.3.3.2 Image analysis 
Sections were imaged using a Nikon ECLIPSE E400 microscope. Images were captured using the 4x, 
10x, 20x and 40x objectives to gain better overview and more detailed images on contusion injury in 
longitudinally sectioned muscle samples. 
  




















2.3.4 Immunohistochemistry (IHC) 
2.3.4.1 Reagents 
The following markers were used in IHC studies: 
A. α-Bungarotoxin (α-btx)  - stains the acetylcholine receptors of the neuromuscular junction 
B. anti-Laminin – stains laminin, a structural protein of the sarcolemma, which delineates 
boundaries of nascent and mature myofibres 
C. anti-BrdU – stains BrdU+, proliferated nuclei , i.e. satellite cells and white blood cells 
D. Hoechst – stains all nuclei (e.g. myonuclei, satellite cells, white blood cells) 
Figure 2.5 H&E staining trials to observe myofibres in longitudinal sections using plantaris muscle, 
7 days post-contusion injury. A) 10x magnification depicting infiltrating immune cells on left hand 
side of connective tissue (scale bar: 200 µm) B) 20x magnification of new, thinner myofibres being 
regenerated (scale bar: 100 µm)  C) 40x magnification of individual nuclei of cells involved in the 
regeneration processes (scale bar: 50 µm)  D) Non-injured plantaris muscle (10x magnification) 









 All dilutions were made with 10x phosphate buffered saline (PBS). 
Details of the primary and secondary antibodies used for immunohistochemistry are summarised in 
Table 2.2 below: 
 
 







1:50 B35131 Invitrogen, 






Bungarus multicinctus 1:1000 B13422 Invitrogen, 
Life  Technologies, 
Molecular Probes 
 
Laminin Rabbit polyclonal 1:250 Z0097 Dako 
 
Secondary antibodies 
AlexaFluor® 594 Donkey anti-rabbit 1:250 A21207 Life Technologies 
 
Nuclear stain 




Detailed procedures for IHC staining are listed in Appendix E.  
Briefly, slides were dried and sections were encircled with a wax pen to confine the reagents within 
the area of the section. Non-specific binding sites were blocked by incubating the sections with a 
combination of 5 % donkey serum (Jackson ImmunoResearch Laboratories, Inc.; 017-000-001) and 
10% Bovine Serum Albumin (Roche Diagnostics, Mannheim, Germany; 10735086001) at room 
temperature for 60 minutes. The serum was then drained off and sections requiring DNA 
denaturation were treated with 4 M hydrochloric acid (HCl) (Merck (Pty) Ltd,; SAAR3063040LP) for 
30 minutes. HCl was washed off and sections neutralised with PBS for 10 minutes.  Primary antibody 
was added to the slides and left to incubate overnight at 4 °C in a humidified environment to prevent 
drying out. From here on slides were kept in the dark in a humidified environment. Slides were 
washed with 0.1 M PBS (1 ℓ of 1 M phosphate buffer, 90 g NaCl, 9 ℓ ddH2O; pH 7.4) prior to addition 
of the secondary antibody (raised in donkey). After 60 minutes of incubation at RT, slides were 
Table 2.2 Antibodies used to identify muscle membrane (laminin), acetylcholine receptors (α-btx), 
satellite cells (BrdU) and myonuclei (Hoechst). 




washed with PBS and a nuclear stain, Hoechst 33342 (Sigma-Aldrich, Schnelldorf, Germany; 14533), 
was added for 15 minutes. Sections were washed with PBS and coverslips were mounted on labelled 
slides with fluorescent mounting medium (Dako, North America, Inc.; 53023). Throughout the 
staining protocol, slides were kept in the dark in a humidified environment. PBS controls were used 
to test the specificity of the antibodies. 
PBS controls were used to test the specificity of the antibodies. 
Combinations with other antibodies can be seen in the ‘trouble-shooting’ section in Appendix H. 
Earlier work was imaged using a wide field microscope (Olympus IX81 Wide field) at magnifications 
of 4x, 10x and 20x for L/S laminin trials and α-btx optimization. Sections stained with anti-BrdU 
AlexaFluor® 555 conjugate and confocal images for NMJ morphology were imaged on a confocal 
microscope (Carl Zeiss LSM 780 with Elyra S.1 super-resolution platform).  
A diode laser was used to detect Hoechst-stained nuclei; an argon laser was used to detect 
AlexaFluorTM488 and a helium-neon laser was used to detect AlexaFluorTM555 and 594. Ranges for 
detection of the various wavelengths for confocal images of NMJs were 410-515 nm for Hoechst; 
490-586 nm for AlexaFluorTM488; and 623-753 nm for AlexaFluorTM594. In BrdU images, the ranges 
for AlexaFluorTM555 and AlexaFluorTM594 were slightly different with (560 – 595 nm and 618-654 nm 
respectively) to avoid overlap between their closely associated fluorescent spectrums. 
2.3.4.3 Tile scan analysis of NMJs arrangement on longitudinal muscle sections 
Samples from the day 14 group for both GI and GN muscles (n = 6 per GI/GN group) were selected 
for NMJ analysis over the whole muscle. Samples were cryosectioned and sections were stained 
immunohistochemically in a two-step manner (see Pilot study 3). Firstly slides were stained with for 
α-btx, anti-laminin and Hoechst (see Appendix E with options 10.1 and 12.1). Coverslips were 
mounted temporarily using 1x PBS. Tile scans were taken at 10x magnification on a confocal 
microscope. Number of tiles ranged from 4 by 4 to 7 by 7, depending on the size of muscle sample. 
Using the tile scan as a reference, separate images were taken of all the NMJs on each section at 40x 
magnification for better visualisation of NMJ shape and structure as well as number of subsynaptic 
nuclei. Coverslips were then removed and sections underwent the second staining step with anti-
BrdU and Hoechst (step 6.3 of Appendix E, option 10.2 and 12.2). 
Slides were re-mounted with fluorescent mounting media and images were taken in the same view 
as individual NMJ, located by use of the initial tile scan as well as laminin and light transmission for 
topographical similarities. Single colour stained controls were used to optimise detection settings, in 




order to eliminate spill over between the dyes, especially AlexaFluorTM555 and AlexaFluorTM594 
fluorescence separately. 
2.3.4.4 Analytical method for NMJ classification and presence of subsynaptic nuclei 
NMJs in each section were counted and categorised according to appearance as Over (O), Around 
(A), Side (S) or Tip (T). 
For each NMJ the following was counted: 
• Subsynaptic nuclei 
• Subsynaptic nuclei enclosed by laminin 
• Number of NMJs per number of fibres in view 
Once re-stained with BrdU, number of BrdU+ subsynaptic nuclei was also investigated. 
2.3.4.5 3D analysis of NMJ morphology 
NMJ selection 
Separate longitudinal sections from mice at day 5, 7 and 14 post-injury were stained 
immunohistochemically with α-btx for NMJ visualisation; anti-laminin for myofibre membrane 
visualisation and Hoechst for nuclei (according to Section 2.3.4.2). NMJs representing the various 
regenerating states and orientations on the sectioned myofibre were selected from the different 
samples. Confocal images (40x magnification) of the area containing the selected NMJs for each 
chosen position on each section were taken in order to select NMJs with various characteristics (e.g. 
en face, side view, injured). After confocal imaging, these NMJs were located and imaged with Super 
Resolution Microscopy. 
Super Resolution Imaging 
Selected NMJs were imaged using the super-resolution platform of the microscope. Z-stacks were 
acquired to include the whole neuromuscular junction in the section. Super-resoluiton images were 
processed using Carl Zeiss ZEN2011 software and visualised as 3D constructs. 3D images of each NMJ 
were produced through Structured Illumination using Zen Black 2011 software.  
Surface Area Measurement 
Surface area of each NMJ was measured using Image J version 1.47.  Positive threshold was 
determined and surface area measurement was provided in µm2  




3D Rendering and Volume Measurement 
3D Rendering and volume measurements were performed using VGStudioMax 2.2 software. 
TIFF files of each Z stack image were analysed as 16-bit images to create a 3D model of each super 
resolution image. A region of interest (ROI) was selected per NMJ for images containing more than 
one NMJ and surface area was determined by measuring all positive signal within each image 
(images with only 1 NMJ) or ROI (images containing more than one NMJ ). Edge threshold was 
determined to exclude any autofluorescence surrounding the NMJ structures. Background was 
extracted and volume was analysed by surface determination across the three planes. The angle of 
the image was then rotated to produce an image that showed the most informative view of the 
NMJ. 
Analysis 
NMJs were categorised according to 1) their appearance on the sectioned myofibre; 2) their integrity 
and 3) organisation of surrounding laminin and nuclei. Surface area and volume were compared 
across the time points post injury as well as in intact samples and between categories of NMJ 
orientation (e.g. side view; en face; diagonal section).  
2.4. Statistical analysis 
Statistical analysis was done using GraphPad Prism 5 software. Column analyses were performed for 
PCR data using one way analysis of variance (ANOVA) with Bonferroni post hoc tests, comparing all 
columns. p<0.05 was accepted as significant. Outliers of more than 2.5 times the standard deviation 
were omitted from analyses. The Means of each time point were calculated in Prism. Weights at 
time of Injury (WtI*) and at Sacrifice (WtS*) were compared separately for each time point and two 
tailed T-tests were done between each pair of weights.  
2.5 Pilot studies 
Due to the variability in methods reported in the literature to administer 5-Bromo-2’-deoxyuridine 
(BrdU), it was necessary to optimise the experimental procedure. In order to achieve this, two pilot 
studies were carried out. These are discussed below. 




2.5.1 Pilot study 1: Comparison between two different BrdU brands (Sigma 
and Life Technologies) in C2C12 cells and BALB/C mice 
2.5.1.1 Introduction 
The use of BrdU incorporation into the satellite cells is a new method for our research group and 
two popular brands of BrdU were chosen to compare in order to obtain the best BrdU results 
possible. These products were: 
A. Sigma - 5-Bromo-2’-deoxyuridine (B5002) 
B. Life Technologies - 5-Bromo-2’-deoxyuridine (B23151) 
We tested the efficacy of these two brands in both in vitro (C2C12 cells) and in vivo (BALB/C mice) 
models (see Appendix I for a summary of BrdU doses from the literature). 
2.5.1.2 Materials and Methods 
Immunocytochemistry (ICC) 
First, the BrdU was tested in cell culture on C2C12 (ATCC CRL-177 D57962; Yaffe and Saxel, 1977) 
muscle cells. Cells were routinely cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma 
Aldrich, Schnelldorf, Germany; D5796) supplemented with 10% Fetal Bovine Serum (FBS), 1% 
Penicillin Streptomycin (Gibco® from Life Technologies; 15410-122) and 1% L-glutamine (Sigma® 
Germany; G7513) in a 37°C humidified incubator (Shell Lab) with a 5% CO2 (see Appendix F). Two T75 
flasks of cells were cultured for 2 days, allowing them to reach 60% confluency. Sigma BrdU was 
added to one flask and Life Technologies BrdU to the other, at a concentration of 10µM for both 
brands (see Appendix J). Cells were left to proliferate for 12 hours. Cells were stained according to 
Appendix G with various concentrations of anti-BrdU antibody (1:50; 1:100; 1:200; 1:500 and 
1:1000). 
Immunohistochemistry (IHC) 
Mice were given intraperitoneal (i.p.) injections of both brands of BrdU on days 0 and 1 post-injury 
(injury as in section 2.1.3.2.3 and muscle harvesting as in section 2.2). Cryo-sectioned muscle was 
stained according to section 2.3.4.2 with anti-BrdU 555 conjugate and Hoechst to view BrdU+ cells 
co-localised with Hoechst-stained nuclei to confirm positive staining. 




Imaging for both cells and mouse muscle was performed on a Confocal Microscope. Nuclei stained 
by both Hoechst and anti-BrdU were accepted as cells that had already proliferated or were in the 
process of proliferating. 
2.5.1.3 Results 
No quantitative data was obtained for images captured. 
In the in vitro studies, only the Sigma brand at a 1:50 concentration showed successful BrdU 
incorporation (see Figure 2.6). 
In the in vivo studies, both brands showed BrdU positivity, but the Sigma BrdU displayed brighter 
fluorescence than Life Technologies (see Figure 2.7), in agreement with the ICC trial. 
2.5.1.4 Conclusion 
We found the Sigma brand superior as a high concentration (1:50) of the Sigma anti-BrdU antibody 
achieved positive BrdU staining in proliferating C2C12 myonuclei in vitro, while the Life Technologies 
brand showed no BrdU positive stained myonuclei. Although the most potent brand and 
concentration were clear, this study was performed before adding a step of incubation in HCl (see 
Appendix I). The importance of the HCl step is to depermeabilize the nuclear membrane in order for 
the anti-BrdU antibody to penetrate the nucleus and bind to the BrdU incorporated in the DNA. The 
HCl step is discussed further in Pilot Study 3 in Section 2.5.3. 
However, the sections obtained in the in vivo study were stained with the improved immuno-
staining protocol, which included the HCl step (see Appendix E). Here the superiority of the Sigma 
brand is observed and henceforth decided to proceed with the Sigma BrdU for the upcoming 
experiments. 
2.5.2 Pilot study 2:  Viability of intraperitoneal (i.p.) injection method for 
delivery of BrdU 
2.5.2.1 Introduction 
The injection time points for BrdU needed to be optimised in order to determine which combination 
of days before and after contusion injury would label the greatest number of proliferating cells. The 
literature concerning injection time points for satellite cell studies varies greatly as seen in Appendix 
I. Frequency of i.p. injections range from once before injury93, on combinations of days post injury7, 
daily75 and even twice per day9 following injury (see Appendix I for BrdU Dose Tables).  




As BrdU remains in the body for 5-6 hours, and our facilities do not have suitable restraining facilities 
for the rather invasive daily i.p. injections, it was important to determine which combination of days 
would yield the most BrdU incorporation into the greatest number of dividing satellite cells. 
2.5.2.2 Materials and Methods 
Mice (n = 6) were administered i.p. injections of 0.3256M BrdU on different combinations of days 
before and after contusion injury (see Section 2.1.3.2.) as seen in Figure 2.9. The mice were 
restrained manually and received their injections without anaesthesia. A single mouse per time point 
combination was used due to the large number of combinations and the limited amount of BrdU 
available for time point determination. 
Mice were sacrificed at 7 days post injury and muscle was excised and preserved as per Section 2.2.1 
and 2.2.2. Sections were stained according to the BrdU steps in the IHC protocol (see Appendix E) 
and analysed on the confocal microscope. 
2.5.2.3 Results 
No quantitative data were obtained for the images captured. 
‘Mouse F’ - which received intraperitoneal (i.p.) BrdU injections on days 0, 1 and 3 post-injury -
showed the greatest occurrence of BrdU+ cells(see Pilot 3 for images of BrdU in tissue from Mouse 
F). 
Figure 2.8 Study Design with combinations of BrdU injection treatments for mice A – F. D
0
 
denoted the day of contusion injury (I*), negative values represent days before contusion injury 
and positive values represent the number of days after contusion. Animals were sacrificed (S*) 7 
days post injury (D
0
 + 7). 





Treatment combination for Mouse F was considered the best combination for i.p. administration of 
BrdU. However, through observations on Mouse F during its treatment, it was decided that the 
regular i.p. injections were too stressful for the animal and we investigated the option of inserting 
mini-osmotic pumps, an invasive, but once-off procedure. This would ascertain a constant delivery of 
BrdU to the muscles and overcome the obstacle of the limited time BrdU is available in the body. 
A trial of the mini-osmotic pumps was run in BALB/C mice (n = 2) to learn pump insertion surgery as 
well as to determine the efficiency of BrdU delivery via the pumps. Pump implantation was as per 
Section 2.1.3.1 and mice were sacrificed at 14 days post injury. Immunohistochemically stained 
gastrocnemius muscles from the injured and non-injured leg showed satisfactory BrdU= results (See 
Figure 2.10 and 2.11).  
2.5.3 Pilot study 3: HCl trials to permeabilize nucleus for BrdU visualisation 
2.5.3.1 Introduction 
In order to visualise BrdU in the nucleus, nuclear DNA must be denatured into single-strands. This 
allows the antibody to bind to the BrdU, incorporated into the nucleotide sequence. Failure to reach 
the BrdU results in no specific binding and fluorescence, as seen in Figure 2.12. Various methods to 
denature DNA exist, including subjection to acid, microwave treatment, rapid heating, or DNase 
treatment (Magavi et al. 2008). Hydrochloric acid is a popular, simple and readily available agent for 
nuclear depermeabilization (see Appendix I). We opted for treatment with hydrochloric acid (HCl) 
for this study. 
While most literature suggests treatment in 2M HCl for 30 minutes (see Appendix J), little success 
was seen with this method and it was decided to investigate various combinations to ascertain the 
best method for this study. 
2.5.3.2 Materials and Methods 
Sections from Mouse F (Pilot Study 2) were analysed and stained according to the IHC protocol in 
Appendix E, using HCl (Merck (Pty) Ltd; SAAR3063040LP) in Step 6 in the following dose/time 
combinations: 
A. 2M HCl for 30 min 
B. 2M HCl for 60 min 
C. 2M HCl for 90 min 




D. 3M HCl for 60 min 
E. 4M HCl for 30 min 
Samples were tested in duplicate with one section receiving treatment with Sudan Black instead of 
1x PBS for the acid neutralising Step 7 in Appendix E. 
2.5.3.3 Results 
The most successful DNA denaturation was observed with 2M HCl for 90 minutes. Treatment with 
4M HCl for 30 minutes resulted in the brightest BrdU+ fluorescence, but the Hoechst stain was 
compromised (see Figure 2.12 E,F). 
2.5.3.4 Conclusion 
Treatment with 4M HCl exhibited brighter fluorescence, but the intense acidity compromised the 
Hoechst stain, which was necessary to ascertain specificity of BrdU staining. Therefore, treatment 
with 2M HCl for 90 minutes was chosen as the best method for DNA denaturation. 
However, in IHC work the following year on mice used for this study, the chosen treatment was not 
effective and 4M HCl for 30 minutes option was revisited. This treatment proved effective, without 
compromising the Hoechst stain and was continued henceforth. 
An important discovery was made in further trials to image BrdU+ satellite cells and NMJs together, 
when it was realised that treatment with HCl destroyed the α-bungarotoxin stained AChRs (see 
Figure 2.13). 
HCl trials using concentrations as low as 0.5M and 1M for 30 minutes resulted in complete lack of 
AChR staining. Alternative DNA denaturing was attempted with 1:1 methanol/acetone. But this 
proved ineffective for BrdU staining. 
A two-step staining protocol was created to overcome this problem (see Section 2.3.4.3). Briefly, 
cryosectioned muscle was initially stained with α-btx, anti-laminin and Hoechst; imaged to locate the 
NMJs; incubated with HCl (which destroyed the NMJ fluorescence) and stained with anti-BrdU and, 
once again, Hoechst to ensure brightness of myonuclei to determine colocalization of BrdU within 
the myonucleus. 
Other options like using DNAse as a nuclear permeabilizing agent offer an attractive solution for 
imaging BrdU and the NMJ together as opposed to the two step method mentioned above. 
However, time constraints prevented the exploration of these options. 







Figure 2.6 Sigma BrdU fluorescence in C2C12 cells. Myoblasts 12 hours 
after of proliferation in BrdU supplemented growth media. Hoechst (blue) 
stains every nucleus while BrdU+ nuclei (red) represent nuclei of daughter 
cells from a divided myoblast. 







Figure 2.7 IHC staining of BrdU from Life Technologies (A, B) and Sigma Aldrich (C, D). Two mice 
received equal concentrations of the respective brands’ BrdU in equal doses and were stained 
with the same IHC protocol. Sigma Aldrich’s product displayed brighter fluorescence and 
specificity in BrdU+ cells than Life Technologies’ product, in agreement with the ICC trial. 














Figure 2.9 BrdU administration via mini-osmotic pump delivery showing presence of 
proliferated myonuclei in non-injured gastrocnemius muscle. 

















Figure 2.10 BrdU administration via mini-osmotic pump delivery in injured gastrocnemius muscle, 
14 days post injury. Hoechst stained nuclei (blue) co-stained with BrdU (red). 
A B 
Figure 2.11 No presence of BrdU
+
 cells in tissue not subjected to DNA denaturing step. Injured 
gastrocnemius stained for BrdU, without the HCl step showing A) light transmission, Hoechst (blue) 
and BrdU (red) and B) Hoechst and BrdU. No positively stained BrdU cells are observed. 
 








Figure 2.12 BrdU+ presence after different concentrations of HCl and incubation periods in 
gastrocnemius muscle, 7 days post injury. A,B) 2M HCl for 30 minutes; C,D) 2M HCl for 90 minutes 
and E,F) 4M HCl for 30 minutes. A, C and E) BrdU
+
 cells (red) co-localised with Hoechst stained nuclei 
(blue) and B, D, F) BrdU
+
 cells only. 
  







A B C D 
Figure 2.13 Presence of NMJ without HCl. A section that did not receive HCl treatment showed NMJs that were not visible on consecutive sections treated 
with HCl. NMJ visible with A) light transmission, α-btx (green) and Hoechst (blue) and B) α-btx and Hoechst at 40x magnification. Note: C) the immaculate 
network structure of this NMJ and D) the particularly dense cluster of subsynaptic nuclei (blue). Scale bar = 50 µm. 
Stellenbosch University  https://scholar.sun.ac.za




Chapter 3 Results  
Mice used to investigate mRNA expression of AChR subunits did not receive BrdU administration or 
have osmotic pumps surgically inserted. These mice are discussed in Section 3.1.1. Mice used in 
histological experiments (with the exception of the plantaris muscle used for initial intact NMJ 
studies seen in Section 3.6.2, 3.6.3 and 3.6.4) did receive osmotic pump insertion surgery and 
subsequent BrdU administration. These mice are discussed in Section 3.1.2.  
(Please Note: All Results microscopy figures can be found at the end of the Results chapter.) 
3.1 Body mass of mice 
3.1.1   Without osmotic pump insertion 
The mean weight of mice at the time of injury was 24.1 g. There were no significant differences in 
mean body mass between mice from different groups. For most of the groups, there were also no 
significant increase in body mass between the day of injury and the day of sacrifice. However, there 
was a significant increase in body mass between injury and sacrifice in the 28 day group (+ 3.7 g; p < 























Mouse Mass - PCR group 
Mass at Injury
Mass at Sacrifice
Figure 3.1.1 Changes in mouse body mass over time, for mice sacrificed between 1 and 28
days post-injury. Data are presented as means of body mass (n = 6 mice per time point), 
with Standard error. Each group was weighed on the day of injury (pale blue) and the day of 
sacrifice (dark blue). Stars indicate degree of significance: **** (p<0.0001) within group 
from pre-injury to sacrifice. 




3.1.2  Before osmotic pump insertion and at sacrifice 
Mean weight of mice at the time of injury was 24.3 g. There were no significant differences between 
groups at this point in time. 
Mean weights in most groups of mice increased in proportion with the number of days post-injury, 
with an additional increase of ± 1.1 g - contributed by the weight of the mini-osmotic pump inserted 
at the time of injury (see Figure 3.1.2). 
Changes in differences between means in time points that were less than 1 week between day of 
injury and day of sacrifice (days 1, 3 and 5) were smaller (< 2.0 g). Of these, only the day 3 group 
showed a significant increase (1.21 g; p < 0.05). Larger increases (>2.0 g) were seen in time points 
that extended for 1 week or longer (days 7, 10, 14 and 28). These increases in body mass (2.28 g; 























Time point groups  
Mouse mass - BrdU group 
Mass at Injury
Mass at Sacrifice
Figure 3.1.2 Changes in body mass over time, for mice sacrificed between 1 and 28 days 
post-injury. Data are presented as means of body mass for n=6 mice per bar, with 
Standard error. Each group was weighed on the day of injury (pale blue) and the day of 
sacrifice (dark blue).  Stars indicate degree of significance: * (p<0.05); ** (p<0.01); *** 
(p<0.001) within group from pre-injury to sacrifice. 




3.2  Gene expression 
3.2.1  AChR-γ: qPCR readings 
Plates run for target gene AChR-γ contained very few acceptable cycle threshold (CT) readings (see 
Figure 3.2.1).  
All other groups had n ≥ 2 acceptable readings. Thus data for AChR-γ was not analysed further. 
3.2.2  AChR-ɛ: qPCR readings 
In the first week following muscle contusion injury, the expression of AChR-ε subunits in the injured 
(GI) remained low (See Figure 3.2.2). However, CT values for AChR-ε subunit mRNA in the injured 
gastrocnemius were significantly higher 7 days post-injury (1.598; p < 0.01) compared to earlier time 
points, with nearly a 5-fold increase from day 1 (0.3327; p < 0.0001) and a >3-fold increase from days 
3 (0.5237) and day 5 (0.4143) to day 7 (p < 0.01). Expression levels in GN decreased on day 10 to 
similar levels to the earlier time points. However, at day 14 levels increased significantly again (day1 
vs D14 and  day 5 vs day 14; p < 0.05) (see Figure 3.2.2). 
In the non-injured gastrocnemius (GN) expression levels remained low for the first 5 days (CT values 
were 0.4832; 0.4347 and 0.4725 for days 1, 3 and 5 respectively).As with the GI group, AChR- ε 
subunit expression peaked at day 7, with more than 3 fold increase in comparison to the earlier time 
points (1.507; p < 0.05). Levels further decreased by day 10, remaining significantly different to days 
1, 3 and 5 (1.536; p < 0.01), with a slight increase at day 14 (0.9813), which did not differ significantly 
from any of the other groups. 








Figure 3.2.1 StepOne® PCR readings of target gene AChR-γ on Plate 1 and 2 (both injured (GI) and non-
injured (GN) gastrocnemius samples). A) Combined amplification plot of readings of all the plated 
samples (Plate 1). B) Plate 1 (days 1 – 5) and C) Plate 2 (days 7 - 14) layouts showing sample numbers and 
outcome of each samples PCR reaction. Yellow flags indicate readings with error. “1” indicates cycle 
threshold values of sample duplicates differed by ≥1 unit; “2” means CT value was undetermined. Graphs 
in D and E) show a successful amplification plot for duplicates of the same sample of a single sample of an 
uninjured gastrocnemius from the day 1 group. 









3.3  Effects of the injury on the structure of the muscle 
3.3.1  Effects of the injury on the structure of the non-injured 
gastrocnemius 
Non-injured contralateral leg showed organized longitudinal fibres running parallel to one another. 
Groups of diagonally- and/or cross-sectioned myofibres were visible in the distal areas (near the 
origin or insertion points or on the borders of the section) in most of the samples. Eosin stained 
fibres appeared intact, with the exception of some samples that exhibited freeze fracture, 
particularly on the exterior portions of the cryo-preserved muscle. Connective tissue separated 
medial and lateral heads of the gastrocnemius and tendons were visible as large circular entities 
with dark pink-stained, wavy interiors of collagen fibres, surrounded by a lighter stained tendon 
sheath. Haematoxylin stained oval shaped myonuclei were present, spaciously arranged along the 
borders of the myofibres while rounded blood cell nuclei were only present in large numbers inside  
the blood vessels (visible as dark pink-stained rings of epithelium brimming with purple-stained 
nuclei) (See Figure 3.3.1.1). 
Figure 3.2.2 AChR-ε mRNA expression in the gastrocnemius muscle following muscle 
contusion injury, with contralateral leg serving as non-injured control. AChR-ε subunit 
expression in the gastrocnemius muscle following muscle contusion injury in mice. The 
epsilon subunit levels remained low in the early time points then dramatically increased 
at 7 days post-injury for both injured and non-injured groups (p < 0.05). Injured group 
decreases on day 10 then increases slightly by day 14. Non-injured group increases 
marginally on day 10 then decreases noticeably by day 14. GN data is set 0.2 units before 
and GI 0.2 units after the correct day for ease of viewing.  




Longitudinally sectioned gastrocnemius samples stained immunohistochemically for laminin and 
nuclei showed clear, straight, largely uninterrupted lines of laminin, lined with rows of myonuclei – 
adequately spaced from one another (see Figure 3.3.1.2). 
3.3.2 Effects of the injury on the structure of the injured gastrocnemius (GI) 
3.3.2.1 Border zones 
The border zone surrounds the area that received direct impact from the muscle contusion injury. 
The tissues in this zone are also affected by the injury but to a lesser extent than those receiving the 
direct injury. The border zone shows predominantly intact, organised fibres with some evidence of 
fibre tearing and regeneration (see Figure 3.3.3 A). Nuclei of blood cells are restricted to blood 
vessels although some smaller collections of infiltrating immune cells may be found in regenerating 
areas.  
3.3.2.2 Medial head - impact area 
The medial head of the gastrocnemius received the greatest impact from the contusion injury.  
Figure 3.3.3 B shows a severely impacted area, 14 days post injury, where Eosin-staining shows gaps 
and tears in the myofibres as well as multiple fragments of impacted fibres. Disorganisation and 
discontinuity of myofibres is evident in these samples.  Great immune cell infiltration is observed 
and close series of Haematoxylin-stained myonuclei align along the longitudinally sectioned, but still 
fragmented, myofibres. 
3.3.2.3 Lateral head – impact area 
At 14 days post injury lateral head of the gastrocnemius showed more fibre organisation than in the 
medial head, with a more advanced stage of muscle regeneration and fewer myofibre fragments 
(see Figure 3.3.4). Larger numbers of infiltrating immune cells are present in comparison to the 
medial head. Numerous areas where myonuclei have lined up in series along the regenerating 
myofibre are seen. 
Injured samples from the impact zone of the medial head, were prepared immunohistochemically 
and imaged to reveal sections with discontinuous portions of damaged fibres. Swelling fibres with 
large areas of oedema are evident. Sealing off of torn myofibres, scar tissue formation (parenthesis) 
and fibrosis occur in some areas (see Figure 3.3.2.3). 




3.4  BrdU incorporation 
Mice in Group B were injured on one limb after mini-osmotic pump insertion.  More BrdU+ nuclei 
were seen in blood cells than in the pool of myonuclei in the first few days, although later, more 
myonuclei were stained positively for BrdU. All images shown in this section are from injured 
gastrocnemius muscle. 
3.4.1 Blood cells indicating BrdU uptake 
At 3 days post injury, the proportion of BrdU+ cells in the blood stream is low (see Figure 3.4.1). By 7 
and 14 days post injury BrdU+ nuclei represent about half of the total blood cell nuclei visible (see 
Figure 3.4.2 and 3.4.3 as well as Video 1 on accompanying disc). 
3.4.2  Presence of BrdU positive nuclei in myofibres 
At 3 days post injury, very little BrdU+ cells were observed along the myofibres (see Figure 3.4.1). At 
day 5, individual satellite cells commencing the process of division and proliferation can be located 
(see Figure 3.4.4). By day 14, scores of oval shaped BrdU+ myonuclei occupy regenerating and 
regenerated myofibres (see Figure 3.4.5). BrdU+ satellite cells can be seen between the ends of torn 
myofibres, (see Figure 3.4.6). 
3.5 Neuromuscular junction appearance and location 
3.5.1  Cross-sectional view 
NMJs appeared as crescent-shaped entities in muscle cross sections, curving around the cylindrical 
myofibres (see Figure 3.5.1). NMJs of myofibres were present in sections taken from the middle 
portion of the cryo-frozen muscle sample. 
3.5.2  Longitudinal view 
NMJs visible in their classic coral-like formations in longitudinally sectioned muscle samples. NMJs 
are arranged along a central band - easily demonstrated in smaller muscles such as the plantaris (see 
Figure 3.5.2 and Video 4 on accompanying disc). Tile scans of entire gastrocnemius muscle showed 
NMJs also aligned in bands, but it proved more difficult to show the central position of NMJs in the 
larger muscle (see Figure 3.5.3). 
Some NMJs where only the top or bottom ends of the structure were present on that particular 
section were noted as small articles of fluorescence where only one or two junctional folds were 
evident (see 3D Figures in Section 3.5.4). 




3.5.3 3D imaging to investigate the relationship between NMJs and 
subsynaptic nuclei 
3D images of Hoechst stained myonuclei’s linear arrangement outlines the borders of the individual 
myofibres (see Figure 3.5.4). NMJs are visible on their respective fibres in close proximity to one 
another denoting the central band along which they are arranged. Close up views from various 
angles as well as videos created by linking the z-stack images in sequence reveal the subsynaptic 
myonuclei and how the NMJs are moulded over and around these supporting nuclei (see Video 2 
and 3 on accompanying disc). 
3.5.4 3D imaging to investigate NMJ structure 
Close up 3D images of intact NMJs reveal the intricate organisation of its junctional folds (see Figure 
3.5.5, A and B). Most NMJs observed portrayed the classic coral-like formation, while some NMJs 
displayed straighter processes with less folding (see Figure 3.5.5, C and D). Upon closer inspection, 
thin lines are etched out along the NMJ surface (see Figure 3.5.6). 
3.5.5 Changes in NMJ structures in contusion injured muscle 
Injured NMJ were discernible by their lack of organised (mature) structure as well as presence of 
scattered AChRs on the sarcolemma on either side of the myofibre (see Figure 3.5.7), or in the 
general area of the damaged NMJ if the surrounding membrane was disorganised. 
3.6 Time-dependent changes in NMJ morphology post contusion 
injury  
Uninjured and injured NMJs from mice days 0, 5, 7 and 14 (mouse: n = 1; slide: n = 1) were imaged 
and classified into categories in order to describe and compare the morphology of an intact, 
damaged and regenerating NMJ. A total number of 21 NMJs were analysed. 
3.6.1 Coral-like structure of NMJs in intact uninjured muscle (n = 1) 
The intact NMJ structure is well-organised, displaying clear junctional folds (see Figure 3.6.1). 
Surfaces seen on the 3D render appear smoother than in NMJs visualized on injured samples.  
3.6.2 Different degrees of fracturing and damage, 5 days post injury (n = 5) 
Two NMJs in see Figure 3.6.2 appear visible along the edge of the sarcolemma appear long, straight 
and thin with few junctional folds in confocal microscopy (referred to as Side view). A 3D rendered 
image reveals some junctional folds on both NMJs viewed in the side orientation. NMJ 1 displays a 
more scattered version of an NMJ in side view than NMJ 2.  




NMJ 1 and NMJ 2 in Figure 3.6.3 show a cohesive structural arrangement in en face view, but reveal 
a more jagged appearance in the 3D render than that of the intact NMJ. NMJ 2 shows scattering of 
AChRs on the far ends of the structure. NMJ 3 shows complete fracturing of the structure while 
retaining traces of the junctional fold arrangement. 
3.6.3 Severe damage and disintegration of NMJs, 7 days post injury (n = 4) 
NMJs appear scattered, are faint and show little form in confocal and super-resolution images (see 
Figure 3.6.4). The 3D rendered image reveals severe fragmentation as well as separation of entire 
sections of AChRs, as in NMJ 2. In NMJ 4 - the smallest structure - only three tiny clusters of AChRs 
are seen. These NMJs demonstrate the worst signs of damage between the injured groups. 
3.6.4 Varying degrees of repair and regeneration of NMJ structure, 14 days 
post injury (n = 11) 
In Figure 3.6.5 en face NMJ 1 shows some regained structure but lacks organisation. Increased 
magnification shows lack of complex organisation in NMJ 1 and scattered laminin deposits. 3D 
rendered images reveal deeper levels of organisation, but also expose scatterings of AChRs. 
The confocal and super-resolution images in Figure 3.6.6 show two en face NMJs that appear 
organised and robust, but denser than the uninjured NMJ from Figure 3.6.1. 3D renders reveal a 
considerable structural depth for these NMJs, indicating a greater number of AChRs in these 
regenerating NMJs than in the uninjured NMJ. NMJ 1 in Figure 3.6.6 shows some extending 
processes combined with its traditional junctional folding. The NMJ in Figure 3.6.7 exhibits solely 
extended processes (i.e. no junctional folds), but occupies similar space and depth as its en face 
counterparts. 
In Figure 3.6.8, en face NMJ 1 has repaired itself robustly and with some organisation although it 
appears to still be in the process of regrouping its fragments. It is likely that the strip of NMJ 2 could 
be fragments separated from the NMJ 1 upon injury, but not completely destroyed. 
 The NMJs in Figure 3.6.9 are scarcely visible, identified by minute, separated assortments of AChRs 
reaching across the myofibres. 3D renders revealed very little depth to these NMJs and they were 
categorised as Tip NMJs. 
NMJs in different orientations were also seen in the day 14 group. NMJ 2 in Figure 3.6.5 shows a 
NMJ in a diagonally sectioned orientation. This NMJ’s shape is sharply concave and 3D render shows 
considerable depth of structure, along with a great deal of scattered AChRs – characteristic of a 
damaged NMJ. An NMJ sectioned in a position in between a side view and an en face view was 




captured with its processes wrapping around the myofibre (see Figure 3.6.10 A). However, these 
curved processes were not visible in the super resolution image and thus also not visible in the 3D 
render (see Figure 3.6.10 B and C). 
3.7 Time-dependent changes in NMJ surface area and volume 
measurements post-contusion injury 
A trend of decreased surface area and volume was seen in the injured day 7 NMJs in comparison 
with the intact NMJ. However, in regenerating day 14 NMJs surface area and volume measurements 
were higher than the intact sample. Table 3.1 contains surface area and volume measurements for 
all the NMJs analysed in this study. 
3.7.1 Surface area 
In comparison over time (see Figure 3.7.1), the day 5 group’s NMJ surface area was similar to that of 
the uninjured specimen (Uninjured NMJ average = 96.4 µm2; Day 5 Injured NMJ average = 103.5 
µm2); surface area was markedly decreased on day 7 (39.9 µm2); and was highest overall on day 14 
post injury (average = 160.0 µm2).  
Considering the various categories of NMJ views, the en face NMJs possessed the greatest surface 
areas with measurements ranging from 96.4 µm2 to 222.9 µm2 (See Table 3.1 and Figure 3.8.1), with 
the exception of sample from day 5 NMJ 3 (53.5 µm2). NMJs in other orientations/categories 
(namely, Around, Side and Diagonal Section) fell within a decreased surface area range (between 
25.9 – 57.3 µm2).  
NMJs in Tip categories represented incomplete structures and were henceforth excluded from 
further comparison with the NMJs showing complete structures. 
3.7.2 Volume 
The intact NMJ in en face orientation occupied the lowest volume in their category with a 
measurement of 10 762 µm3, which fell generally in the lower overall range of the NMJ volumes (see 
Table 3.1 and Figure 3.9.2). At day 5 post injury, en face NMJ 1 and 3 remained level with the 
uninjured NMJ (15 283 µm3 and 12 767 µm3 respectively), while NMJ 2 displayed an inflated value of 
43 961 µm3. Day 7 NMJs showed a slightly decreased range (averaging 8 670 µm3) - the average 
being drastically increased by NMJ 2, adding a volume of 200 90 µm3 to the equation. The remainder 
of the NMJs 1 3 and 4 showed lower values (6 436 µm3; 6 241 µm3 and 1 914 µm3 respectively) - 




depicting a trend in agreement to what is seen in the surface area measurements. Volumes for day 
14 NMJs larger (averaging 27 299 µm3) and were more uniform than the aforementioned groups. 
The two Side NMJs from day 5 and the Around NMJ from day 14 had low values (Side: 5 825µm3 and 
12 748 µm3; Around = 7380 µm3), while the Diagonally sectioned NMJ had a remarkably large 
































Figure 3.7.1 Comparison of surface areas for intact and injured NMJs over time. Surface 
areas for en face NMJs at day 5 post injury remain constant, then decrease on day 7 with an 
exaggerated increase by day 14, in comparison to the uninjured NMJ. NMJ numbers correlate 
with those seen on the microscopy images. NMJs were selected from n = 1 mouse (muscle 
section: n =1) for each time point. In the day 14 group, A refers to Fig. 3.7.5; B to Fig. 3.7.6; C 
to Fig. 3.7.7 and D to Fig. 3.7.8.  Surface area was determined by measuring positive 
threshold on Image J version 1.47 software. 
n = 1 
n = 3 
n = 4 
n = 5 










3.7.3 Variation of z-stacks 
Volumes were divided by the number of z-stacks they encompassed obtain the average volume per 
Z-level. This illuminates the compactness or density of NMJs within the third dimension. 
The intact NMJ now had one of the highest densities in comparison with the other NMJs, presenting 
a value of 357 µm3 per Z layer. NMJ C from 14 days post injury had a density of 517 µm3 per Z-layer – 
a value far above the remainder of the NMJs in the day 14 Group as well as the uninjured NMJ. 
Day 7 post injury NMJs had lower densities: NMJ 4 had the lowest value of the day 7 post injury 
group at 70 µm3 and NMJ 3 had the highest value at 231 µm3. The diagonally sectioned NMJ 2 had 




























Figure 3.7.2 Comparison of volumes for intact and injured NMJs over time. Surface areas for en 
face NMJs at day 5 post injury remain constant (with the exception of NMJ 2), and then decrease 
on day 7 (except NMJ 2), where after there is an exaggerated increase by day 14, in comparison 
to the uninjured NMJ. NMJ numbers correlate with those seen on the microscopy images. NMJs 
were selected from n = 1 mouse (muscle section: n =1) for each time point. In the day 14 group, A 
refers to Fig. 3.7.5; B to Fig. 3.7.6; C to Fig. 3.7.7 and D to Fig. 3.7.8. Volume was determined by 
measuring positive threshold of a 3D render of the image on VGStudioMax 2.2 software.  
 Volume was determined by measuring positive threshold of a 3D render of the image on 
n = 1 
n = 3 
n = 4 
n = 5 




Table 3.1 Surface area; volume, z-stack number and volume/z-stack values of categorised NMJs 







Uninjured En face    96.4 10 726 30 357 
    Day 5 NMJ 1 En face /Border zone   112.9 15 283 52 293 
    Day 5 NMJ 2 En face, Border zone   144.0 43 961 57 771 
    Day 5 NMJ 3 En face, Border zone   53.5 12 767 57 223 
    Day 7 NMJ 1 En face, Scattered   25.9   6 436 46 139 
    Day 7 NMJ 2 En face, Scattered   38.0 20 090 93 216 
    Day 7 NMJ 3 En face, Scattered   56.8   6 241 27 231 
    Day 7 NMJ 4 En face, Scattered   38.7   1 914 27 70 
  Day 14 NMJ A1 En face    82.4 30 715 102 301 
  Day 14 NMJ B1 En face, Crushed  152.6 21 740 89 244 
  Day 14 NMJ B2 En face  222.9 29 477 89 331 
  Day 14 NMJ C En face, Extended  154.4 27 450 53 517 
  Day 14 NMJ D1 En face   187.6 27 112 83 326 
NMJs in different categories 
    Day 5 NMJ 1S Side   57.3   5 825 91 64 
    Day 5 NMJ 2S Side   44.7 12 748 91 140 
  Day 14 NMJ 1A Around   29.3   7 380 28 263 
  Day 14 NMJ 1T Tip   12.0   4 290 51 84 
  Day 14 NMJ 2T Tip     3.5   1 274 51 24 
  Day 14 NMJ 3T Tip   15.6   4 277 51 83 
  Day 14 NMJ A2D Diagonal Section   49.2 22 449 104 210 
 
3.8 Visualising BrdU and NMJs together 
After changing to a two-step staining procedure for α-btx and BrdU as described in Pilot 3 (Section 
2.5.3.4), proliferating satellite cells and NMJs could successfully be imaged in the same sample. Due 
to time constraints, only two samples (the injured and contralateral, non-injured gastrocnemius 
muscles from a mouse in the 14 days post-injury group) was imaged. This time point was selected, 
because it is expected that the most BrdU+ cells would be found when significant time has passed for 
cells to have proliferated.  




These images show BrdU+ nuclei occupying the same location as some of the subsynaptic nuclei 
(Figure 3.8.1). In certain areas, NMJs are surrounded by BrdU+ cells in addition to their subsynaptic 
BrdU+ nuclei. Figure 3.8.2 shows a NMJ with one BrdU+ myonucleus directly beneath it. This 
myonucleus is enveloped by a covering of laminin, proving that it is a true satellite cell residing 

















Figure 3.3.2 Immunofluorescent image of non-injured gastrocnemius muscle. IHC 
staining with anti-laminin (red) and Hoechst for nuclei (blue) at A) 10x (Scale bar = 200 
µm); and B) and C) at 40x magnification (Scale bar = 50 µm). Image B) includes light 
transmission. Fibres show organised myofibres and myonuclei. Immune cells (*) are 









Figure 3.3.1 Longitudinal section of non-injured gastrocnemius muscle (10x). An arrow 
indicates the layer of connective tissue dividing the medial and lateral head of the 
gastrocnemius.  Some fibres are seen in cross section (∆). The origin of the muscle shows the 
















Figure 3.3.3 H&E stained medial head of injured gastrocnemius muscle, 14 days post injury, during 
regeneration after severe damage (10x magnification). A) The Border zone shows minor damage. Fibres 
show a good level of organisation. Immune cells (*) are mainly restricted to blood vessels, although 
some smaller clusters of infiltrating immune cells are present (arrows). A few central myonuclei (†) are 
seen while the majority of the myonuclei line myofibre membranes in a normal fashion. B) In the impact 
zone, severe damage is evident. Fibres are discontinuous and lack organisation. Great numbers of 
infiltrating immune cells (*) show that debris is still being cleared and presence of central myonuclei (†) 
indicate myogenesis is at its infant stages. Some myotube formation is perceived along the periphery 
(white arrows). Scale bar = 100 µm. 
 
B A 
Figure 3.3.4 H& E stained tissue from the lateral head of injured gastrocnemius muscle, 14 days post 
injury in the impact zone, during regeneration following severe damage (A) 10x and B) 20x 
magnification. Great numbers of nuclei from both infiltrating immune cells (*) and satellite 
cells/myonuclei (†) are present. Organisation of regenerating fibres is imminent. Some fibres exhibit 
central alignment of myonuclei along regenerating myofibres (white arrows). Scale bar = 100 µm. 




Figure 3.3.5 Characteristics of a contusion-injured myofibre. Gastrocnemius muscle in longitudinal section 14 days post-injury with immunofluorescence A) 
with and B) without light transmission. Large areas of oedema (*) with sealing off of injured myofibre (arrows) are present. Necrotic myofibres experience 
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Figure 3.4.1 BrdU presence in the blood stream in injured gastrocnemius muscle 
tissue, 3 days post injury. IHC stained with anti-BrdU (orange) for proliferated 
nuclei and Hoechst (blue) for all nuclei. A) and C) show both anti-BrdU and 
Hoechst; B) and D) shows only anti-BrdU. A) and B) 20x magnification showing 
some BrdU
+
 cells (arrows). Red arrow shows two BrdU
+
 cells adjacent to one 
another indicating that they are daughter cells from the same proliferated satellite 
cell. C) and D) 40x magnification showing a blood vessel with relatively few BrdU
+
 
cells in comparison with later time points. Scale bar = 50 µm. 







Figure 3.4.2 BrdU incorporation in blood cells in injured gastrocnemius muscle tissue, 7 days 
post injury. More nuclei (blue) and BrdU (orange) presence shows  a dramatic increase in the 
efforts of infiltrating immune- and satellite cells to repair myofibre damage and clear debris. 
Scale bar = 50 µm. 
A B 
Figure 3.4.3 BrdU incorporation in blood cells in gastrocnemius muscle tissue, 14 days post 
injury. A) and D) show light transmission, Hoechst (blue) and anti-BrdU (orange); B) and E) show 
Hoechst and anti-BrdU; C) and F) show only anti-BrdU. An increased presence in BrdU
+ 
cells 
alludes to continued efforts as most of the debris has been cleared away and satellite cells are 
starting to lay foundations to rebuild damaged myofibres and form new ones if necessary. Scale 
bar = 50 µm. 
A B C 
D E F 










Figure 3.4.4 A satellite cell undergoing division (white arrow) in gastrocnemius muscle, 5 days 
post injury (40x magnification). Two characteristically oval shaped BrdU
+
 nuclei (orange) of 
satellite daughter cells soon after splitting in order to multiply and repair myofibre damage. A) 
With Hoechst stained nuclei (blue) to overlap BrdU stain confirming accuracy of BrdU detection 
and B) only BrdU. Scale bar = 20 µm. 
Figure 3.4.5 BrdU presence in severe contusion injury, 14 days post injury (20x magnification). 
Severe damage demands great efforts from the regenerative cells as infiltrating immune cells 
stream in and satellite cells proliferate considerably to seal off the injured myofibres and undergo 
recovery construction. Scale bar = 50 µm. 
A B C 





Figure 3.4.6 Satellite cells in the interstitial space between the ends of damaged fibres. A), B) and C) show a 20x magnification and D), E) and 
F) show a 40x magnification of the split in myofibres of the medial head of a gastrocnemius muscle 14 days post contusion injury. Images show 
BrdU
+ 
satellite cells (white arrows) forming new myotubes to bridge the expanse in an effort to reconnect the opposite ends of torn myofibres. 
A) and D) include light transmission while B), C) , E) and F) show only IHC staining with anti-BrdU (orange) and Hoechst (blue). Red arrow shows 
and BrdU
+
 immune cell, which is distinguishable from the satellite cells due to its rounded (instead of oval) shape. Scale bar = 50 µm. 
A B C 
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Figure 3.5.1 Intact gastrocnemius muscle depicting central location of NMJ in cross section (20x magnification).  A)  Image with light transmission and B) 
solely immunofluorescent image, stained with α-bungarotoxin (green) for AChRs and Hoecsht (blue) for nuclei. Crescent-shaped NMJs are seen wrapping 
themselves around the curve of the cylindrical myofibre. Imaged on Carl Zeis LSM 780 confocal microscope. Scale bar = 100 µm. 
A B 
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Figure 3.5.2 Intact plantaris muscle depicting central location of NMJ in longitudinal section. A) Light transmission image of myofibres in longitudinal 
section (4x magnification) B) Immunofluorescent image of same section stained with α-bungarotoxin (green) for AChRs and Hoechst (blue) for nuclei (20x 
magnification) (Scale bar = 500 µm). C) Zoomed in image of A). Imaged on Olympus IX81 Wide field microscope. 
 
C 
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Figure 3.5.3 Tile scans of the whole gastrocnemius section to locate NMJs and see arrangement 
along muscle. 7x7 Tile scan at 10x magnification of non-injured gastrocnemius sample, 14 Days 
post injury. A) Light microscopy and B) anti-laminin (red) and α-btx (green) (Scale bar = 1 000 
µm). C) Shows a zoomed in view of B) and NMJs are bordered with a block and assigned a 
reference number Scale bar = 500 µm. A few selected NMJs are numbered here for convenience 
of viewing.  










Figure 3.5.4 Myonuclei’s intimate relationship with the NMJ (40x magnification). A) 3D image of intact plantaris muscle, stained with α-bungarotoxin 
(green) for AChRs and Hoescht (blue) for nuclei. B) and C) Digitally zoomed  views of A) viewed at different angles for better perception of the NMJ 
structure. Note how nuclei positioning represents the cylindrical myofibres and how NMJ is moulded around subsynaptic nuclei. Images taken on Zeiss 
LSM 780 confocal microscope. All images were taken as a series of z-stacks and combined to create a 3D image. Scale bar = 50 µm. 
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Figure 3.5.5 3D depictions of NMJs highlighting the junctional folds A) Confocal microscopy image of intact plantaris muscle, stained 
with α-bungarotoxin (green) and Hoechst (blue) (40x magnification). B) Super-resolution image of the same NMJ with α-bungarotoxin 
(green) (63x magnification). The intricate arrangements of AChRs making up the junctional folds can be seen in detail at this 
magnification. This arrangement results in the coral-like appearance of the NMJ. A different α-btx stained NMJ from the same section 
displays less intertwined folding than A), shown in C) with confocal microscopy, which includes Hoechst staining (blue) and D) with 
super-resolution microscopy. Imaged on Zeiss LSM 780 confocal microscope with Elyra S1 Super Resolution Platform. All images were 
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Figure 3.5.6 Striation patterns on the NMJ. A)  IHC stained intact plantaris muscle showing a 
topography of α-btx stained NMJs (green) along striated myofibres - seen as dark lines with light 
transmission (Scale bar = 20 µm). B) We noted etched out lines on the surface of NMJs that had 
been imaged with super resolution at 60x magnification (Scale bar = 5 µm). These patterns may be 
coupled to the striations seen on skeletal muscle tissues, as seen in C) 60x magnification super 
resolution image of laminin (red) showing the striations of the myofibre (Scale bar = 10 µm). 
Figure 3.5.7 Damaged NMJs in injured gastrocnemius muscle, 3 days after muscle contusion 
injury (20x magnification). α-Btx stained NMJs (green) - appearing more dispersed in sites closer to 
severely disrupted myofibres with a great influx of nuclei (Hoechst - blue). NMJs suffering extreme 
damage appear flattened white arrows when viewed in longitudinal section; with AChRs dispersed 
along the sarcolemma of its respective myofibre (white arrows). Scale bar = 100 µm. 






Figure 3.6.1 Intact NMJ in en face view. Section from intact plantaris muscle of mouse, not subjected to contusion injury. A) and B) 3D super-resolution 
image of an α-btx stained NMJ at 63x magnification showing the classic coral-like structure typical of the mature NMJ A) in XY view and B) at an angle to 
include Z plane view.  C) 3D render of z-stack images (n = 30) from super-resolution showing surface area and volume measurements. Note: Further 
organisation can be seen in the 3D render view.  





Figure 3.6.2 Injured NMJs in side-long view, 5 days post injury. Section from injured gastrocnemius A) Confocal image at 40x magnification with α-btx 
stained NMJs (green); anti-laminin for the sarcolemma (red) and Hoechst stained nuclei (blue). Two NMJs (1 and 2, red boxes) are positioned on the side 
of longitudinally-sectioned myofibres. NMJs appear long and slim with little or no apparent organisation. Increased nuclei within the region as well as 
centrally located nuclei (white arrows) show recent myofibre regeneration. Scale bar = 50 µm. B) 3D super-resolution images of NMJ 1 and 2 at 63x 
magnification with laminin. Image is inverted view of confocal image. C) 3D Render of z-stacks (n = 91) of 3D image in B), showing surface area and 
volume measurements.  





Figure 3.6.3 Injured NMJs in en face view in border zone, 5 days post injury. Section from injured gastrocnemius muscle. A) Confocal image at 40x 
magnification of α-btx stained NMJs (green); anti-laminin for the sarcolemma (red) and Hoechst stained nuclei (blue). Three en face NMJs (1, 2 and 3, red 
boxes) are visible in the border zone of muscle contusion injury. NMJs appear damaged, particularly NMJ 3, closer proximity of the impact zone. Increased 
nuclei within the region and laminin accumulation (white arrows) indicate myofibre regeneration. Scale bar = 50 µm. B and D) 3D super-resolution images of 
B) NMJ 1 including laminin and D) NMJ 2 and 3, without laminin. NMJ 3 shows fracturing of the structure; however the junctional folds are still evident. Both 
images taken at 63x magnification. D and E) 3D render of z-stacks ((D) n = 52; E), n = 57) from 3D images in B) and D) respectively, showing of surface area 
and volume measurements. The image below A) shows a schematic view of the effect of contusion injury to NMJs in the impact area (yellow) compared to 
tNMJs in the border zone (within purple circle.)  
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Figure 3.6.4 Scattered NMJs in impact area, 7 days 
post injury. Section from injured gastrocnemius A) 
Confocal image at 40x magnification with α-btx 
stained NMJs (green); anti-laminin for the sarcolemma 
(red) and Hoechst stained nuclei (blue). Four scattered 
NMJs (1, 2, 3 and 4, red boxes) are seen in the impact 
area of muscle contusion injury. Increased nuclei 
within the region and laminin accumulation (white 
arrows) indicate myofibre regeneration. Scale bar = 50 
µm. B), D) and F) 3D super-resolution images of B) 
NMJ 1, D) NMJ 2, shown at an angle, and F) NMJs 3 
and 4. All images were taken at 63x magnification. C, E 
and G) 3D render of z-stacks ((C) n = 46; E) n = 93; G) n 
= 27) of 3D images in B, D and F respectively, showing 
of surface area and volume measurements. 
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Figure 3.6.5. Regenerating NMJs in diagonal section, 14 days post injury. Section from injured gastrocnemius A) Confocal image at 40x magnification with α-
btx stained NMJs (green); anti-laminin for the sarcolemma (red) and Hoechst stained nuclei (blue). Two NMJs (1 and 2, red boxes) are positioned on the side of 
diagonally-sectioned myofibres. NMJ 2 displays characteristic moulding of NMJ around the curve of the fibre. Laminin accumulation and increased nuclei 
within the region as well as centrally located nuclei (white arrows) indicate recent myofibre regeneration. B) and D) 3D super-resolution images of NMJ 1 and 
2 respectively , at 63x magnification. Image is inverted view of confocal image. C and E) 3D render of z-stacks ((C) = 102; E) = 104) of 3D images in B) and D) 
respectively, showing surface area and volume measurements. Scale bar = 50 µm. 
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Figure 3.6.6 Other variations of NMJs in en face view, 14 days post injury. Section from injured gastrocnemius muscle. A) 3D super-resolution image 
of α-btx stained NMJs at 63x magnification, 1) showing a denser version of the normal coral-like structure and 2) showing some of the classic 
complex, but also a few straight, far-extending branches. B) 3D Render of z-stacks (n = 89) of 3D image in B), showing surface area and volume 
measurements.  Presence of scattered AChRs indicate NMJ endured some damage from contusion injury. 
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Figure 3.6.7 Injured NMJ in en face view with extended processes, 14 days post injury. Section from injured gastrocnemius muscle. A) 3D 
super-resolution image of α-btx stained NMJ at 63x magnification, showing little of the normal coral-like structure, but rather has straight, far-
extending branches. B) 3D render of z-stack images (n = 53) from A), showing surface area and volume measurements. Presence of scattered 
AChRs indicate NMJ endured some damage from contusion injury. 
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Figure 3.6.8 Tips of regenerating NMJs as section cuts only the superficial layer of sarcolemma, 
14 days post-injury. Section from injured gastrocnemius muscle of A) Confocal image at 40x 
magnification of α-btx stained NMJs (green); anti-laminin for the sarcolemma (red) and Hoechst 
stained nuclei (blue). The superior tips of three NMJs (1, 2, and 3, red boxes), are found in close 
proximity to one another on longitudinally-sectioned myofibres. Laminin deposits; increased nuclei 
within the region; as well as centrally located nuclei (white arrows) indicate recent myofibre 
regeneration. NMJs themselves are faint and show no organisation at 40x view. Scale bar = 50 µm. 
B) 3D super resolution image of NMJs of interest. Increased magnification shows narrow surfaces, 
many of which are not linked. C) 3D super-resolution image showing NMJs and laminin separately 
and merged. D) 3D super-resolution image showing image at an angle for better spatial perception 
of the slim structures. All super-resolution images were taken with 63x magnification. E) 3D render 
of z-stacks (n = 51) of 3D image in B), showing surface area and volume measurements. Image is 
inverted view of super resolution image.  






Figure 3.6.9 Regenerating NMJ in en face view, 14 days post injury. A) Confocal image at 40x 
magnification with α-btx stained NMJs (green); anti-laminin for the sarcolemma (red) and 
Hoechst stained nuclei (blue). Image shows two NMJs (1 and 2, red boxes) spread over the top of 
regenerating, longitudinally sectioned myofibres. NMJ 1 shows regeneration, with clearly visible 
sub-synaptic myonuclei and 2) a thin strip of damaged AChRs reaching across the myofibre. 
Laminin accumulation; a multitude of nuclei and central nuclei (white arrows) indicate this was 
the impact area of the contusion injury. Scale bar = 50 µm. B) 3D super-resolution images of NMJ 
1 and 2, taken at 63x magnification and C) shown at an angle for better spatial perception. D) 3D 
render of z-stacks (n = 83) of 3D image in B), showing surface area and volume measurements. 




Figure 3.6.10 NMJs wrapping around longitudinally sectioned myofibre in regenerating muscle section from border zone, 14 days post injury. Section 
from injured gastrocnemius A) Confocal image at 40x magnification with α-btx stained NMJ (green); anti-laminin for the sarcolemma (red) and Hoechst 
stained nuclei (blue). NMJ has sidelong appearance on the edge of the myofibre, but also has extensions wrapping around the curve of the cylindrical 
myofibre. Laminin build-up and increased nuclei within the region indicate some myofibre regeneration. Scale bar = 50 µm. B) 3D super-resolution image 
of NMJ at 63x magnification. White arrow indicates portion of AChRs of the distal edge of the curved extensions coming back into view, although 
continuity of the structure was not captured in this image. C) 3D render of z-stacks images (n = 28) from B), showing surface area and volume 
measurements. Curved processes were not evident in the 3D images. 
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 Figure 3.8.1 Visualising BrdU
+
 subsynaptic nuclei. 40x magnification of non-injured gastrocnemius, 14 days post injury. Section 
stained with α-btx for NMJs (green), anti-laminin for muscle membrane (red), Hoechst for nuclei (blue): A) with light microscopy; 
B) anti-laminin (red) and α-btx (green); C) α-btx and anti-laminin; D) α-btx, anti-laminin and Hoechst; E) laminin and anti-BrdU 
(orange) (second round of staining) and F) anti-laminin and Hoechst. Scale bar = 50 µm. 
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Figure 3.8.2 Visualising BrdU
+
 subsynaptic satellite cell. 40x magnification of non-injured gastrocnemius, 14 days 
post injury. Top arrow indicates a subsynaptic BrdU+ nucleus enclosed in a pocket of laminin – a satellite cell. A) 
includes light microscopy; B) anti-laminin (red) and α-btx (green); C) α-btx and anti-laminin; D) α-btx, anti-laminin 
and Hoechst; E) anti-BrdU (orange) (second round of staining) and F) anti-laminin and Hoechst. Note:. Arrows mark 
the correlating areas for the slightly magnified BrdU stained image in E). Scale bar = 50 µm. 
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Chapter 4 Discussion  
4.1 Introduction 
To our knowledge, this is the first study to investigate the effect of a muscle contusion injury on the 
morphology of the NMJ. This is important because the reality of peripheral nerve injury includes 
causes other than complete severance of nerve supply and related neurally released factors. The 
data will be discussed within the context of other studies, but it should be noted that similar findings 
may not necessarily be expected. 
 This focus is supported by qPCR analysis of the effect of a muscle contusion injury on the AChR γ- 
and ε-subunit expression. Furthermore, this study touches on visualising SCs located beneath the 
NMJ by means of confocal microscopy.  
4.2 Mouse mass 
Mice were all above 20 g and past the rapid growth phase. Therefore, maturation would not have 
influenced any results in the study. Weight increased steadily, but duration of 28 days post injury 
was required for the growth to be significant.  
The added weight of the mini-osmotic pump increased the mass at sacrifice of all mice in the BrdU 
group by ~ 1.1 g. This contributed towards bigger differences between the mass at injury and mass 
at sacrifice and for these differences to be significant at additional time points of day 3, 7, 10 and 14. 
No decrease in mass resulting from stress of the pump implantation was perceived. 
4.3 AChR-ε mRNA expression 
AChR-ε subunit expression was low in both legs in the groups sacrificed earlier (days 1, 3 and 5) in 
comparison with the later groups (days 7, 10 and 14). This is in agreement with Jianjun et al. (2005) 
who noted a peak in ε-subunits at 7 days post injury in gastrocnemius muscle denervated by an 
intramuscular injection of BoTX30. However, while Jianjun et al. (2005) found the ε-subunit mRNA 
levels returned to normal by 15 days post injury30, our results indicated only a small decrease at day 
10 and not anywhere close to the extent of being back to normal. At day 14 post injury AChR-ε 
subunit mRNA remained high.  
The differences for the slower recovery of ε-subunit mRNA in our study can be due to the nature of 
the injury sustained by the muscle. While Jianjun et al. focused on solely denervating the muscle30 




(BoTx denervates the muscle by inhibiting the release of ACh from the motor neuron31, a muscle 
contusion injury affects both the nerve, NMJ and the muscle fibre. Hence the damage sustained by 
the postsynaptic apparatus and the muscle fibre are sure to contribute to the regeneration time 
course over and above the lack of neurotransmitter and neural stimuli. 
The increase seen in later time points in the non-injured gastrocnemius could be due to factors 
released from the injured limb causing a systemic change sufficient to stimulate AChR-ε subunit 
mRNA synthesis. Jianjun et al. found that ε-subunit mRNA levels in the non-injured muscle of the 
contralateral leg followed the same pattern of the injured muscle30; hence this is not a novel finding. 
The systemic change in response to injury could have included an increase in inflammatory 
molecules and growth factors that could cause upregulation of AChR subunits (in this case the ε-
subunit, but possibly all AChR subunits). Typically muscle injury first follows a path of degeneration 
before inflammation3 hence immune cell released factors appear later. 
In order to determine whether this is a systemic effect, a group of mice that are not subjected to any 
injury in either leg is necessary as a completely negative control. Additionally, it would be interesting 
to compare the AChR subunit expression between the popular method of NMJ damage (nerve 
transection) and this muscle contusion injury model. This can be done by adding one or more groups 
of mice that have undergone a nerve transection of their sciatic nerve and sacrificed at the same 
time point/s as used here. 
 One technical possibility for the difference in both legs between the earlier and later time points 
exists: the samples were run on two different plates for qPCR experiments due to the large sample 
size - days 1, 3 and 5 on the first plate and days 7, 10 and 14 on the second plate. Great 
consideration for this arrangement was given prior to the experiments and, as per procedure, a 
reference sample (in duplicate as per the experiment samples) was added to each plate and CT 
readings were taken during the experiment. The difference of the readings between reference 
samples on each plate was applied to the calculations in order to eradicate any discrepancies 
between the two plates.  
As we used the largest of the qPCR plates (96 well plate) it is not possible to include all samples on 
one plate. Another arrangement of samples that could be used is adding half the duplicated samples 
of each group to one plate (n = 3) and the other half to the other plate. However, the chance that 
this difference was due to a variation between the two plates is highly unlikely as reference samples 
were used and samples treated exactly the same and within 2 hours of one another on the same day 
in the same conditions. 




4.4 Muscle selection and sectioning  
This study employed an injury model familiar to our research group. Our research group has also 
used the BALB/C mouse; the gastrocnemius muscle and the cryopreserving technique in previous 
studies on muscle contusion injury. Longitudinal sectioning is, however, an unexplored technique for 
our research group and this technique was refined in our study in terms of the precise location of 
injury as well as the location and arrangement of the NMJs – also a region of interest previously 
uncharted by our research group. 
4.4.1 Longitudinal Sectioning 
Four factors determine the successful sectioning of a longitudinally orientated muscle sample. 
Firstly, one must identify the orientation of the first sections and be able to adjust the orientation of 
the muscle should fibres appear diagonal- or cross sectioned (see Figure 3.3.1.1). For a large muscles 
like the gastrocnemius, it difficult to section purely longitudinally orientated fibres. Due to its 
enlarged shape, the muscle bulges and hence a single section can include fibres in all three 
orientations. Efforts were made to obtain the largest possible area of longitudinally oriented fibres 
in each case (See Figures 3.3.1.1, 3.3.1.2 and 3.5.3). 
The second factor is to discern between the various causes of damage to the tissue. We found 
freezer damage that produced multiple areas of artefact visible as large unstained areas of water. 
Freezer damage was seen in the practise mice samples and resulted from the suboptimal 
temperature of the isopentane. When the isopentane was cooled to freezing point, the integrity of 
the muscle samples improved. 
Damage from possible thawing and refreezing causes the myofibres to lose their structure and 
normally elongated fibres are seen as fragmented and lacking sarcolemma organisation. H&E 
staining reveals no increase in nuclei; therefore no immune response has occurred as is the case in 
true injured myofibres. 
Damage resulting from the cryo-sectioning blade shows portions of fibres split and crinkled up at the 
ends. This is similar to the phenomenon of the sealing off of the fibre seen in regenerating muscle, 
but H&E staining reveals no accumulation of myonuclei in the areas of artefact. 
True damage resulting from the muscle contusion injury is identified by i) swelling of the myofibre as 
oedema (fluid accumulation) sets in with necrotic fibres; ii) disrupted fibres; iii) large numbers of 
infiltrating immune cells and proliferated SCs (seen as purple stained nuclei in H&E staining); iv) scar 
tissue formation (parenthesis); v) sealing off of torn myofibres; vi) fibrosis and vii) SC activity for the 




repair of damaged fibres and the construction of new fibres (seen in regenerating muscle) (see 
Figure 3.3.2 .1–3.3.2.3). 
Finally, one must consider the ideal thickness of sections for visualising both NMJ and SCs. SC studies 
show best results when muscle is sectioned at ~5 - 10 µm3,84, while NMJ studies used thickness of up 
to 50 µm84,94. In our study, NMJs in initial assessments were better captured in thicker sections of 15 
– 20 µm (see Figures 3.5.2, 3.5.5, 3.5.6). Later work proved a thickness of 10 µm to be sufficient for 
both NMJ and SC visualisation (see Figures 3.8.1 and 3.8.2). 
4.4.2 Selection of muscle 
The gastrocnemius is the largest muscle in the calf muscle complex and lies superficially to its 
synergists. This makes it the best candidate for muscle contusion injury by our specialised apparatus. 
The gastrocnemius is densely innervated along its deep surface by the tibial branch of the sciatic 
nerve27and thus motor endplates may overlap.  
To fully understand location and arrangement of NMJ bands along gastrocnemius muscle in 
longitudinal orientation, it is beneficial to take serial sections of muscle as well as various 
orientations of different samples and view on a basic fluorescent microscope. This practise will 
enable accurate targeting of the location of the NMJs.  Alternatively, use a smaller muscle, i.e. the 
plantaris, soleus or tibialis anterior. These muscles have a smaller fibre area which allows for easier, 
more intact section with more chance of obtaining solely longitudinally orientated myofibres. 
However, our contusion injury model is designed to specifically injure the gastrocnemius muscle. The 
proposed muscles lie beneath the gastrocnemius and are therefore not directly impacted. Hence, 
development of a new technique is necessary in order to assess injury of another muscle. 
The soleus is innervated by the tibial nerve in the same fashion as the gastrocnemius. The long, thin  
tibialis anterior muscle is innervated by the deep peroneal branch of the sciatic nerve and has 
proved to be a useful muscle to study NMJ morphology27. Intact plantaris produced a better quality 
image for method development.  
4.5 Tracing the uptake of BrdU into the regenerating muscle tissue 
and its proximity to the NMJ 
4.5.1 BrdU+ cells increase according to the time lapsed after injury  
As expected, the prevalence of BrdU+ cells within the muscle and adjacent blood vessels increased 
with the number of days post injury. At day 3 and 5, only a small portion of BrdU+ cells were visible 




in the bloodstream and very few BrdU+ were detected along the muscle. In these samples there had 
been less time for blood cells and satellite cells to proliferate in comparison to samples takes at 7 
and 14 days post injury. In the latter, BrdU+ cells occupied the larger proportion in the blood stream 
and were readily detected in the myofibres,  particularly around the sites of injury. This is a good 
representation of the amount of repair work occurring at the sites of myofibre injury. 
BrdU+ cells were also noted in the non-injured samples at day 14 post injury, in similar large 
proportions in the blood stream as the injured muscle as the turnover rate blood cells is high and 
thus cells are constantly dividing and proliferating. In the non-injured myofibres, BrdU+ cells were 
noted in uniform arrangement along the myofibres (see Figure 2.9), indicative of the continual 
maintenance role of the satellite cell in normal muscle tissue. This is in contrast to the clusters of 
BrdU+ cells found in injured muscle samples at the same time point post injury (see Figure 2.10, 
where satellite cells have focused on a particular site on the myofibre. 
4.5.2 Using tile scans as a technique to plot NMJ arrangement and 
determining the location of BrdU+ cells in proximity to the motor end-plate 
Challenges lay in imaging BrdU with α-btx (see Pilot study 3), as well as in locating the innervation 
pattern of the NMJs along the larger gastrocnemius muscle. A method of creating tile scans of the 
entire surface of the section enabled one to relocate NMJs for further imaging and to determine 
NMJ sites to analyse for co-localisation of BrdU+ nuclei. This method allows one to analyse sections 
of larger muscle groups (e.g. the gastrocnemius) as a whole which is especially useful in studies done 
on longitudinally sectioned. 
4.6 NMJ morphology 
Little research has been published on the actual morphological changes of the NMJ following an 
injury (of any nature) and subsequent regeneration.  
Pratt et al. 2013 used an injury model consisting of a series of lengthening contractions to compare 
the morphology of an uninjured wild type NMJ to a) an injured wild-type NMJ; b) an uninjured NMJ 
from a dystrophic mouse (mdx NMJ) and c) an injured mdx NMJ26. This study made use of α-btx 
staining of AChRs to portray the NMJ and images show injured NMJs at 24 hours post-injury. No 
noticeable difference was seen in the injured wild type mouse, but the organization of the mdx NMJ 
severely lacked junctional folds or any sort of organization. 24 hours after muscle lengthening, the 
AChRs of the mdx NMJs aggregated into multiple, unconnected islands26. 




4.6.1 Intact NMJ 
The en face view of the intact NMJ demonstrates the classic coral-like arrangement that NMJs are 
renowned for (see Figure 3.6.1). The super resolution images show that this particular section of the 
NMJ does not contain some of the connecting junctional folds. A 3D render of this sample shows 
smooth edges (in Z plane) and continuity of AChRs on the visible folds of this NMJ. The smooth edges 
demonstrate the mature organization of the AChRs on an intact adult NMJ.  
In comparison, all the NMJs on the injured samples showed a granular appearance along the Z plane 
(see Figures 3.6.2 – 3.6.10). These NMJs are referred to as the injured and regenerating NMJs. The 
majority of these injured and regenerating NMJs show discontinuous and scattered AChRs to various 
extents. It can be concluded that the crush injury had a completely different localised damage than 
induced by a stretch-induced injury. In terms of application, both the models have value.   
4.6.2 Day 5 post injury NMJs 
The sidelong NMJs from the day 5 sample, view A, in Figure 3.6.2, show AChRs arranged in a long 
thin line as NMJs are presented by only one of their folds bordering the sarcolemmal periphery of 
the myofibre. NMJ 1 displays a more scattered version of a Sidelong NMJ than NMJ 2. Increased 
magnification shows beginnings of the superficial NMJ folds (NMJ 2) while the wispy, slightly 
dispersed appearance of (NMJ 1) suggests more damage was incurred to this structure.  
We can presume that NMJ 1 was situated closer to the impact zone and therefore more affected by 
the contusion than NMJ 2. However, both NMJs have maintained their basic level of organization 
implying that this muscle section lay in the border zone of the injury area. 
On the same day 5 sample, in Figure 3.6.3, 3 examples of NMJs could be seen in the en face view, 
also on border zone of Injury. NMJ 1 is located above NMJ 2 and 3 in the confocal image (Panel A). 
NMJ 1’s structure seems robust, but its organization appears as a combination of junctional folds 
and slightly extended processes (Panel B and C). This peculiar organization could be a product of a 
mildly damaged/recovering NMJ. NMJ 1 displays a staggered Z plane surface, characteristic of the 
injured NMJs, but no noticeable scattered AChRs.  
NMJ 2 has maintained a highly complex level of organization although scattered AChR clusters 
appear on either side of the structure (Panel D and E). NMJ 3 has the most fractioned appearance 
implying that damage was severe, although it has maintained perceptible organization of junctional 
folding (Panel D and E). All three NMJs show damage seen by the jagged appearance of the Z axis 
(compare to uninjured sample), especially NMJ 3 with its remarkable fragmentation of the structural 




complex. From this it can be deduced that NMJ 3 lay in closer proximity to the impact zone, although 
not directly in the impact zone as this would have caused more severe scattering of the AChRs (as 
seen in day 7 NMJs) that would not have recovered enough to show any organization within this 
short period of time. Interpretation of images with only some organisation is difficult because it isn’t 
clear if they are damaged to that particular extent, or if regeneration is progressing. This issue is 
partly answered by observations that day 7 NMJs were actually morphologically more severely 
disrupted, suggesting that the process of degradation is still present at 7 days. 
4.6.3 Day 7 post injury NMJs 
Severe fragmentation is seen in all NMJs analysed on the day 7 post injury sample (see Figure 3.6.4). 
The confocal image (Panel A) shows NMJs as faint bodies made up of small collections of AChRs that 
show no organization to resemble a characteristic motor end-plate. 3D super resolution images 
(Panel B, D, and F) and 3D renders (Panel C, E and G) emphasize the fragmentation of the injured 
NMJs. NMJ 2 displays the separation of entire sections of AChRs from the original motor end plate 
(Panel D and E). In NMJ 4, the smallest structure, most AChRs have degenerated completely (Panel F 
and G). 
The fragmented appearance and diminished amount of AChRs indicate that these NMJs were in the 
area that received direct impact from contusion injury and are still in the degenerated stage. 
4.6.4 Day 14 post injury NMJs 
In Figure 3.6.7, the en face NMJ 1 appears to be regrouping its fragments that were separated by 
contusion injury. It is likely that the slight strip of AChRs referred to as NMJ 2 could be fragments 
separated from the main NMJ 1 upon injury, but not completely destroyed. 
Figure 3.6.8 shows the tips of NMJ structures in close proximity to one another, alluding to an 
injured en face NMJ that has been scattered and additionally, sectioned to contain only the 
superficial tips of the end-plate. 
Figure 3.6.5 shows NMJs positioned in diagonally sectioned muscle. NMJ 1 has a vaguely en face 
structure although it has short, spiky processes that extend instead of making junctional folds. The 
confocal image in Panel A shows an influx of nuclei in the region of NMJ 1 and Panel B shows 
fragmented laminin alluding to a damage to the sarcolemma of the myofibre – confirming that this 
area was subjected to serious contusion injury. NMJ 2 represents a true diagonally sectioned NMJ as 
one clearly observes the sharp curving around the periphery of the myofibre in Panel A and D.  The 
3D super resolution image in Panel D also shows scattered laminin, indicating injury while the 3D 




render in Panel E shows scattered AChR deposits – albeit more voluminous in the 3D render - 
confirming the occurrence of an injury to this particular area. The unorganised condition of NMJ 1 
and dispersed NMJs surrounding the area of interest show that this site was the point of impact 
from the contusion injury. 
Figure 3.6.10, contains a NMJ wrapping around the myofibre. While the confocal image in Panel A 
shows the NMJ’s processes/folds curving around the cylinder form of the myofibre, 3D super 
resolution microscopy (Panel B) and the 3D render (Panel C) failed to portray these curved processes 
for closer observation of their structure. A reason for this could be that when taking the 3D image, 
the Z planes containing the curving processes were excluded from the portion of the section imaged 
(insufficient Z-stacks) or that these processes were simply not picked up on the super resolution 
microscopy at the later imaging stages. 
The en face NMJs in Figures 3.6.6 and 3.6.7 demonstrate the morphology of NMJs that are in the 
process of regeneration. Figure 3.6.6 shows robust NMJs with evident junctional folding (Panel A) 
and structural depth (Panel B) – indicating large numbers of AChRs.  
Figure 3.6.7 shows an NMJ with extended processes. This arrangement was not identified in samples 
of intact muscle, leading to the conclusion that this morphology is part of the later response to injury 
- either the NMJ arrangement of folds in this extended manner is part of a premature regenerating 
NMJ or NMJ morphology may have an adaptive response. These possibilities create scope for further 
study involving analysis of numerous NMJs from both injured and uninjured samples to determine 
the occurrence of the arrangement of extended junctional processes. 
4.7 NMJ Surface Area and Volume Measurements using super-
resolution imaging 
Morphological assessments discussed above are open to interpretation and hence provide only a 
qualitative collection of different typical arrangements. Advances is microscopy software, however, 
enable researchers to start quantifying NMJ sizes and shapes. The process of data collection in this 
section of the study was an exploratory venture to harness the power these novel analytical tools for 
quantitative investigation of the NMJ. 
Surface area was measured using the area of each individual NMJ from the super-resolution images 
on Image J software. The Z-stacks of the entire imaged NMJ were combined and underwent 
structured illumination to create a clear, single image for measurements.  




The VGStudioMax 2.2 software combined the number of TIFF files (e.g. 30 z-stacks = 30 TIFF files) to 
render a 3D reconstruction of the individual NMJs. The volume of these 3D renders was then 
measured by the same programme. 
A total of 20 NMJs from 4 gastrocnemius samples (1 intact sample and 3 injured samples at 5, 7 and 
14 days post-injury) were analysed for this section. All measurements discussed here are according 
to Table 3.1. Bar graphs comparing measurements across the time points are seen in Figures 3.9.1 
(surface area) and 3.9.2 (volume). 
4.7.1 Intact NMJ 
The intact NMJ (n = 1 assessed; Z-stacks: n = 30) had a surface area of 96.4 µm2; a volume of 10 726 
µm3; a density of 357 µm3/Z-stack. These acted as a bench mark for the values of the injured NMJs.  
4.7.2 Day 5 post injury NMJs 
In the Side view NMJs from Figure 3.7.2, NMJ 2’s volume is more than double that of NMJ 1 (12748 
µm3 > 5825 µm3). This shows that NMJ 2 has maintained its deeper AChR layers, remaining more 
secure, intact and in place compared to those of NMJ 1. 
In contrast, the en face NMJ 3 from Figure 3.7.3 shows discernible organisation, but lacks continuity 
and depth. Diminished surface area and volume measurements confirm that this NMJ has been 
subjected to a more severe injury in comparison to NMJ 1 and 2 on the same image. This indicates 
that NMJ 3 was closer to the site of impact, although not exactly at the site of impact as - in 
comparison to the scattered NMJs seen at 7 days post-injury – some level of organisation and 
presence of AChRs is still evident.  
The amplified value of en face NMJ 2 (see Figure 3.7.3 and Table 3.1) hints at an exaggerated 
increase in AChR production as seen in the later stages of the PCR analysis of the AChR-ε subunit 
(see Figure 3.2.2). Although the PCR results only show a significant increase in AChR-ε subunit 
production by day 7, one must take into account that the PCR samples comprised of multiple 
sections including many NMJs and there may well be a number of NMJs that have already increased 
their AChR supply. Additionally, as this NMJ is found in the border zone, it may have experienced a 
prematurely accelerated AChR accumulation. The large value of NMJ 2 can be explained by these 
NMJs being present in their section in near entirety, while the other NMJs are only captured in part 
in the section analysed.  




4.7.3 Day 7 post injury NMJs 
The Scattered NMJs’ surface areas (ranging between 25.9 µm2 – 56.8 µm2) were the lowest values 
analysed (excluding the Tip categories for reasons discussed below). The low volumes (NMJs 1, 3 and 
4) represent the diminished numbers of AChRs in these severely damaged structures. 
4.7.4 Day 14 post injury NMJs 
The Tip category NMJs in field of view B – as well as NMJ 2 from field of view A if one considers it 
separately from NMJ 1 - had the smallest surface area, volume and volume/Z-stack values of all 
NMJs measured in this experiment. This highlights that these sections contained only the tip of NMJ 
and therefore AChRs visualized did not occupy a large surface area or any depth of structure. This 
demonstrates the difference between the nature of a scattered NMJ, as seen in day 7 samples, and a 
tip NMJ as discussed here. This was a learning curve to discover that the quantification of Tip NMJs is 
meaningless and can be excluded from future studies. 
The diagonally sectioned NMJ 2 in Figure 3.7. 5 showed a lesser surface area than the en face NMJs 
of day 14, but its volume and volume/Z-stack measurements were analogous with the en face 
values. This illustrates that the NMJ was orientated in the muscle section to be sectioned along its 
narrow side, with the complex arrangement of AChRs residing beneath, not visible in the 2D imaging, 
but clearly visible in 3D analysis. 
Since 3D imaging failed to pick up the curving arms of the wrapped around NMJ in Figure 3.7.10, it is 
not necessary to divulge into further comparisons of this category. 
Surface areas of en face NMJs in the day 14 sample were, on average, higher than the intact NMJ, 
averaging 160.0 µm2. This can be attributed to the increased production of AChR subunits as part of 
the regeneration process, which is elevated in the second week following muscle contusion injury as 
seen Section 4.3.2. 
4.7.5 NMJs with extended processes rather than junctional folding 
The NMJ arranged with multiple extended processes rather than junctional folds in Figure 3.6.7 did 
not differ from its day 14 en face counterparts in surface area and volume, although volume/z-stack 
value was  strikingly high (517 µm3). The similarity in surface area is logical when one takes into 
account that the folding of processes only makes the NMJ arms occupy a shallow area, but does not 
actual make them smaller. This fact also holds true for volume measurements. One can rationalize 
that the stark increase seen when the volume is divided by the number of z-stacks it traverses 
results from the extended processes traversing a smaller Z plane than NMJs that had a more 3D 




structure due to junctional folding. The z-stack number is therefore smaller for the extended NMJ, 
but includes a more complete NMJ than some NMJs with junctional folds that were only captured in 
part. The volume is similar to the en face NMJs with standard junctional folding because the larger 
XY plane measurements of the extended NMJ even though it occupies a less space along the Z plane, 
This extended type NMJ has not been presented in the literature to date and it is worth considering 
that the arrangement of these long extensions rather than detailed folding of their junctional 
processes may be an alternative manner of NMJ regeneration.  
4.8 Effectivity of antibodies tested 
This study used some other techniques that were new to our research group. As we strove to 
visualize the NMJ staining antibody (α-btx) together with the SC staining antibody (BrdU), it was 
important that these two antibodies were both effective on their own and compatible with one 
another. 
4.8.1 α-Btx as a tool to visualize NMJs 
α-Btx proved an excellent tool to identify and visualize NMJs. According to Invitrogen detection 
technologies, 488 is popular because of brightness, pH insensitivity and much greater photostability 
than fluorescein α-bungarotoxin pH-insensitivity82. 
It is important to mention one set back with regards to the α-btx antibody which was the long delay 
in the delivery of the antibody due to recent changes in South African import laws. The resulting 9 
month long wait delayed the commencement of laying the ground work for NMJ location and 
description. This step is crucial as to understand the NMJ’s distribution along the chosen muscle of 
one’s study. 
It is important to identify a damaged NMJ and track progression of recovery before adding any 
interventions. 
Another attractive option is to co-stain the NMJ sections with an antibody against the nerve (e.g. 
against neurofilament) in order to describe the morphology of the nerve in the crush or border zone 
areas of a contused muscle sample. To date staining of the nerve has been used mostly to identify 
neural degeneration and regeneration in muscle subjected to nerve transection27 and there is scope 
for studies on analyses of the nerve following a muscle targeted injury, like the muscle contusion 
injury. 




4.8.2 BrdU as a tool to visualize SCs 
BrdU proved a valuable, but complex tool for visualizing SCs in the regenerating muscle and many 
obstacles arose that compromised the staining success of the anti-BrdU. 
For animal work, the added variables of dose and administration efficacy complicate the quest for 
obtaining identifiable BrdU+ nuclei with the proper IHC techniques – particularly when trouble 
shooting for the nuclear membrane permeabilization step. In addition, this method requires a 
number of practise animals and thus alternative procedures for BrdU troubleshooting should be 
considered. 
Cell culture provided a good platform to test efficacy of the BrdU brands. Therefore I suggest further 
ICC work to clarify a successful method of nuclear depermeabilization and other questions 
concerning the staining and imaging aspects of BrdU analysis. A simpler method to assess efficiency 
of BrdU dose, delivery and circulation in the body is to collect blood smears from the animals since 
white cell proliferation is high. BrdU+ nuclei in the blood stream are abundant and easily visible. 
Concerning administration by injection one could also determine when BrdU effect starts, peaks and 
subsides by taking multiple blood smears from the same animal over a period of time. 
4.8.3 α-Btx and BrdU as tools to visualize NMJs and SCs together 
The nuclear permeabilization step was the truly confounding factor in this project. It required large 
amounts of trouble shooting to obtain clear BrdU immunofluorescence in the muscle sections. Then, 
the severity of our chosen permeabilizing agent - HCl - obliterated the neuromuscular junctions, 
making the goal of visualizing the two counterparts – the NMJ and the SC – together far more 
complicated than originally anticipated. Options to explore include the use of heat to denature DNA 
or digestion by DNAse. Alternatively one could use EdU – a nucleoside analogue of thymidine similar 
to BrdU, but with no need for a nuclear permeabilization step. 
The use of DNAse or heat (or replacing BrdU for EdU to eliminate the nuclear permeabilization step) 
could preserve the α-btx stained AChRs. This is appealing as one could visualize the NMJ and the SC 
together and capture a single image. This reduces the time spent imaging on the microscope and 
creates a more unified picture than the two-step staining procedure. Additionally, this method 
allows us to obtain super-resolution images of the muscle membrane, NMJ, and subsynaptic 
myonuclei as currently our confocal microscope has no laser to detect Hoechst stained nuclei. Super-
resolution images of combined BrdU and AChRs allow for better accuracy in counting subsynaptic 
nuclei as well further exploring the possibilities of quantifying the dimensions of the neuromuscular 
components.  




4.9  Conclusion 
In this study, we successfully induced a standardised skeletal muscle contusion injury in mice using a 
non-invasive technique. We found an increase in adult (ɛ) AChRs in injured as well as non-injured 
mouse gastrocnemius muscle during the second week following muscle contusion injury. This 
indicates that there may be a systemic response to the muscle contusion injury that increases this 
AChR subunit’s mRNA expression, although it is necessary to add a non-injured control group to the 
study to verify this finding. 
We depicted muscle fibres in longitudinal section in a) intact and b) injured skeletal muscle and 
identified NMJs in both of these sections. We effectively administered BrdU to the mice in this study 
by means of mini-osmotic pumps and successfully stained immunohistochemically for and imaged 
BrdU+ cells in the bloodstream (white blood cells) and well as along the myofibres (proliferated SCs). 
We witnessed a considerable increase in BrdU+ nuclei in muscle sections taken at 3, 5, 7 and 14 days 
post injury. We detected BrdU+ myonuclei residing beneath the NMJ confirming that the NMJ is 
indeed an area of SC activity. 
We made use of cutting edge technologies to create interactive tile scan images of the entire 
gastrocnemius muscle section; image NMJs in super-resolution and render 3D NMJ constructs to 
describe and measure intact, damaged and regenerating NMJs. We noted altered morphologies in 
NMJs following muscle contusion injury as well as a trend towards severe reduction in NMJ size 7 
days after the injury event. Thereafter, we observed an increase in NMJ size in regenerating muscle 
at 14 days post injury that exceeded the values of uninjured, intact NMJ. 
This study overcame technical obstacles and laid down foundations to propel future quantitative and 
qualitative research in the largely unexplored field of neuromuscular regeneration. 
 
  





1. MacIntosh B.R., Gardiner P.F., McComas A.J. Skeletal Muscle: Form and Function. 22–48, 257–
270. Human Kinetics (2006). 
2. Hootman, J.M, Macera, C.A., Ainsworth, B.E., Addy, C.L. and Martin, M.B.S. Epidemiology of 
musculoskeletal injuries among sedentary and physically active adults. Med. Sci. Sport. Exerc. 
34, 838–844 (2008). 
3. Kruger, M.J. Antioxidant (OxiproviTM) supplementation and muscle recovery from contusion 
injury – an in vivo study (Thesis). Stellenbosch University (2007). 
4. http://www.kinatex.com/en/CommonProblem/Muscle-injuries-12.html. 
5. Tatsumi, R., Sankoda, Y., Anderson, J.E., Sato, Y., Mizunoya, W., Shimizu, N., et al. Possible 
implication of satellite cells in regenerative motoneuritogenesis : HGF upregulates neural 
chemorepellent Sema3A during myogenic differentiation. American Journal of Physiology - 
Cell Physiology 297 C238-C252 (2009). 
6. Conboy, I.M., Conboy, M.J., Smythe, G.M. and Rando, T.A. Notch-mediated restoration of 
regenerative potential to aged muscle. Science 302, 1575–7 (2003). 
7. Conboy, M.J., Karasov, A.O. and Rando, T.A. High incidence of non-random template strand 
segregation and asymmetric fate determination in dividing stem cells and their progeny. PLoS 
Biol. 5, 1120 – 1126 (2007). 
8. Casio, M. Structure and function of the glycine receptor and related nicotinicoid receptors. J. 
BIiological Chem. 279, 19383–19386 (2004). 
9. Christov, C., Chre´tien, F., Abou-Khalil, R., Bassez, G., Vallet, G., Authier, F., et al. Muscle 
satellite cells and endothelial cells : close neighbors and privileged partners. Mol. Biol. Cell 18, 
1397–1409 (2007). 
10. Ferreira, R., Neuparth, M.J., Ascensão, A., Magalhães, J., Vitorino, R., Duarte, J.A., et al. 
Skeletal muscle atrophy increases cell proliferation in mice gastrocnemius during the first 
week of hindlimb suspension. Eur. J. Appl. Physiol. 97, 340–6 (2006). 
11. Caldas, E. and Araujo, D.A. Adaptation of proof of concepts into quantitative NMR methods : 
Clinical application for the characterization of alterations observed in the skeletal muscle 
tissue in neuromuscular disorders. Univ. Paris Sud (2014). 
12. Gervásio, O.L., Armson, P.F. and Phillips, W.D. Developmental increase in the amount of 
rapsyn per acetylcholine receptor promotes postsynaptic receptor packing and stability. Dev. 
Biol. 305, 262–275 (2007). 
13. Shi, H., Verma, M., Zhang, L., Dong, C., Flavell, R.A. and Bennett A.M. Improved regenerative 
myogenesis and muscular dystrophy in mice lacking Mkp5. J. Clincal Investig. 123, 2064–2077 
(2013). 




14. Hirata, M., Sakuma, K., Okajima, S., Fujiwara, H., Inashima, S., and Yasuhara, M. Increased 
expression of neuregulin-1 in differentiating muscle satellite cells and in motoneurons during 
muscle regeneration. Acta Neuropathol. 113, 451–459 (2007). 
15. Mizunoya, W., Upadhaya, R., Burczynski, F.J., Wang, G. and Anderson, J.E. Nitric oxide donors 
improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm. Am. J. 
Physiol. Cell Physiol. 300, C1065–1077 (2011). 
16. Sakuma, K., Nishikawa, J., Nakao, R., Watanabe, K., Totsuka, T., Nakano, H., et al. Calcineurin 
is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-
2. Acta Neuropathol. 105, 271–280 (2003). 
17. Shinin, V., Gayraud-morel, B., Gomès, D. and Tajbakhsh, S. Asymmetric division and 
cosegregation of template DNA strands in adult muscle satellite cells. Nat. Cell Biol. 8, 677–
687 (2006). 
18. Serrano, L.S., Baeza-Raja, B., Perdiguero, E., Jardí, M., Muñoz-Cánoves, P. Interleukin-6 is an 
essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 7, 33–
44 (2008). 
19. Stratos, I., Zhengdong, L., Herlyn, P., Rotter, R., Behrendt, A., Mittlmeier, T., et al. Vitamin D 
increases cellular turnover and functionally restores the skeletal muscle after crush injury in 
rats. Am. J. Pathol. 182, 895–904 (2013). 
20. Wang, Q. and Mcpherron, A.C. Myostatin inhibition induces muscle fibre hypertrophy prior to 
satellite cell activation. J. Physiol. 590, 2151–2165 (2012). 
21. Bourke, D.L., Wylie, S.R., Theon, A., Bandman, E. Myosin heavy chain expression following 
myoblast transfer into regenerating chicken muscle. Basic Appl. Myol. (1995). 
22. Yang, S.Y., and Goldspink, G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in 
myoblast proliferation and differentiation. FEBS Lett. 580, 2530 (2006). 
23. Reinecke, H., Veronica, P., and Murray, C.E. Skeletal muscle stem cells do not 
transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell Cardiol. 34, 241–249 
(2002). 
24. Cascio, M. Structure and function of the glycine receptor and related nicotinicoid receptors. 
The Journal of Biological Chemistry. 279, 19, 19383–19386 (2004). 
25. Punga, A.R. and Ruegg, M.A. Signaling and aging at the neuromuscular synapse: lessons learnt 
from neuromuscular diseases. Curr. Opin. Pharmacol. 2, 1–7 (2012). 
26. Pratt, S.J.P., Shah, S.B., Ward, C.W., Inacio, M.P., Stains J.P. and Lovering, R.M. Effects of in 
vivo injury on the neuromuscular junction in healthy and dystrophic muscles. J. Physiol. 591, 
559–70 (2013). 
27. Magill, C.K., Tong, A., Kawamura, D, Hayashi, A., Hunter, D.A., Parsadanian, A., Mackinnon, 
S.E., et al. Reinnervation of the tibialis anterior following sciatic nerve crush injury: A confocal 
microscopic study in transgenic mice. Exp. Neurol. 207, 64–74 (2007). 




28. Apel, P.J., Alton, T., Northam, C., Ma, J., Callahan, M., Sonntag, W.E., et al. How age impairs 
the response of the neuromuscular junction to nerve transection and repair: An experimental 
study in rats. J. Orthop. Res. 27, 385–393 (2009). 
29. Ma, J., Shen, J., Garrett, J.P., Lee, C.A., Li, Z., Elsaidi, G.A. et al. Gene expression of myogenic 
regulatory factors, nicotinic acetylcholine receptor subunits, and GAP-43 in skeletal muscle 
following denervation in a rat model. J. Orthop. Res. 25, 1498–1505 (2007). 
30. Ma, J., Shen, J., Tan, K.H., Lee, C.A., Elsaidi, G.A., Smith, T.L., et al. Gene expression of nAChR, 
SNAP-25 and GAP-43 in skeletal muscles following botulinum toxin A injection: a study in rats. 
J. Orthop. Res. 23, 302–309 (2005). 
31. Shen, J., Ma, J., Lee, C.A., Smith, B.P., Smith, T.L., Tan, K.H., et al. How muscles recover from 
paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats. 
J. Orthop. Res. 24, 1128–35 (2006). 
32. Janssen, I., Heymsfield, S.B., Wang, Z., Ross, R.. Skeletal muscle mass and distribution in 468 
men and women aged 18 – 88 yr. J. Appl. Physiol. 89, 81–88 (2000). 
33. Saladin K.S. Anatomy & Physiology: The Unity of Form and Function. 4th edition McGraw Hill 
(2007). 
34. Sanes, J. R. The basement membrane / basal lamina of skeletal muscle. J. Biol. Chem. 278, 
12601–12604 (2003). 
35. Proctor, D.N., O’Brien, P.C., Atkinson, E.J., Nair, K.S. Comparison of techniques to estimate 
total body skeletal muscle mass in people of different age groups. Am. J. Physiol. - Endocrinol. 
Metab. 277, E489–495 (1999). 
36. Zammit, P.S., Partridge, T.A. and Yablonka-reuveni, Z. The skeletal muscle satellite cell : The 
stem cell that came in from the cold. J. Histochem. Cytochem. 54, 1177–1191 (2006). 
37. Zammit, P. S. All muscle satellite cells are equal , but are some more equal than others ? J. 
Cell Sci. 121, 2975–2982 (2008). 
38. Hawke, T.J. and Garry, D.J. Myogenic satellite cells: physiology to molecular biology. J. Appl. 
Physiol. 91, 534–551 (2001). 
39. Lindström, M., Pedrosa-Domellöf, F. and Thornell, L.E. Satellite cell heterogeneity with 
respect to expression of MyoD, myogenin, Dlk1 and c-Met in human skeletal muscle: 
application to a cohort of power lifters and sedentary men. Histochem. Cell Biol. 134, 371–
385 (2010). 
40. Mackey, A. L., Kjaer, M., Charifi, N., Henriksson, J., Bojsen-Moller, J., Holm, L., et al.  
Assessment of satellite cell number and activity status in human skeletal muscle biopsies. 
Muscle nerve 40, 455–465 (2009). 
41. Engelbrecht, L. Grape seed extract affects adhesion competence and maturation of primary 
isolated rat myoblasts after contusion injury (Thesis). Stellenbosch University (2013). 




42. Shefer, G., Rauner, G., Yablonka-Reuveni, Z. and Benayahu, D. Reduced satellite cell numbers 
and myogenic capacity in aging can be alleviated by endurance exercise. PLoS One 5, e13307 
(2010). 
43. Borisov, A.B., Dedkov, E.I. and Carlson, B.M. Differentiation of activated satellite cells in 
denervated muscle following single fusions in situ and in cell culture. Histochem. Cell Biol. 
124, 13–23 (2005). 
44. LeGrand, F. and Rudnicki, M.A. Skeletal muscle satellite cells and adult myogenesis. Curr. 
Opin. Cell Biol. 19, 628–633 (2007). 
45. Wozniak, A.C. and Anderson, J.E. Single-fiber isolation and maintenance of satellite cell 
quiescence. Biochem. Cell Biol. 676, 674–676 (2005). 
46. Rantanen, J., Hurme, T., Lukka, R., Heino, J. and Kalimo, H. Satellite cell proliferation and the 
expression of myogenin and desmin in regenerating skeletal muscle: evidence for two 
different populations of satellite cells. Lab Investig. 72, 341–347 (1995). 
47. Sadeh, M., Czyewski, K. and Stern, L.Z. Chronic myopathy induced by repeated bupivacaine 
injections. J Neurol Sci 67, 229–238 (1985). 
48. Studitsky, A.N. Free auto- and homografts of muscle tissue in experiments on animals. Ann. 
New York Acad. Sci. 120, 789–801 (1964). 
49. Zammit, P.S., Heslop, L., Hudon, V., Rosenblatt, J. D., Tajbakhsh, S., Buckingham, M.E., et al. 
Kinetics of myoblast proliferation show that resident satellite cells are competent to fully 
regenerate skeletal muscle fibers. Exp. Cell Res. 281, 39–49 (2002). 
50. Van Tubbergh, K. Skeletal Muscle Repair after Micro-Damage: Effect of Ice Therapy on 
Satellite Cell Activation (Thesis). Stellenbosch University (2005). 
51. Kummer, T.T., Misgeld, T. & Sanes, J.R. Assembly of the postsynaptic membrane at the 
neuromuscular junction: paradigm lost. Curr. Opin. Neurobiol. 16, 74–82 (2006). 
52. Wurz, J. Why does the body maintain many isoforms of any receptors for any given 
physiological ligand? (Honours Brain Teaser) Stellenbosch University (2013). 
53. Albuquerque, E.X., Pereira, E.F.R., Alkondon, M. and Rogers, S.W. Mammalian nicotinic 
acetylcholine receptors: From structure to function. Physiol. Rev. 89, 73–120 (2009). 
54. Purves, D., Augustine, G.J., Fitzpatrick, D., Hall, W.C., LaMantia, A.S., McNamara, J.O. et al. 
Neuroscience (4th ed.). 122–126 (2008). 
55. Unwin, N. Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J Mol 
Biol. 2005 Mar 4;346(4):967-89. Epub 2005 Jan 25. J. Mol. Biol. 346, 967–989 (2005). 
56. Witzemann, V., Brenner, H.R. and Sakmann, B. Neural factors regulate AChR subunit mRNAs 
at rat neuromuscular synapses. J. Cell Biol. 114, 125–141 (1991). 




57. Court, F.A., Gillingwater, T.H., Melrose, S.H., Sherman, D.L., Greenshields, K.N., Morton, A.J. 
et al. Identity, developmental restriction and reactivity of extralaminar cells capping 
mammalian neuromuscular junctions. J. Cell Sci. 121, 3901–3911 (2008). 
58. Sandrock Jnr, A.W., Dryer, S.E., Rosen, K.M., Gozani, S.N., Kramer, R., Theill, L.E. et al. 
Mainenance of acetylcholine receptors by neuregulins at the neuromuscular junction in vivo. 
Science  276, 599 – 603 (1997). 
59. McCarthy, J.J., Mula, J., Miyazaki, M., Erfani, R., Garrison, K., Farooqui, A.B., et al. Effective 
fiber hypertrophy in satellite cell-depleted skeletal muscle. Dev. and Stem Cells 138, 3657–
3666 (2011). 
60. Kues, W.A., Brenner, H.R., Sakmann, B. & Witzemann, V. Local neurotrophic repression of 
gene transcripts encoding fetal AChRs at rat neuromuscular synapses. J. Cell Biol. 130, 949–
957 (1995). 
61. Gordon, T. The physiology of neural injury and regeneration: The role of neurotrophic factors. 
J. Commun. Disord. 43, 265–273 (2010). 
62. Goldman, D., Brenner, H. R., Heinemann, S., Arbor, A. and Diego, S. Acetylcholine mRNA 
levels Are Regulated by Muscle Activity. Neuron 1, 329–333 (1988). 
63. Macpherson, P.C.D., Wang, X. and Goldman, D. Myogenin Regulates Denervation-Dependent 
Muscle Atrophy in Mouse Soleus Muscle. J. Cell Biochem. 112, 2149–2159 (2011). 
64. Gigo-Benato, D. Russo, T.L., Geuna, S., Domingues, N.R.S.R., Salvini, T.F. and Parizotto, N.A. 
Electrical stimulation impairs early functional recovery and accentuates skeletal muscle 
atrophy after sciatic nerve crush injury in rats. Muscle nerve 41, 685–693 (2010). 
65. Mozaffar, T., Strandberg, E., Abe, K., Hilgenberg, L.G., Smith, M.A., and Gupta, R. 
Neuromuscular Junction Integrity after Chronic Nerve Compression Injury. J. Orthop. Res. 27, 
114–119 (2009). 
66. Tsai, S.W. Tung, Y.T., Chen, H.L., Shen, C.J., Chuang, C.H, et al. Treadmill running upregulates 
the expression of acetylcholine receptor in rat gastrocnemius following botulinum toxin A 
injection. J. Orthop. Res. 31, 125–31 (2013). 
67. Pintér, S., Mendler, L. and Dux, L. Neural impacts on the regeneration of skeletal muscles. 
Acta Biochem. Pol. 50, 1229–1237 (2003). 
68. Sharp, P.S., Dick, J.R.T. amd Greensmith, L. The effect of peripheral nerve injury on disease 
progression in the sod1 ( g93a ) mouse model of amyotrophic lateral sclerosis. Neuroscience 
130, 897–910 (2005). 
69. Nadine, S., Mohammed, A., Gajendran, N., Martinez-Pena, I., Wakefield, S., Thumheer, R., et 
al. Neuregulin/Erb regulate neuromuscular junction development by phosphorylation of 
dystrobrevin. J. Cell Biol. 195, 1171–1184 (2011). 




70. Stratos, I., Graff, J., Rotter, R., Mittlmeier, T. and Vollmar, B. Open blunt crush injury of 
different severity determines nature and extent of local tissue regeneration and repair. Am. J. 
of Pathol. 182 (3), 950–957 (2010). 
71. Tatsumi, R., Sankoda, Y., Anderson, J.E., Sato, Y. , Mizunoya, W., Shimizu, N., et al. Possible 
implication of satellite cells in regenerative motoneuritogenesis : HGF upregulates neural 
chemorepellent Sema3A during myogenic differentiation. Am. J. of Physiol. - Cell Physiol. 297, 
238–252 (2009). 
72. Beiner, J. M. et al. The effect of anabolic steroids and corticosteroids on healing of muscle 
contusion injury. Am. J. Sports Med. 27, 2–9 (1999). 
73. Herbernick, M.A. Contusions. Medscape emedecine.medscape.com/article/88153–overview 
(2013). 
74. Winkler, T., von Roth, P., Matziolis, G., Schumann, M.R, Hahn, S., Strube, P., et al. Time course 
of skeletal muscle regeneration after severe trauma muscle function against the background 
of MRI and histological findings. Acta Orthop. 82, 102–111 (2011). 
75. Guo, B., Cheung, K., Yeung, S. S., Zhang, B. and Yeung, E. W. Electrical stimulation influences 
satellite cell proliferation and apoptosis in unloading-induced muscle atrophy in mice. PLoS 
One 7, e30348 (2012). 
76. Kami, K. & Senba, E. In vivo activation of STAT3 signaling in satellite cells and myofibers in 
regenerating rat skeletal muscles. J. Histochem. Cytochem. Off. J. Histochem. Soc. 50, 1579–
1589 (2002). 
77. Macaluso, F. Ethics Application: A Skeletal Muscle Injury Model for Mice. #2009B02002 
(2009). 
78. Hirata, M., Sakuma, K., Okajima, S., Fujiwara, H. & Inashima, S. Increased expression of 
neuregulin-1 in differentiating muscle satellite cells and in motoneurons during muscle 
regeneration. Acta Neuropath. 82 (1), 451–459 (2007). 
79. Sakuma, K. and Yamaguchi, A. The recent understanding of the neurotrophin’s role in skeletal 
muscle adaptation. J. Biomed. Biotechnol. 2011, 201696 (2011). 
80. Viguie, C. A., Lu, D., Huang, S. and Rengen, H. Quantitative study of the effects of long-term 
denervation on the extensor digitorum longus muscle of the rat. Anat. Rec. 248, 346–354 
(1997). 
81. Shi S.L., Fu, A.K.Y., Ip, N.Y. Molecular mechanisms underlying maturation and maintenance of 
the vertebrate neuromuscular junction. Trends Neurosci. 35, 441–453 (2012). 
82. Molecular ProbesTM Invitrogen Detection Technologies. α -Bungarotoxin and Conjugates: 
Product Information. MP 01175, 1–2 (2005). 
83. Rupp, A., Morrison, I., Barrie, J.A., Halstead, S.K., Townson,K.H., Greenshields, K.N., et al. 
Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and 




complement-mediated injury: An in and ex vivo imaging study in the mouse. Exp. Neurol. 233, 
836–48 (2012). 
84. Deschenes, M.R., Roby, M.A., Eason, M.K. and Harris, M.B. Remodeling of the Neuromuscular 
Junction Precedes Sarcopenia Related Alterations in Myofibers. Exp. Gerontol. 45, 389–393 
(2010). 
85. Yumoto, N., Kim, N. & Burden, S.J. Lrp4 is a retrograde signal for presynaptic differentiation at 
neuromuscular synapses. Nature 489, 438–442 (2012). 
86. Mauro A. Satelite cell of skeletal muscle fibres. J. Biophys. Biochem. Cytol. 9, 493–495 (1961). 
87. Exalpha Inc. In Vitro Labeling with Bromodeoxyuridine. 
https://www.exalpha.com/protocols/brdu–labeling 
88. Magavi, S.S.P. and Macklis, J.D. Identification of Newborn Cells by BrdU Labeling and 
Immunocytochemistry In Vivo. 198, 283–290 (2008). 
89. Sigma Aldrich. BrdU Product Information Sheet. 398, 9285 (1992). 
90. The Office of Environmental Health and Safety Boston University. OEHS policies and 
guidelines: Bromodeoxyuridine (BrdU) treatment 
http://www.bu.edu/orc/files/2013/06/EHS–Brdu_Treat (2008). 
91. Livak K. J., S. T. D. Analysis of Relative Gene Expression Data using Real-time Quantitative PCR 
and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408 (2001). 
92. IHC world H&E staining protocol. www.ihcworld.com/_protocols/special_stains/h&e_el 
93. Chan, R.W. and Gargett, C.E. Development of a label retaining cell method to identify stem 
cells in mouse endometrium. 80, 2004 (2004). 
94. Payne, A.M., Zheng, Z., Messi, M.L., Milligan, C.E., González, E. and Delbono, O. Motor 
neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle. J. Physiol. 
570, 283–294 (2006). 
95. Kuppers, D. Simultaneous cell surface and BrdU staining for flow cytometry. Fero Lab 
http://labs.fhcrc.org/fero/Protocols/BrDUstaining. (2011). 




97. Conboy, I.M., Conboy, M.J., Smythe, G.M. & Rando, T.A. Notch-mediated restoration of 
regenerative potential to aged muscle. Science 302, 1575–7 (2003). 
98. Giordano, C., Rousseau, A.S., Wagner, N. and Gaudel, C. Peroxisome proliferator-activated 
receptor β activation promotes myonuclear accretion in skeletal muscle of adult and aged 
mice. Pflugers Arch - Eur J Physiol 458, 901–913 (2009). 




99. Sellathurai, J., Cheedipudi, S., Dhawan, J. and Schrøder, H. D. A novel in vitro model for 
studying quiescence and activation of primary isolated human myoblasts. PLoS One 8, e64067 
(2013). 
100. Srikuea, R., Zhang, X., Park-Sarge, O.K., Esser, K.A. VDR and CYP27B1 are expressed in C2C12 
cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. 
Am. J. Physiol. - Cell Physiol. 303, 4 C396–C405 (2012). 
 
  




Appendix A PCR sample preparation 
 Section frozen sample 
 Section samples of ± 30 mg and collect in 2ml RNAse-free Eppendorf tube 
 Add 750µl Tri Pure Isolation Reagent 
 Place samples on ice 
(Can freeze down at this step and continue later) 
 Homogenize sample 
 Clean Homogenizer (Kinematica ; Polytron PT2100) with tissue paper and ddH2O (x2). Check 
for protein debris. 
 Allow to  air dry or wash with Tri Pure Reagent if using immediately 
 Place individual tube of sample in beaker of ice to keep cool 
 Homogenise at 30 000 rpm for 3 x 10 sec 
 Wash Homogenizer tip in between samples with ddH2O (x2) 
 Wipe tip with paper towel, check for debris. 
Can leave samples for 1 hour on ice or freeze down at this step 
 RNA Isolation 
 Add 200µl chloroform to each tube 
 Mix by shaking tube 
 Leave for 10min at RT 
 Centrifuge 15min at 12g 
 See 3 layers 
a) Top (clear fluid) – RNA  
b) Middle (whitish layer) – DNA 
c) Bottom (pink fluid) – Protein 
 
 Carefully remove only top RNA layer with pipette and place in fresh RNAse-free 1.5ml Eppendorf 
tube 
 Add equal volume of isopropanol to the same volume of RNA  
 Shake vigorously  
 




 Leave for 10 min at RT 
 Centrifuge for 10min at 12 000 g 
 White pellet should now be visible 
 Ensure pellet is not free to float in fluid (usually stuck on the bottom tube) 
 Gently tip out isopropanol and aspirate the remaining bit out with a pipette  
 Add 400µl 70% Sigma Ethanol 
 Resuspend the pellet by inverting the tube (this washes away any left over isopropanol) 
 Centrifuge for 6min at 8500g – ensure pellet is lying at the bottom 
 Remove the ethanol, leave cap open at RT to evaporate any remaining ethanol (5 – 10min) 
 Pellet should become invisible 
 Add TBE buffer (20 or 30µl, according to size of pellet) – this is now the stock solution 
 Can freeze down or quantify RNA immediately 
  




Appendix B Sample preparation and 
RNA Quantification 
Sample preparation 
 Label small 0.5ml RNAse- free eppendorf tubes accordingly  
 Add 14 µl of RNAse- free H2O at a dilution of1:15, or 19 µl if RNA content is high and need a 
more diluted (more reliable) 1:20 solution. NOTE DILUTION USED. 
  Pipette 1µl of RNA sample into tube and pipette up and down to mix 
 Keep eppendorf tubes on ice 
 Prepare a separate Eppendorf tube of RNAse- free H2O (for cleaning) as well as a solution 
with 1µl of TE buffer in place of sample (as blank) 
Quantification 
Quantify with Nanodrop Lite Spectrophotometer (Thermo Scientific) 
 Lift lid and rinse with a 1µl of H2O sample, repeat. 
 Wipe dry 
 Choose ‘RNA’ option 
 Measure Blank (TE control) 
• Add 4µl of TE close lid and press “Blank” 
• Repeat step to “Confirm” 
 Wipe dry and add same amount of first sample 
 Close lid and press “Measure” 
 Note reading 1 
• RNA reading in ng/µl 
• A260/A280 value 
 Repeat until satisfied with consistent readings (3-5x) 
• Readings should be within 0.03 of each other (values lay between 1.7 – 2.1) 
 Wipe dry and repeat with next sample 
Calculate average of readings for each sample to get RNA concentration 
  




Appendix C Reverse Transcription 
Protocol 
Step 1: Sample preparation 
 1µg mRNA per sample 
 Prepare each sample in duplicate 
 Make up a total volume of 11ul 
1 Add: 
1) 7µl sample 
2) 2µl DNAse buffer 
3) 2µl DNAse enzyme 
2 Incubate for 20 min at 30°C (Applied Biosystems 2720 Thermal Cycler) 
3 Add 0.22µl of 0.2M EDTA 
4 Heat at 75°C for 10min 
5 Place samples on ice. 
Step 2: Reverse Transcription   RNA     →    cDNA 
1. Add 2µl primer (random hexamer primers, Roche ) – therefore 13µl of volume in tube 
2. Heat for 10min at 60°C 
3. Add to solution: 
3.1. 4µl 5x Buffer 
3.2. 0.5µl RT enzyme 
3.3. 0.5µl protector RNAse 
3.4. 2µl DNTP deoxynucleotide triphosphate 
= total volume of 20µl in tube to give a final RNA concentration of 1000/20 = 50ng/µl 
4. Heat for 10min at 25°C and 60 min at 50°C 
5. Heat at 85°C for 5min 
6. Place tubes on ice 
 
  




Appendix D Haematoxylin and Eosin 
Staining Protocol 
Cryo-sections: 
Leave frozen slides in Coplin jar for 3 minutes to thaw 
 
i) Rinse in distilled water (ddH2O) – 2 dips 
ii) Harris haematoxylin – 3 min 
iii) Rinse in ddH2O 
iv) Acid alcohol – 20 dips -4 min 
v) Rinse in ddH2O 
vi) Blue in Scott’s Tap water – 2 dips 
vii) Rinse in ddH2O 
viii) Eosin – 30 s 
ix) Rinse in ddH2O 
x) Mount with a coverslip using DPX Mountant/ mounting media 
 
  




Appendix E Immunofluorescence 
Staining Protocol 
i) Leave slides  to thaw  (if stored in freezer , -4˚C): thaw for 3 min 
ii) Paraformaldehyde (2% in 10x PBS):  incubate for 8 min 
iii) Triton X-100 (0.25%): incubate for 15 min 
iv) Wash with 1x PBS: 3 x 5 min 
v) Dry around section and circle with wax pen 
vi) Denaturing/depurinating step (for BrdU sections only): 
i) HCl 2M : incubate for 30 min (initial work) 
ii) HCl 2M: incubate for 90 min (2013 – best results) 
iii) HCl 4M: incubate for 30 min (2014 – best results) 
iv) Methanol/Acetone 1:1: incubate for 10 min (for BrdU/α-btx sections) 
vii) Wash with 1x PBS: 1 x 10 min; 1 x 5 min 
(First wash longer to neutralize HCl or methanol/acetone) 
viii) Blocking serum (5% Donkey serum and 1% BSA  in 1x PBS) 
ix) Wash with 1x PBS: 3 x 5 min 
x) Primary Antibodies: incubate overnight (5 pm – 8 am) 
a. Laminin (1:250) 
b. BrdU555 (1:20) 
c. BrdU555 (1:20)/ Laminin (1:250) 
d. BrdU555 (1:20)/ CD56 (1:50)/ Laminin (1:250) 
e. fMHC (1:200)/ Dystrophin (1:200) 
xi) Wash with 1x PBS: 3 x 5 min 
xii) Secondary Antibodies: incubate for 1 hr 
a. AlexaFluor594 (1:250)/ α-btx488 (1:1000)  
b. (no secondary antibodies for BrdU555 staining alone) 
c. AlexaFluor594 (1:250) 
d. AlexaFluor488 (1:100)/ AlexaFluor594 (1:250) 
e. AlexaFluor555 (1:200)/ AlexaFluor594 (1:250)/ α-btx488 (1:1000) 
xiii) Wash with 1x PBS  
xiv) Hoechst (1:500): incubate for 15 min 
xv) Wash with 1x PBS: 3 x 5 min 




xvi) Dry and mount with tissue mounting medium 
xvii) Wrap in foil for transport or storage 
 
Briefly, slides were immersed in 4% Paraformaldehyde for 8 minutes followed by 0.1% Triton-X for 
15 minutes. After washing with 0.1M PBS (1 ℓ of 1 M phosphate buffer, 90 g NaCl, 9 ℓ ddH2O; pH 
7.4; 5 minutes x 3 for all the washing steps mentioned) slides were dried, and sections encircled with 
a wax pen. For nuclear permeabilization of BrdU sections, sections were left in 2M Hydrochloric acid 
for 90 minutes followed by another washing step. Non-specific binding sites were blocked by 
incubating the sections with Blocking serum (5 % donkey serum; 1% BSA) at room temperature for 1 
hour. The serum was then washed off and primary antibody added to the slides and incubated at 4°C 
overnight (5pm – 9am). In the morning, slides were washed prior to addition of secondary 
antibodies for 1 hour. After washing, the nuclear stain, Hoechst (1:500) was added and left for 15 
minutes. Slides were dried and fluorescent mounting medium (Dako, Diagnostech) added to allow 
the coverslip to be laid on top. 
Descriptions of antibodies and motivation for using these: 
4 Anti-Laminin: attaches to laminin – the structural protein of the sarcolemma 
5 -Bungarotoxin Alexa488 Conjugate: neurotoxin from bungarus multicinctus snake that targets 
AChRs of the NMJ 
6 Anti-BrdU: attaches to BrdU - labels proliferated nuclei that have incorporated BrdU into their 
DNA 
7 Anti-NCAM: attaches to CD56 (or NCAM) - membrane marker of activated SC (also of Natural 
Killer cells) 
8 Anti-fMHC: attaches to fMHC - indicator of regenerating muscle fibre 
9 Hoechst: standard nuclear stain 
 
  




Appendix F Cell Culture Protocol 
Media: 
1. Proliferation medium (PM)   
1. 440ml Dulbecco’s modified eagles medium (DMEM) 
2. 50ml FCS (10%) 
3. 5mL Penstrep Penicillin/Streptomycin (1%) 
4. 5ml L-glutamine (1%) 
2. Sterile 1x Phosphate buffered saline (PBS) 
3. Trypsin-EDTA 
Cell thawing and proliferating: 
4. Warm up proliferation medium in water bath (37oC) 
5. Add 2 ml warm PM to 15 ml falcon tube 
6. Remove 1 vial of C2C12 cells (1 x 106 cells/1 ml per vial) from liquid nitrogen cell tank 
7. Thaw cells (± 2 min ) 
8. Add cells to falcon tube 
9. Centrifuge (3 min at 1500 r.p.m) 
10. Add 4 ml PM in T25 or 9 ml PM in T75 
11. After centrifugation, Remove supernatant(PM and specifically DMSO- cryoprotectant, but 
toxic to cells) 
12. Resuspend cells in 1 ml PM and add to T25/T75 
13. Incubate for 1 day (T25) or 2 days (T75) 
 
Seeding: 




14. Remove PM from flask 
15. Wash with sterile PBS (sPBS) 
1. ± 8ml (T75) 
2. ± 4ml (T25) 
16. Remove PBS  
17. Add 4ml Trypsin-EDTA (T75) (?2ml for T25) 
18. Incubate (37oC, 4 min) 
19. Add PM (8 ml) in 15 ml Falcon tube 
20. Spin down (3 min, 1 500 R.P.M) 
21. Remove medium 
22. Resuspend pellet in 1ml PM 
23. Count cells (10μl per window on haemocytometer) 
24. Make up resuspended solution of ± 5 000 cells per 500μl PM 
25. Seed in 24 well plates (500μl per well ∴ 5 000 cells per well) 
(Can seed extra in a T25 if necessary to repeat cell staining procedure) 
26. Leave to settle for ± 2 hours in incubator 
27. Add BrdU diluted in PM (final concentration of 10μM per well ) to each well 
 
  




Appendix G Immunocytochemistry 
Protocol  
(Adapted for anti-BrdU AlexaFluor 555 Conjugate from work by Lize Bruwer, Thesis 2013) 
Staining Protocol in wells  
Work on a black box with damp tissue paper in the middle compartment 
When working with BrdU+ cells work in dark conditions (light sensitive) 
Keep all of following items on ice (calculate amounts according to amount of sections to stain and 
size of wells): 
1. Fixative – acetone: methanol (1:1) (in Molecular Lab – work in fume hood) 
2. Blocking – 2% BSA in 10x PBS 
3. BrdU AlexaFluor 555 Conjugate- made up in 10x PBS (made up at optimum concentration, in 
an eppendorf covered in foil – LIGHT SENSITIVE) 
4. Hoechst – 1:1000 made up in 10x PBS (made up at optimum concentration, in an eppendorf 
covered in foil – LIGHT SENSITIVE) 
Methods 
Steps for staining cells in 24 well dish: 
5. Washing x2:  Add 250μl 1x PBS to each well    5 min 
6. Fixing:   Add 250μl acetone:methanol per well    10 min 
7. Washing x3:  Add 250μl 1x PBS to each well    5 min 
8. Blocking:  Add 250μl 2% BSA to each well    1 hour 
9. Pipette blocking solution gently off cells 
DO NOT WASH NOW!  
WORK IN THE DARK FROM THIS STAGE ONWARDS! 




10. Primary ab:  Add 100μl of antibody solution to each well  2 hour RT 
11. Remove by gentle pipetting 
12. Washing x3:  add 250μl 1x PBS     10 min 
13. Remove by gentle pipetting 
14. Hoechst: add 200μl Hoechst solution    10 min 
15. Remove by gentle pipetting 
16. Washing x3:  add 250μl 1x PBS     10 min 
17. Remove by gentle pipetting 
18. Let wells air dry for a few minutes before imaging 
  




Appendix H Antibody combinations 
H.1 Introduction 
Following the complications of staining BrdU and α-btx on the same section, the decision was made 
to image two consecutive sections, one with BrdU, the other with α-btx. Antibodies that would 
complement the study were chosen to be imaged as the fourth frequency in each section - 488 in 
the BrdU stained section and 555 in the α-btx stained section. 
Nuclear membrane marker, CD56 (or NCAM) marks activated satellite cells (K4) was therefore 
chosen to assist in confirming satellite cells in the BrdU-stained section. 
Fetal Myosin Heavy Chain (fMHC) is present in newly formed or regenerating muscle fibres and thus 
distinguishes these from normal adult muscle fibres (K4). We chose fMHC to stain with the α-btx 
sections to help determine whether the NMJs imaged were residing on regenerating fibres or not. 
Table H.1 Antibody Combinations 
Purpose Antibody, Concentration, 
Brand and Catalogue nr 











































Life Technologies A21207 
Donkey 
anti-rabbit 
   



















CD56 (NCAM) (1:50) 

































IH2. Methods  
Two sections per slide were stained in combinations as per Table I.1 according to the IHC protocol in 
Appendix H with adaptations as per Table I.2 
Table H.2 Staining guide for different antibody combinations (for IHC protocol in Appendix E). 
Antibody Combinations Step 6 Step 10 Step 12 
BrdU/CD56/Laminin 6.2 10.4 12.4 
fMHC/α-btx N/A 10.5 12.5 
Images were taken with confocal microscope (Zeiss LSM 780) at 20x and 40x magnification. 
H.3. Results 
CD56 as a complimentary antibody to BrdU 
CD56 was most prominently seen in Natural Killer Cells in blood vessels of the myofibre (see Figure 
I.1). CD56 was successfully visualised in myofibres, fitting the criteria for satellite cell determination 
(see Figure I.2).  However the secondary antibody created crystals resulting in grainy images with too 
much autofluorescence which compromised the search to pinpoint activated satellite cells. 
BrdU staining was unsuccessful and therefore not possible to envision with CD56 stain. 
fMHC as a complimentary antibody to α-btx 
fMHC was successfully imaged with α-btx (see Figure I.3). However, fMHC fluorescence picked up 
many of the sarcolemma structures, questioning the specificity of the antibody. 
H.4 Conclusion 
Due to the unreliability of the AlexaFluor 488 for CD56 staining as well as uncertainties of the fMHC 
antibody’s true positivity, another technique was chosen of of staining sections for α-btx – imaging – 











Figure H.1 Natural Killer cells (white arrows) in the blood stream in the gastrocnemius muscle, 7 days post injury. A) Positive NCAM staining 
(green) in the membrane of the Hoechst stained nucleus (blue) B) NCAM staining the nuclear membrane (40x magnification.) 
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Figure H.2 Satellite Cells (white arrows) in gastrocnemius muscle, 7 days post injury. Satellite cells are indicated by A) and 
D) nucleus (blue) surrounded by B) and E) CD56 stained myonuclei enclosed within C) and F) the sarcolemma, shown by 
laminin staining (red). (40x magnification) 
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Figure H.3 fMHC surrounding the NMJ in injured gastrocnemius muscle sections, 7 days post injury. A) Showing positively stained myofibres (orange) 
with centralised nuclei (blue) (white arrows) confirming myofibre regeneration. B) A 40x magnification showing a damaged NMJ (green) with a 
localisation of fMHC. C) A 3D image at 20x magnification showing NMJs arranged along a number of fMHC+ stained fibres.  
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Appendix I BrdU in vivo Dose Table 
Author, Journal 
& Date 
Species & Age 
(if available) 
BrdU Dose &  
Source (if 
available) 
Time of injections Intervention and time of 
analysis 
Analysis DNA denaturing 
(depurinate) step 
General Protocols 
Fero Lab95  / / 30-100 mg/kg BW 
(0.1mL/gm) 
1-2 hours before 
sacrifice 
 /  / 2.5 N HCl, 37°C 
15min or 0.1N 





 / / 2 mg in 100μl of sPBS 
IP injections daily for 
up to 1 week. 
 Injection a few hours 
before analysis 





 / 1 ml 
concentrated 
reagent per 100 g 
BW 
Life Technologies 
2 hours before 
sampling 











50 mg/kg BW Twice daily  
From postnatal days 
3–8 
 None Tibialis anterior 
6 weeks (42 days) 
2 N HCl for 30 min 
at 37°C 










2days after injury 
2hrs before sampling 
Or 3 days before 
sampling, ie d5 after 
Injections (Notch inhibitor 
/activator/control) 
For SC analysis: pierced 
multiple times with a 23-
Proliferating cells  Not specified 
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adult - 5/7 
months, and 
aged - 23/24 
months 
injury gauge needle 
Tissue response to injury: 
dry ice for 5  
seconds  





30 mg/kg  BW 
Sigma 
Two doses  (4h apart)  
within first 48h after 
muscle injury 





2.5 M HCl for 30 
min 
 
Court et al.57 
J of Cell Science 
2008 
C57Bl/6 Not specified 3 days or 4 days after 
denervation injection 
2.5 μl botulinum toxin type 
A injection 
TS muscle Not specified 
Ferreira et al.10 
Eyr J of Appl 
Physiol.  
2006 
Male CD1 mice 50 mg/kg Once 48hr before 
sacrifice 
 Hind limb suspension  Gastrocnemius  2 M HCl 
30 min at 56°C 
Giordano et al. 98 
Eur J Physiol  
2009 





Daily (9am)  None  Tibialis anterior 
muscles and 
duodenum 
 not specified 
Guo et al.75 
PLoS ONE  
2012 
BALB-C Mice 10mg/ml Daily for 14 days Unloading 
Electrical stimulation 
Proliferating SCs  2 N HCl   
Time not specified 
Hao Shi et al.13  








Once, 24hours after 
injection, 
18hrs before sampling 
Injection of CTx 
50 μl CTX (tibialis anterior) 






 1.5 M HCl  
30 minutes at RT 









 1 h before sampling intramuscular injection - 
bupivacaine 
Tibialis anterior 
and spinal chords 
 Not specified 
Mizunoya et al.15  





100 mg/kg  
Sigma 
Two hours before 
euthanasia 
 Oral administration of 
Nitric oxide donor reagents 
Diaphragm; 
quadriceps; 
triceps surae and 
heart 
 2 N HCl  
1 hour 
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Rats - 10 and 20 
weeks & DWJ 




1 hr before sampling Intramuscular injection - 
bupivacaine 
Tibialis anterior 
4, 6 and 8 days 
post-surgery 
Not specified 
Serrano et al.18 
Cell Metab  
2008 
IL-6−/− mice 30 mg/kg BW 
Sigma 
Daily for 2 days Immobilization of muscle 
via tendon transection  
Plantaris muscle Not specified 
Shinin  et al.17  





25 μg /g (post-
natal growth)  
Or 30µg/g (post 
freeze injury) 
Sigma 
Twice daily for 6 days, 
4-10  weeks of chase 
Or Three times daily 
for 3 days 4-12 weeks 
of chase 
 None  isolated 
myofibres 
 4N HCl (20 
minutes) 
Or cells: 
DNAse I 30 min at 
37 °C  
Stratos et al.19 2 
Am J of 
Pathology 
013 
Male Wistar rats 
300-325 g 
50 mg/kg IP 48h prior to final 
experiments at days 1, 
4, 14, 42 post-injury 
 Muscle crush injury  Soleus Not specified 
 
Wang et al.20  
J of Physiology 
2012 
Male Mstn WT 





48hr; 7 days; and 14 
days 
 
Injections of soluble activin 
receptor 
type IIB or control 
 






DNase I (Roche) 
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Appendix J BrdU in vitro Dose Table 
Author & Journal Cell type & BrdU Source BrdU Dose & Incubation Time DNA denaturing step 
Life technologies 
BrdU Labelling protocol96 
/ 
Life Technologies 
1:100 from concentrate 
37°C for 60 minutes to overnight 
1:1 Denaturing solution from 
Invitrogen BrdU Staining kit 
30 minutes at 37
o
C  
Bourke et al.21 
BAM 
1995 
 myoblasts (unspecified) 
Brand unspecified 
10mM BrdU 
14-16 hours  
Not specified 
Reinecke et al.23  
J Mol Cell Cardiol.  
2002 




0.1 N HCl for 30 min at 37
o
C then 1.5 
N HCl for 15 min at 37°C then 0.1 M 
boric acid for 10 min at RT. 
Sellathurai et al.99 
 PLOS One  
2013 
3 human primary myoblast cultures 
BrdU (Sigma- Aldrich). 
100 µM BrdU 1 hr pulse or 10 µM 
fcumulative BrdU incorporation 
2 N HCL for 30 min  
Serrano et al.18  





1 h at 37ºC prior  
Not specified 
Shinin et al.17  
Nature Cell Biology 
2006 
Isolated myofibres from Myf5nlacZ/+ 
knock-in mice 
BrdU (Sigma, St Louis, MO) 
0.2µM BrdU  
48 hrs - replaced with new BrdU for 
chase (18-16hrs) 
2000U DNAse I (Roche, Basel, 
Switzerland) per 2–5 × 10
5
 cells 
30 min at 37 °C 
Srikuea et al.100 
AJP – Cell Phys 
2012 
C2C12 cmyoblasts 
BrdU (Sigma)  
10 µM 




Tatsumi et al.71  
AJP-Cell Phys  
2009 
Cultured SCs isolated from muscle 
groups 9-mo-old (adult) male 
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